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ABSTRACT 
 
 
 The various uses of antibiotics in feedlot cattle have been a concern as a potential source of 
antibiotic resistant Salmonella infections in humans. A 26-day randomized controlled 
longitudinal field trial was undertaken to assess the effects of injectable ceftiofur crystalline-free 
acid (CCFA) versus in-feed chlortetracycline (CTC) on the temporal dynamics of Salmonella 
enterica subsp. enterica in feedlot cattle. Two replicates of 8 pens (total of 176 steers) received 
one of 4 different treatment regimens. All, or one, out of 11 steers were treated with CCFA on 
day 0 in 8 pens, with half of the pens later receiving three 5-day regimens of CTC. We isolated 
Salmonella from fecal samples, and antimicrobial susceptibility was assessed. Salmonella in the 
feces were quantified with probe real-time qPCR targeting invA gene and by direct spiral plating 
on brilliant green agar. Whole-genome sequencing was performed for all Salmonella isolates to 
analyze serotype, resistance genotype, MLST, and to explore the phylogenetic relations of the 
isolates. 
 The mean Salmonella prevalence was 75.0% on day 0, and most isolates were 
pansusceptible to 14 antibiotics. Both CCFA and CTC reduced the overall prevalence of 
Salmonella; however, these treatments increased the proportion of multi-drug resistant (MDR) 
Salmonella. Ceftriaxone and tetracycline resistant Salmonella were detectable in day 0 samples, 
suggesting that resistant Salmonella existed in the population before antibiotics use. The quantity 
of resistant Salmonella remained at approximately 103 CFU / gram of feces throughout the study. 
Significantly (P < 0.05) more animals were detected with resistant Salmonella following 
antibiotic treatments. Among the six serotypes detected, all S. Reading isolates were MDR and 
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carrying an IncA/C2 plasmid, suggesting a strong association between serotype and resistance 
type. The S. Reading isolates consisted of 2 phylogenetic clades with differential selection by 
CCFA versus CTC (alone). Our study demonstrated that the selection pressures of a 3rd 
generation cephalosporin and of CTC during the cattle feeding period selects for antibiotic 
resistant Salmonella and increases the proportion of cattle carrying resistant Salmonella, even 
after the treatment period ends. Further investigations are needed to assess whether an extended 
feeding period of 150 days provides a sufficient ‘wash-out’ period for the gut microbiota to 
return to normal status.  
 
 iv 
DEDICATION 
 
In memory of my best friend Fumiki Ui.  
 
 
 
 v 
ACKNOWLEDGEMENTS 
I would like to thank my committee chair, Dr. H. Morgan Scott, who has believed in me 
and guided me throughout my PhD research. I am fortunate and honored to have had him as my 
advisor. I thank him for believing in me, for giving me the opportunity to work with him, for 
being patient with me, and for not giving up on me. I could not have completed my PhD program 
without his guidance and pursued my dreams. I thank Dr. Keri Norman for her support and 
guidance, and especially for patiently correcting my writing. I also would like to thank my other 
committee members, Dr. Sara Lawhon for sharing her knowledge, love, and passion for 
Salmonella. Thank you to Dr. Guy Loneragan for sharing his expertise in feedlot cattle and 
Salmonella. I also thank Dr. Hendrik den Bakker for his expertise in bioinformatics and his 
guidance towards the analysis.  
Thanks also go to Dr. Barbara Gastel, Ms. Callie Rainosek, and the Specific Aims group 
for correcting and editing my writing. I also thank Dr. Michael Dickens from the Texas A&M 
High Performance Research Computing for consulting on the bioinformatics analysis.  
Great thanks go to Dr. Javier Vinasco for his technical support in the lab. His creativity to 
come up with efficient methods helped us to process a large number of samples in a short time. 
Thank you, Ms. Roberta Pugh, for managing the lab, ordering, and for organizing regular 
celebrations and lab socials to overcome the tough life of a graduate student! I would like to 
thank all my lab colleagues and student workers who shared their busy time by helping me with 
the sample processing.  
My great thanks go to my special friends Maribel Leon and Selma Gonzalez. Their 
heartwarming encouragement and the time we spent together will be in my heart forever. Their 
continuous love and support are among the best things that I have received in my life.  
 
 vi 
Finally, I thank my mother, father, sister and her family for their support and 
encouragement. 
 
 
 vii 
CONTRIBUTORS AND FUNDING SOURCES 
 
This research received financial support from USDA-NIFA-AFRI (formerly CSREES; 
grant numbers 2008-35201-30235 and 2008-35201-04682) entitled: “Novel pre-harvest 
interventions to protect antimicrobials of critical importance in human and veterinary medicine” 
for the cattle field trial, while the subsequent phenotypic analysis was funded by USDA-NIFA-
NIFSI (grant number 2010-51110-21083) entitled: “Practical interventions to effectively manage 
antibiotic resistance in beef and dairy cattle systems: a fully integrated approach.” Any opinion, 
findings, conclusions, or recommendations expressed in this publication are those of the authors 
and do not necessarily reflect the view of the U.S. Department of Agriculture.  
Whole-genome sequencing of Salmonella isolates by Illumina MiSeq was funded by the 
National Cattlemen’s Beef association, a contractor to the Beef Checkoff. Whole-genome 
sequencing of Salmonella by Oxford Nanopore MinION was funded by College of Veterinary 
Medicine Graduate Student Core Facility Experiential Learning Program Funds.  
The publication of Chapter III “Population dynamics of enteric Salmonella in response to 
antimicrobial use in beef feedlot cattle” in open access journal Nature: Scientific Reports was 
supported by OAKFund by Texas A&M University libraries.  
Portions of this research were conducted with the advanced computing resources and 
consultation provided by Texas A&M Performance Research Computing. 
This work was supported by a dissertation committee consisting of Professor H. Morgan 
Scott, Professor Sara D. Lawhon of the Department of Veterinary Pathobiology, Professors Keri 
N. Norman of the Department of Veterinary Integrative Biosciences, Guy H. Loneragan of the 
Department of Animal & Food Sciences at Texas Tech University, and Hendrik den Bakker of 
 
 viii 
the Center for Food Safety at University of Georgia. All work for the dissertation was completed 
independently by the student. 
Graduate study was supported by a graduate assistantship and a Lechner Scholarship 
from Texas A&M University. 
 
 
 ix 
TABLE OF CONTENTS 
                      Page 
 
ABSTRACT ............................................................................................................................... ii 
DEDICATION ........................................................................................................................... iv 
ACKNOWLEDGEMENTS ........................................................................................................ v 
CONTRIBUTORS AND FUNDING SOURCES ...................................................................... vii 
TABLE OF CONTENTS ........................................................................................................... ix 
LIST OF FIGURES .................................................................................................................. xii 
LIST OF TABLES .................................................................................................................. xvii 
CHAPTER I  INTRODUCTION................................................................................................. 1 
1.1 Background ................................................................................................................. 1 
1.2 Study objectives .......................................................................................................... 6 
CHAPTER II LITERATURE REVIEW ...................................................................................... 7 
2.1 Antibiotic resistance as public health issue .................................................................. 7 
2.2 Feedlot operations and antibiotic use ........................................................................... 7 
2.3 Salmonella description .............................................................................................. 15 
2.3.1 Salmonella taxonomy ................................................................................. 15 
2.3.2 Host relation of Salmonella ........................................................................ 16 
2.3.3 Salmonella infection ................................................................................... 16 
2.4 Methods for identification and characterization of Salmonella ................................... 19 
2.4.1 Isolation methods for Salmonella ............................................................... 19 
2.4.2 Typing of Salmonella ................................................................................. 22 
2.4.3 Antimicrobial susceptibility testing and genotyping of resistance genes in 
Salmonella ................................................................................................. 33 
2.5 Salmonella epidemiology and antibiotic resistance in humans and cattle .................... 37 
2.5.1 Salmonella epidemiology in humans .......................................................... 37 
2.5.2 Antibiotic resistant Salmonella in humans .................................................. 38 
2.5.3 Salmonella epidemiology and antibiotic resistance in feedlot cattle ............ 40 
2.5.4 Comparison of resistant bacteria in human and animal populations ............ 45 
2.6 Control of Salmonella ................................................................................................ 46 
2.7 Antibiotics and Antibiotic Resistance Mechanisms .................................................... 53 
2.7.1 Antibiotics and antibiotic resistance ........................................................... 53 
2.7.2 Cephalosporins and their resistance mechanisms ........................................ 54 
2.7.3 Transmission of cephalosporin resistance via blaCMY-2 gene ....................... 58 
2.7.4 Tetracycline and resistance mechanism ...................................................... 62 
 
 x 
2.7.5 Effect of ceftiofur on Salmonella and E. coli in feedlot cattle ..................... 64 
2.7.6 Effects of chlortetracycline and ceftiofur on E. coli in feedlot cattle ........... 71 
2.7.7 Therapeutic and subtherapeutic CTC on Salmonella and E. coli in cattle 
and pigs ...................................................................................................... 74 
2.8  Strategies to tackle antimicrobial resistance derived from animal ............................... 80 
2.8.1 Precautionary principle (Ban the growth promoter use) .............................. 80 
2.8.2 Judicious use principles in the United States ............................................... 83 
2.9 Summary of literature review .................................................................................... 84 
CHAPTER III POPULATION DYNAMICS OF ENTERIC SALMONELLA IN RESPONSE   
TO ANTIMICROBIAL USE IN BEEF FEEDLOT CATTLE* ................................................. 87 
3.1 Introduction ............................................................................................................... 87 
3.2 Materials and Methods .............................................................................................. 90 
3.2.1 Experimental design ................................................................................... 90 
3.2.2 Salmonella isolation from fecal samples ..................................................... 93 
3.2.3 Antimicrobial susceptibility testing ............................................................ 96 
3.2.4 Salmonella DNA extraction for whole-genome sequencing ........................ 98 
3.2.5 Whole-genome sequencing by Illumina MiSeq........................................... 99 
3.2.6 Illumina Sequencing data analysis ............................................................ 100 
3.2.7 Statistical analysis .................................................................................... 101 
3.2.8 Data Availability ...................................................................................... 102 
3.3 Results..................................................................................................................... 103 
3.3.1 Descriptive statistics of Salmonella among fecal samples of feedlot     
cattle ........................................................................................................ 103 
3.3.2 Descriptive statistics of Salmonella isolates resistant to antibiotics ........... 103 
3.3.3 Mixed effects logistic regression model of Salmonella prevalence and    
MDR Salmonella prevalence .................................................................... 105 
3.3.4 Identification of serotypes and MLST ...................................................... 108 
3.3.5 Associations of phenotypic antimicrobial resistance profile and    
serotypes of Salmonella............................................................................ 111 
3.3.6 Serotype pattern per individual animal ..................................................... 113 
3.4 Discussion ............................................................................................................... 117 
CHAPTER IV QUANTITATIVE DYNAMICS OF SALMONELLA IN FECES OF      
FEEDLOT CATTLE TREATED WITH CEFTIOFUR AND CHLORTETRACYCLINE ....... 126 
4.1 Introduction ............................................................................................................. 126 
4.2 Materials and Methods ............................................................................................ 130 
4.2.1 Experiment design and sample collection ................................................. 130 
4.2.2 Broth enrichment method for Salmonella detection .................................. 131 
4.2.3 Quantification of Salmonella by colony counting ..................................... 131 
4.2.4 Hydrolysis probe quantitative real-time PCR (qPCR) ............................... 133 
4.2.5 Statistical Analysis ................................................................................... 137 
4.3 Results..................................................................................................................... 138 
4.3.1 Descriptive statistics of broth enrichment, qPCR, and spiral plating 
methods.................................................................................................... 138 
 
 xi 
4.3.2 Comparison of the quantity by qPCR and direct plating on BGA-plain, 
BGA-tet, and BGA-cef ............................................................................. 146 
4.3.3 Effects of antibiotic treatments on quantifiable levels of Salmonella......... 154 
4.3.4 Modelling the effects of antibiotics on quantity dynamics ........................ 169 
4.4 Discussion ............................................................................................................... 190 
4.4.1 Detection methods .................................................................................... 190 
4.4.2 Quantification by qPCR vs. direct spiral plating ....................................... 192 
4.4.3 Effects of antibiotics on the quantity of Salmonella .................................. 194 
4.4.4 Imputation of missing values .................................................................... 199 
4.5 Summary and conclusion of Chapter IV .................................................................. 201 
CHAPTER V GENOMIC COMPARISON AND CHARACTERIZATION OF      
SALMONELLA ENTERICA ISOLATED FROM FEEDLOT CATTLE TREATED WITH 
CEFTIOFUR AND CHLORTETRACYCLINE ...................................................................... 203 
5.1 Introduction ............................................................................................................. 203 
5.2 Materials and Methods ............................................................................................ 204 
5.2.1 Study design and Salmonella isolation...................................................... 204 
5.2.2 Salmonella DNA extraction for whole-genome sequencing ...................... 205 
5.2.3 Whole-genome sequencing by Illumina MiSeq and de novo assembly...... 206 
5.2.4 Whole-genome sequencing by Oxford Nanopore MinION ....................... 207 
5.2.5 Serotype, MLST, resistant genes, and plasmids determination .................. 207 
5.2.6 Assembly of MinION data and Illumina short reads ................................. 208 
5.2.7 Core-genome alignment, single nucleotide polymorphism (SNP)     
analysis and phylogenetic tree construction .............................................. 208 
5.2.8 Validation of WGS based serotyping with traditional serotyping .............. 209 
5.2.9 Statistical analysis .................................................................................... 209 
5.3 Results..................................................................................................................... 210 
5.3.1 Description of studied population from prevalence study .......................... 210 
5.3.2 Descriptive statistics of WGS assembly results ......................................... 212 
5.3.3 Oxford Nanopore MinION and Illumina short reads assembly .................. 215 
5.3.4 Antimicrobial Resistant genes and plasmids ............................................. 215 
5.3.5 IncA/C2 Plasmids from S. Reading .......................................................... 219 
5.3.6 Phylogenetic relation of all isolates by core-genome SNPs with      
publicly obtained sequences ..................................................................... 226 
5.3.7 Salmonella Reading core-genome analysis ............................................... 230 
5.3.8 Salmonella Mbandaka phylogenetic analysis ............................................ 238 
5.3.9 Salmonella Kentucky phylogenetic analysis ............................................. 240 
5.3.10 Salmonella Give phylogenetic analysis ..................................................... 244 
5.3.11 Salmonella Montevideo ............................................................................ 248 
5.4 Discussion ............................................................................................................... 250 
CHAPTER VI SUMMARY, CONCLUSIONS, AND FUTURE DIRECTION ....................... 262 
REFERENCES ....................................................................................................................... 264 
 
 
 xii 
LIST OF FIGURES 
                          Page 
Figure 1. Beef cattle operation system ......................................................................................... 9 
Figure 2. Schematic illustration of Salmonella infection ............................................................ 18 
Figure 3. Ceftriaxone-resistant Salmonella from food-animals .................................................. 45 
Figure 4. Schematic illustration of b-lactamases according to the Ambler classification 
scheme ....................................................................................................................... 57 
Figure 5. Bayesian consensus phylogenetic tree of Citrobacter freundii AmpC allele. ............... 61 
Figure 6. Study design.  Four pens were allocated to each treatment over two replicates ........ 92 
Figure 7. Trek Sensititre® CMV3AGNF plate design ............................................................... 98 
Figure 8. Library preparation workflow with Nextera XT library preparation kits ................... 100 
Figure 9. Total number of isolates and proportion of MDR isolates per day and treatment 
group ....................................................................................................................... 105 
Figure 10. Modelled marginal mean prevalence of Salmonella by day and treatment       
group. Modelled marginal mean prevalence of Salmonella and 95%        
confidence intervals in cattle fecal samples by sample day and treatment     
group. ...................................................................................................................... 106 
Figure 11. Modelled marginal mean prevalence of MDR Salmonella by day and treatment 
group. ...................................................................................................................... 108 
Figure 12. Number of Salmonella enterica isolates within serotypes by treatment group and 
sample day. Six serotypes (Anatum, Give, Kentucky, Mbandaka, Montevideo, and 
Reading) were found among tested fecal samples ..................................................... 110  
Figure 13 Distribution of Salmonella enterica isolates within serotypes by replicate and day  
of sampling across all treatment groups .................................................................... 111 
Figure 14. Total number of animals harboring each serotype pattern across all sampling   
days. Serotype patterns were clustered per treatment group across different  
sampling days. ......................................................................................................... 115 
Figure 15. Salmonella serotypes detected per individual animal per day and treatment      
group ....................................................................................................................... 116 
Figure 16. Illustration of E-Mode 50 µl spiral plating and methods for colony counting .......... 132 
 
 xiii 
Figure 17. Figure on the left is the presumptive Salmonella colonies grown on Brilliant    
Green Agar (BGA). Figure on the right is the same plate shown on the Flash &  
Go® colony counter. ................................................................................................ 133 
Figure 18. Example of the standard curve regression plot amplified from template genomic 
DNA of Salmonella enterica Typhimurium targeting the invA gene. ........................ 139 
Figure 19 Number of samples detected by broth enrichment, probe qPCR, and direct spiral 
plating methods shown in a Venn diagram out of 1,040 samples tested in total by 
each of the three methods ......................................................................................... 142 
Figure 20 Detection pattern of individual cattle by treatment group and detection methods. 
Each row represents an individual steer with pen and animal identifier .................... 143 
Figure 21. Linear prediction line and scatter plot of quantities of log10 invA genes via     
qPCR and log10 CFU on BGA-plain agar. (a) Including samples detected with 
either method (n=386), (b) Only samples detected with both methods (n=190). .... 148 
Figure 22. Quantity differences of qPCR and BGA-plain agar counts. (a) Quantity 
differences of qPCR and BGA-plain agar. BGA-plain agar was subtracted from 
qPCR. (b) Linear prediction of log10 invA qPCR by rounded log10 CFU of direct 
plating ..................................................................................................................... 149 
Figure 23. Distribution of mean quantity of invA gene copies that was detected with qPCR.  
(a) Over all distribution. (a) was further breakdown into those detected only with 
qPCR (yellow) and broth enrichment (gray) in (b). (b) was further broken down     
in (c). ....................................................................................................................... 151 
Figure 24. Growth of Salmonella on brilliant green agar (BGA), BGA-tetracycline          
(BGA-tet), and BGA-ceftriaxone (BGA-cef) from PBS diluted fecal samples. ......... 154 
Figure 25. Proportion of animals with Salmonella shedding at levels over the limit-of-
quantification (LOQ) by direct plating. .................................................................... 156 
Figure 26. Observed quantity of susceptible, tetracycline, and ceftriaxone resistant   
Salmonella by antibiotic treatments by day. ............................................................. 158 
Figure 27 Frequency of animals per number of serotypes detected in one animal by    
treatment groups. ..................................................................................................... 163 
Figure 28 (a) Serotype and invA gene quantity, (b) number of serotypes detected per animal 
and invA gene quantity, (c) and (d) Serotypes detected from animals and growth     
on BGA-tet and BGA-cef. ........................................................................................ 164 
Figure 29. Description of overall population per treatment pens by detected serotypes per 
sampled days (0, 4, 8, 14, 20, and 26) and quantity of Salmonella per gram feces   
by direct plating and invA qPCR for 176 steers tested in this study. .......................... 165 
 
 xiv 
Figure 30 Distribution of log10 invA gene copies from observed data. (a) Overall      
distribution of log10 invA gene copies per gram feces. .............................................. 171 
Figure 31. Distribution of 16s rRNA standardized log10 invA gene copies from observed  
data. ......................................................................................................................... 172 
Figure 32. Histogram and Kernel density of observed and imputed data. (a) Observed data 
(red) and imputed data from 8 imputations (other lines), X-axis is log10 invA gene 
copies and Y-axis is density. (b) Distribution of observed (red) and represented 
imputed data (yellow) .............................................................................................. 173 
Figure 33. Distribution of log10 invA gene copies before (a) and after (b) interval censored 
regression per missing value groups. (a) is with missing value 0 and (b) is after 
imputation. .............................................................................................................. 174 
Figure 34. Distribution of log10 invA gene copies per gram feces per treatments before (a)   
and after imputation (b). ........................................................................................... 175 
Figure 35. Distribution of log10 invA gene copies per gram feces by treatments and day      
from (a) observed and (b) imputed data. ................................................................... 176 
Figure 36. (a) Distribution of rounded log10 invA gene copies per gram feces and (b)  
modelled margins prediction of invA quantity by zero-inflated Poisson regression 
with 95% CI. (c). Distribution of 16s standardized rounded log10 invA gene   
copies per gram feces and (d) modelled prediction of invA by zero-inflated 
Poisson regression 95% CI...................................................................................... 178 
Figure 37. Modelled margins prediction with single imputed data (a) and 20 multiple 
imputed data (b) for log10 invA gene copies per gram feces by treatments and   
days with 95% CI. 95% CI is not shown in multiple imputed data because of the 
limitation of the mimrgns program to predict accurate values ................................... 181 
Figure 38. Distribution of 16s standardized invA +10. (b) Mixed linear regression model    
with observed value. (c) imputed 16s standardized invA (+10) log10 gene copies    
per gram feces. (d) Mixed linear regression model with imputed value..................... 182 
Figure 39. Histogram of log10 CFU per gram feces counted on BGA (a) before and (b) after 
imputation. ............................................................................................................... 184 
Figure 40. Distribution of log10 CFU per gram feces per individual antibiotic treatment from 
(a) observed and (b) imputed data by treatments. Missing value was given a      
value 1, which are shown as 0 after log10 transformation .......................................... 185 
Figure 41. Distribution of log10 CFU per gram feces by treatment and day from (a) observed 
and (b) imputed data ................................................................................................ 186 
 
 xv 
Figure 42. (a) Distribution of rounded integer log10 CFU per gram of feces and (b) zero-
inflated Poisson regression on observed log10 CFU per gram feces from direct 
plating on BGA. ....................................................................................................... 188 
Figure 43. (a) Multilevel mixed linear regression model with representative imputed log10 
CFU per gram of feces from direct plating on BGA and (b) multiple imputation 
multilevel mixed linear regression model with data from all 20 imputations. ............ 189 
Figure 44. Numbers of Salmonella isolates detected per treatment group, serotype,                
and day .................................................................................................................... 211 
Figure 45. Descriptive statistics of de novo assemblies by serotype and presence of     
plasmids. Total length of de novo assembled Salmonella genome by serotypes     
and plasmids. ........................................................................................................... 214 
Figure 46. Circular map representation of the IncA/C2 plasmid derived from S. Reading 
hybrid-assembled by MinION and Illumina sequencing and visualized with DNA 
Plotter. ..................................................................................................................... 220 
Figure 47. Dotplot analysis of S. Reading derived IncA/C2 and pSN254b (left),           
pSAN1-1736 (CP014658.1) (middle), and pAM04258 (FJ621587.1) (right). ........... 222 
Figure 48. Comparison of plasmids assembled from Illumina reads with plasmidSPAdes     
and Illumina&MinION. The inner arrowed circle in brown is the forward and 
reverse reads of the Illumina&MinION assembled contig_04 (reference genome)     
 ................................................................................................................................ 225 
Figure 49. Spider tree of 568 isolates (6 serotypes) from this study, and 32 NCBI sequences 
from the same 6 serotypes, and other common serotypes analyzed by core-genome 
SNP analysis ............................................................................................................ 228 
Figure 50. Maximum-likelihood tree of Salmonella enterica including two representative 
isolates from each of the 6 serotypes identified in this study, publicly available 
sequences from the 6 representative serotypes, and other common serotypes 
analyzed by core-genome SNP alignment with Parsnp ............................................. 229 
Figure 51. Epidemiologic curve of Salmonella Reading newly detected infections .................. 230 
Figure 52. Maximum likelihood tree of core-genome SNPs of S. Reading with publicly 
available S. Reading contigs analyzed with Parsnp and visualized with FigTree. ...... 232 
Figure 53. Maximum likelihood tree of S. Reading by core-genome SNP alignment (left)    
and corresponding isolate data per animal, treatment, replicate, and pen (right) ........ 234 
Figure 54. Distribution of phylogenetic Clusters 1a, 1b, and 2 by treatment group among     
the 88 S. Reading isolates. ........................................................................................ 235 
Figure 55. SNP differences identified in the modC gene between Cluster 1 and Cluster 2. ....... 237 
 
 xvi 
Figure 56. Maximum likelihood phylogenetic tree of S. Mbandaka isolates ............................. 239 
Figure 57. Maximum likelihood phylogenetic tree of S. Kentucky isolates. S. Kentucky    
core-genome was aligned using CVM 29188 (ST152) as a reference genome .......... 242 
Figure 58. Phylogenetic analysis of Salmonella Kentucky from this study aligned with    
Parsnp (left) and corresponding table of isolates per replicate, treatment group,   
day, and animal (right). ............................................................................................ 243 
Figure 59. Salmonella Give core-genome phylogenetic tree including publicly available 
sequence data. .......................................................................................................... 245 
Figure 60. Phylogenetic maximum likelihood tree of S. Give from our study .......................... 246 
Figure 61. Visualized SNPs of S. Give within the sampled population..................................... 247 
Figure 62. S. Montevideo phylogenetic maximum likelihood tree ........................................... 249 
 
 
 xvii 
LIST OF TABLES 
                          Page 
 
Table 1.Tetrathionate broth formulas per liter purified water .................................................. 94 
Table 2. Iodine solution formula .............................................................................................. 94 
Table 3. Rappaport-Vassiliadis broth ....................................................................................... 95 
Table 4. Brilliant Green Agar ................................................................................................... 95 
Table 5. MIC range and breakpoints for Salmonella spp. antimicrobial susceptibility      
testing by NARMS (2014) [26] .................................................................................. 97 
Table 6. Multi-Locus Sequence Type (MLST) and serotypes of the Salmonella isolates .......... 109 
Table 7. Proportion of Salmonella serotype and AMR phenotype by treatment group ............. 113 
Table 8. Primers and probes used for qPCR ............................................................................ 135 
Table 9. qPCR reaction protocol ............................................................................................. 136 
Table 10. qPCR thermocycler protocol .................................................................................... 136 
Table 11. Number of samples detected with Salmonella in broth enrichment, probe qPCR,  
and direct spiral plating. ........................................................................................... 140 
Table 12. 2x2 table comparing the detection of Salmonella by broth enrichment and direct 
spiral plating methods. ............................................................................................. 144 
Table 13. 2x2 table comparing the detection of Salmonella by broth enrichment and probe 
qPCR methods. ........................................................................................................ 145 
Table 14. 2x2 table comparing the detection of Salmonella by direct spiral plating and     
probe qPCR methods. .............................................................................................. 145 
Table 15. Kappa (κ) and PABAK and agreement between direct spiral plating, broth 
enrichment, and probe qPCR. ................................................................................... 146 
Table 16. Numbers of samples and mean quantities by qPCR and direct plating on BGA by 
tested days. .............................................................................................................. 147 
Table 17. Sample numbers tabulated by day and treatment groups among 48 detected with 
qPCR ....................................................................................................................... 152 
Table 18. Prevalence and mean quantity of Salmonella on BGA, BGA-tet, and BGA-cef. ....... 153 
 
 xviii 
Table 19. Prevalance and Salmonella quantity by day and treatment group by qPCR and   
direct plating on BGA .............................................................................................. 159 
Table 20. Prevalence and Salmonella quantity per treatment group and days by direct     
plating on BGA-tet and BGA-cef ............................................................................. 160 
Table 21. Counts of super shedder (shedding >104 per gram feces) .......................................... 161 
Table 22. Observed and 16s rRNA standardized log10 invA gene copies per gram feces per 
qPCR reaction. ......................................................................................................... 170 
Table 23. Descriptive statistics of de novo assemblies by serotype. The numbers in 
parentheses are the minimum and maximum. CDS: coding sequence ....................... 213 
Table 24. Comparison of the assembly results between Illumina reads and the hybrid 
assembly of Oxford Nanopore MinION and Illumina reads ...................................... 215 
Table 25. Antimicrobial resistance phenotype and genotype patterns per serotype and   
plasmid replicon type ............................................................................................... 217 
Table 26. Kappa agreement between antimicrobial resistance phenotype and detected 
antimicrobial resistance genes .................................................................................. 218 
 
 
 
 
 
 
 1 
CHAPTER I  
INTRODUCTION 
1.1 Background 
1.1.1 Antibiotic resistance 
Antimicrobial resistance is a global public health problem [1, 2]. Bacterial infections with 
resistance to last-resort antimicrobials, such as carbapenems and colistin, are increasing and can 
be life threatening due to the lack of additional treatment options [3, 4]. In 2015, the World 
Health Organization (WHO) announced a Global Action Plan to combat antimicrobial resistance 
and to address the problem using a “One Health” approach in collaboration with the Food and 
Agriculture Organization of the United Nations (FAO) and the World Organization for Animal 
Health (OIE) [5]. It is estimated that 60% of all antimicrobials produced are utilized in animal 
agriculture for growth promotion, disease prevention, disease control, or treatment [6]. The use 
of antimicrobials in food producing animals is alleged to be one of the major sources of 
antimicrobial resistant bacteria transmitted to humans [7, 8].  
Several critically important antimicrobials for humans health have been prohibited for 
extra-label use and disease prevention purposes in food-animal production in several European 
countries and in the United States to address the issue of antimicrobial resistance [9]. Such 
strategies have had conflicting results. For example, in Denmark, since 1998 the total mass of 
antimicrobials has been reduced by banning antimicrobial use for disease prevention and growth 
promotion purposes in food animal production; however, the total use of antimicrobials for 
treating sick animals has been increasing [10, 11]. Consequently, it is not yet clear whether the 
cases of antimicrobial resistant bacterial infections have decreased in humans through more 
restrictive use of antimicrobials in food animals [12]. Due to the complex nature of this issue, it 
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is important to investigate the best and most effective intervention strategies to reduce the further 
expansion of antimicrobial-resistant bacteria [13-15].  
1.1.2 Antibiotics use in feedlot operations in the United States 
The United States is the top beef producing country in the world, with an output of more 
than 12 million tons of beef per year [16]. Total annual beef consumption in the United States is 
around 24.8 billion pounds, averaging 67 pounds per person, and comprising about 40% of meat 
consumption in the country [17]. The high demand for beef is met by feedlot operations, where 
weaned calves from cow-calf operations are assembled and fed high-energy rations to reach the 
necessary weight and carcass characteristics to be sent to slaughter. The sizes of feedlots in the 
United States range from less than 1,000 head (small commercial feedlot) to more than 16,000 
head of cattle (large commercial feedlot). The largest feedlots comprise 60% of the U.S. fed-
cattle market [17].  
Antimicrobials are important for the prevention, control, and treatment of disease and are 
necessary to maintain healthy cattle in the feedlot. Metaphylactic (control) and prophylactic 
(prevention) use of antimicrobials are two of the primary methods to treat animals, which leads 
to mass consumption of antimicrobials, rather than individualized treatment. The most common 
disease problem in feedlots is bovine respiratory disease (BRD). BRD is caused by an infection 
with bacterial and/or viral pathogens along with complex environmental and host factors, such as 
transportation stress and comingling with calves from different sources. Metaphylactic treatment 
of calves upon arrival to the feedlot is a common practice for the control and treatment of BRD, 
for at-risk and sick calves, respectively. Several antibiotics are approved by the U.S. Food and 
Drug Administration (FDA) for the control and treatment of BRD, including labeled indications 
for ceftiofur crystalline-free acid (CCFA) and chlortetracycline (CTC). There is little research 
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concerning the effects of CCFA and CTC on the gut microbiota in cattle. The effects of 
antimicrobials on commensal and pathogenic bacteria residing in the cattle microbiota, such as 
non-typhoidal Salmonella and Shiga-toxin producing E. coli (e.g., O157:H7), are a public health 
concern because these bacteria are common foodborne pathogens and can cause life-threatening 
infections in humans.  
1.1.3 Foodborne non-typhoidal Salmonella 
Non-typhoidal Salmonella, the causative agent of most cases of salmonellosis in the 
developed world, was the leading cause of death (215 out of 552 (39%) of all deaths) in the U.S. 
from 1996 to 2005 attributed to foodborne pathogens, according to the data from FoodNet [18]. 
Children under 5 years old and adults over 65 years old are at the highest risk [18, 19]. An 
estimated 1.2 million cases, 23,000 hospitalizations and 450 deaths occur due to non-typhoidal 
Salmonella infections in the United States annually [19-21]. In the United States, from 2008 to 
2012, 30% of foodborne outbreaks and 45% of illnesses were caused by Salmonella [22].  
Clinical salmonellosis in humans is typically self-limiting and affected individuals 
recover within 5-7 days. However, in severe cases involving invasion of the host by the 
bacterium, such as bacteremia and meningitis, hospitalization and antimicrobial treatments are 
often necessary. At present, the primary choices of antimicrobials are third-generation 
cephalosporins (e.g., ceftriaxone) and fluoroquinolones (e.g., ciprofloxacin). Due to the potential 
toxicity of fluoroquinolones to cartilage development as reported in animal models [23] and in a 
child [24], ceftriaxone is the primary choice of treatment for infants, children, pregnant women, 
and immunocompromised people.  Ceftriaxone has been classified as a critically important 
antibiotic for human use according to the WHO [25], According to the Centers for Disease 
Control and Prevention (CDC) Threat Report (2013), 3% of human-derived non-typhoidal 
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Salmonella isolates are resistant to ceftriaxone [20]; further, approximately 9.8% of Salmonella 
were multidrug resistant in 2014 [26]. Chicken and eggs are the most common source of 
Salmonella; however, Salmonella infections have been attributed to beef consumption. 
Salmonella commonly reside in the cattle gut microbiota; however, most are subclinical and 
cause no measurable negative effects on the animal host.  
1.1.4 Ceftiofur and chlortetracycline 
Ceftiofur is a beta-lactam antibiotic used in dairy cattle, beef cattle, pigs, poultry and 
horses. Ceftiofur is the only third-generation cephalosporin that is approved for treatment of 
BRD in cattle in the U.S.; however, a fourth-generation cephalosporin, cefquinome, is approved 
for this purpose in Europe [27]. Ceftiofur was first approved in 1988 by the FDA in an 
inconvenient powdered form that required reconstitution as an injectable liquid; later, a ready-to-
use (RTU) injectable formulation was introduced in the 1990s, and finally a long-lasting 
ceftiofur crystalline-free acid (CCFA; Excedeâ, Zoetis) formulation was approved in 2003.  
Ceftiofur is in the same antibiotic class as ceftriaxone which is used for the treatment of 
salmonellosis in humans and classified as a critically important antibiotic. A significant increase 
in cephalosporin resistant Salmonella was seen after 1997 and although fluctuating annually, an 
overall decreasing tendency has been reported since 2010 by the National Antimicrobial 
Resistance Monitoring System (NARMS) [26]. The beta-lactamase gene, blaCMY-2 is most often 
responsible for ceftiofur resistance in commensal and pathogenic bacteria of livestock, such as 
Escherichia coli and Salmonella, in the United States, which typically exhibit cross-resistance to 
ceftriaxone and a nearly identical minimum inhibitory concentration [28-30]. In 2012, the FDA 
prohibited certain extra-label uses of ceftiofur in food-producing animals in an effort to reduce 
cephalosporin resistant Enterobacteriaceae [9]. A study in Denmark showed that the voluntary 
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ban of cephalosporins in its pig production system reduced the prevalence of extended-spectrum 
cephalosporinase producing Escherichia coli [11]. Several observational studies have been 
conducted concerning the effects of ceftiofur use on the emergence, spread and propagation of 
antimicrobial resistant E. coli and Salmonella in feedlot cattle; however, no randomized 
controlled studies have been reported.  
Because of its broad-spectrum activity and product safety, chlortetracycline (CTC; 
Aureomycinâ, Zoetis, Kalamazoo, Michigan) has a long history of use as an in-feed antibiotic 
for disease prevention and growth promotion purposes. However, all label claims of antibiotics 
for growth promotion in livestock disappeared as of January 1st, 2017 in the United States and 
the use of CTC in feed now is mandated under the Veterinary Feed Directive (VFD) which 
requires veterinarian’s supervision [31]. Chlortetracycline is used for the control and treatment of 
BRD in feedlot cattle. The NARMS 2015 Integrated Report showed that approximately 26.5% of 
Salmonella from cattle and 50% from retail ground beef were resistant to tetracycline [32]. 
Tetracycline resistant isolates are often also co-resistant to ampicillin, chloramphenicol, 
streptomycin, and sulfonamides (in the penta-resistant ACSSuT phenotype) [33].  
A previous study from our research group showed that chlortetracycline treatment by 
itself reduced phenotypic ceftiofur resistant E. coli in feedlot cattle [34]. In contrast, a follow-up 
study by Kanwar et al., showed an increase of ceftiofur resistant non-type specific (NTS) E. coli 
following CTC treatment, often in cattle previously treated with ceftiofur [35]. These conflicting 
results may be due to different populations of tetracycline resistant E. coli. Or, the priming of the 
E. coli populations with CCFA may have changed the population that the CTC was impacting. 
The tetracycline resistant E. coli from the Platt et al. study were likely to have primarily harbored 
the tet(B) gene, while E. coli in the Kanwar study were primarily carrying the tet(A) gene 
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following prior CCFA selection of the IncA/C plasmid bearing E. coli that carry both tet(A) and 
blaCMY-2 genes. The tet(B) gene is the most detected tetracycline gene in Gram-negative bacteria 
coded on chromosomes [36]. Additionally, at the protein level TetA and TetB are not compatible 
proteins. We investigated the population dynamics of Salmonella in the same cattle population as 
used in the Kanwar study. The population dynamics of Salmonella in cattle feces following 
antibiotic treatment have not been previously reported. 
 
1.2 Study objectives 
The objectives of this study were to determine the effects of ceftiofur and 
chlortetracycline use on the temporal dynamics of multidrug-resistant Salmonella in feedlot 
cattle. The prevalence and quantity of Salmonella were determined and compared across 
treatment groups and days using broth enrichment and direct culture on brilliant green agar 
(BGA) and via a quantitative real-time probe PCR (qPCR). The quantity of antibiotic resistant 
Salmonella was determined by plating on BGA containing tetracycline (16 mg/L) and 
ceftriaxone (4 mg/L). We compared the antibiotic resistant phenotypes and genotypes using 
antibiotic susceptibility testing and whole-genome sequencing (WGS), respectively, comparing 
among days and treatment groups and their interactions. Additionally, serotypes and plasmids 
were determined by WGS and the phylogenetic relations of the isolates among the days and by 
treatments were explored. Finally, we assessed the utility of WGS in determining antimicrobial 
resistance profiles and serotypes in comparison to standard serological serotyping methods and 
antimicrobial susceptibility testing. 
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CHAPTER II 
LITERATURE REVIEW 
 
 
2.1 Antibiotic resistance as public health issue 
Antimicrobial resistance has been a public concern for decades, since the first antibiotic, 
penicillin, was discovered by Alexander Fleming in 1928. Penicillinase, the enzyme that digests 
penicillin and causes penicillin resistance in bacteria, was discovered shortly afterward in 1940. 
Resistance mechanisms to antibiotics have been discovered anywhere from 2 to 16 years after 
the introduction of the antibiotic into the market [1, 37]. Antibiotic resistant mechanisms have 
been discovered in bacteria isolated from permafrost or isolated caves where no human activities 
have been recorded, nor antibiotics have been used [38-40]. Antibiotic resistance is a basic 
system that bacteria have developed as a defense mechanism for their survival. However, when 
soil samples from the 1940s, which were never exposed to antibiotics, were compared with 
samples from the 1970s, more than 15 times the number of tetracycline resistance genes were 
detected from the 1970s soil sample [41]. This provides evidence that the recent problem 
involving the emergence and widespread dissemination and propagation of antibiotic-resistant 
bacteria in humans, animal populations, and environments is largely the result of selective 
pressure from antibiotics derived from human activities [41-43]. Antibiotics have saved millions 
of human and animals lives from mortality due to bacterial infections for over 80 years [44].  
2.2 Feedlot operations and antibiotic use 
2.2.1 Feedlot operations 
Feedlot cattle operations are designed to raise weaned calves to an acceptable size, carcass 
grade, and weight for slaughter [45]. In the United States, the cattle and calve industry is worth 
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$76.4 billion and the feedlot cattle industry is worth $36.4 billion [46]. The feedlot cattle 
industry accounts for 26% of total U.S agricultural sales [46]. Beef cattle operations are divided 
into multiple stages in the United States starting from cow-calf operations that produce calves 
and sell to other producers (Figure 1) [47]. Seedstock breeders maintain herds for purebred 
breeding stock [47]. Calves from cow-calf operations are weaned at 6 to 10 months of age and 
may be sent to background-stocker operations or else directly to feedlots. The purpose of 
background-stocker operations is to raise calves that are too small to enter the feedlots, often on 
a maintenance ration. Calves are grazed and fed an additional high roughage ration and at 12 to 
18 months of age, calves then are moved to feedlots or finishing operations to be fattened for 
slaughter. Typically, cattle spend 4 to 6 months in feedlots and finishing operations and are fed 
high-energy rations until they reach a weight between 1,100 to 1,300 pounds. Once the cattle 
reach the desired weight and carcass grade, they are sent to the slaughterhouse [47].  
Feedlot operations are a style suited to raising a large number of cattle at a faster rate by 
utilizing limited land efficiently. The use of feedlots started before the U.S. Civil War when 
grain farmers were trying to sell excess commodities and to maintain workers year-round; 
therefore, they started to sell grains to feed food animals. Later, they discovered that feeding 
grains to food animals increased the growth rate of the animals. Nowadays, beef cattle feedlot 
operations are located mainly in the high plains of the United States in the Texas Panhandle, 
Oklahoma, western Kansas, eastern Colorado, and western Nebraska [45]. Not coincidentally, 
this region also provides access to a very large aquifer (Ogallala) of water. 
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(Adapted from Overview of the United States Cattle Industry June 2016 [47]) 
 
 
Cattle are assembled from different sources and taken to the feedlot. Due to weaning, 
shipping, climatic and mingling stresses, they often are susceptible to bovine respiratory disease 
(BRD) or “shipping fever”. BRD is one of the most common diseases that feedlot operators 
Figure 1. Beef cattle operation system 
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encounter [45, 48]. Economic losses due to BRD are estimated to be around $1 billion in the 
United States and more than $3 billion worldwide [49, 50]. The National Animal Health 
Monitoring System (NAHMS) 2011 Feedlot study reported that approximately 16.2% of cattle 
were affected by BRD [45]. BRD is a complex disease that is caused by a number of bacterial 
pathogens including Mannheimia haemolytica, Pasteurella multocida, Histophilus somni, and 
Mycoplasma bovis, in combination with a number of viruses [51]. Bacteria responsible for BRD 
are mostly commensal bacteria of the upper respiratory tract that become opportunistic 
pathogens by expressing virulence factors when the host is under stress and immune conditions 
change [52]. Coinfection with viruses can suppress the host immune response and initiate 
replication of the bacterial pathogen in the upper respiratory tract, and eventually the bacteria 
reach the lung [52].  
The risk of BRD in cattle is highest upon arrival to the feedlot because of the stress from 
transportation, weaning, bad weather, and comingling of cattle from different sources in the same 
pen. Diagnosing BRD accurately is a challenging task for pen riders, who check the cattle daily. 
Diagnosis often is based on visual observations, such as depression, loss of appetite, and 
coughing. This is further complicated by the fact that cattle and other ruminants have evolved to 
conceal their illness to deter predators [50]. Therefore, prevention of BRD infection is critical in 
the feedlot. The NAHMS Feedlot 2011 study reported that 96.6% of feedlots vaccinated cattle 
against viral pathogens that cause BRD, such as bovine viral diarrhea (BVD) virus, infectious 
bovine rhinotracheitis (IBR) virus, and bovine herpes virus 1. Two thirds of feedlots vaccinated 
against bacterial agents such as Mannheimia haemolytica and Pasteurella sp. upon arrival. The 
effectiveness of vaccination is inconsistent, but several articles provide evidence that vaccination 
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reduces the morbidity and mortality risk associated with BRD compared with unvaccinated cattle 
[53, 54].  
2.2.2 Antibiotic use in feedlot operations 
Metaphylactic treatment is one of the most common antibiotic practices used to control BRD 
[55]. Metaphylaxis is defined as “ the timely mass medication of a group of animals with an 
antibiotic to eliminate or minimize an expected outbreak of disease”; meanwhile, it is referred to 
as “disease control” by the U.S. FDA [45]. Several injectable antibiotics are labeled for both the 
treatment and control of BRD, such as oxytetracycline, tilmicosin, tulathromycin (and other 
macrolides), florfenicol, several fluoroquinolones and ceftiofur [50]. According to the NAHMS 
Feedlot 2011 study, the top 3 injectable antibiotics to prevent or minimize BRD were tilmicosin 
(57.6% of feedlots), tulathromycin (45.3%), and ceftiofur (39.7%) and metaphylactic use of 
antibiotics to decrease morbidity and mortality from BRD was reported at 59.4% of feedlots 
[45].  
Choice of antibiotics for the metaphylaxis often is based on several factors including history 
of BRD at the feedlot, source of the cattle, cost-effectiveness, and the effectiveness of antibiotics 
[45]. Injectable antibiotics are precise and easier for the feedlot operators to handle and often a 
one-time injection is all that is required, especially when using a longer-acting formulation of the 
drug. The effectiveness of metaphylaxis for BRD is proven for a number of different antibiotics 
[50, 56-60]. Metaphylactic use of oxytetracycline reduced morbidity but did not affect mortality 
attributed to BRD in a Canadian feedlot [59]. Treatment with tulathromycin reduced recurrence 
for BRD compared with tilmicosin treated cattle [56].  Cattle that received metaphylactic 
treatment with ceftiofur crystalline-free acid (CCFA) on arrival to the feedlot also had lower 
mortality and morbidity compared with those did not receive treatment [57]. Recent concern 
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regarding the rise of antibiotic resistant bacteria is also the case for bacteria that cause BRD [49, 
51, 61]. Overall resistance rates in of M. haemolytica, P. multocida, and H. somni remained low 
between 1994-2002 at the Oklahoma Animal and Disease Diagnostic Laboratory. However, 
resistance increased in M. haemolytica against florfenicol, spectinomycin, tilmicosin, and 
erythromycin, and to spectinomycin, erythromycin, and tetracycline in P. multocida [61, 62]. For 
another of the BRD pathogens, Mycoplasma bovis, that were collected from Canadian feedlot 
cattle that received oxytetracycline metaphylaxis were largely susceptible to the antibiotics tested 
except for tilmicosin. Further, genetic diversity of the isolates was not affected by metaphylaxis 
treatment [59].  
In-feed and in-water antibiotics are other convenient method for mataphylaxic treatment. 
Oral antibiotics are incorporated either into the water or feed for disease treatment, prevention, 
and (previous to 2017) for enhanced productivity (subtherapeutic dose). Ionophores are the most 
common antibiotics fed throughout the feeding period (90% of cattle in feedlot) to enhance 
production efficiency and for the control of coccidiosis; however, they are not considered to be 
medically important for human medicine. Tylosin is another common in-feed antibiotic that 
31.0% of feedlots used for control liver abscess [45]. Chlortetracycline (CTC) is one of the most 
common in-feed antibiotics. It has been reported that 71.7% of feedlots use CTC for disease 
prevention and control [45]. In-feed CTC treatment for 5-days upon arrival reduced morbidity 
and the use of critically important antibiotics in next 120 days [63]. One study showed that 
metaphylactic treatment by CTC at subtherapeutic concentrations did not result in any benefits in 
reducing BRD in cattle derived from a single source, which generally are considered as low-risk 
of BRD [60].  
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One of the issues with antibiotics provided in feed is that the amount of antibiotic available 
and consumed may be inconsistent, especially if the cattle lack appetite. The FDA prohibited the 
extra-label use of the medically important antibiotics fluoroquinolones (danofloxacin and 
enrofloxacin) in 1997 and cephalosporins (ceftiofur, but not cephapirin) in 2012. Additionally, 
the FDA announced the final rule of Veterinary Feed Directive (VFD), which requires 
involvement of veterinarians to use medically important antibiotics in-feed or water for food 
animals as of January 1, 2017. This includes CTC and tylosin but not ionophores, because 
ionophores are not considered to be medically important antibiotics. Even though there are 
efficacy differences between antibiotics, overall, metaphylaxis is an effective method to reduce 
morbidity from BRD. As summarized here, antibiotic treatment is necessary for disease 
treatment, prevention and control in cattle feedlots; however, the emergence of antibiotic 
resistant bacteria including Salmonella has become a worldwide public health issue that poses a 
threat to the status quo [12].  
After the wide dissemination of antibiotic resistant bacteria in human populations was 
revealed, uncontrolled use of antibiotics in food animals began to be blamed for the expansion of 
resistant bacteria responsible for human infections [7, 43, 64, 65]. It is estimated that around 
60% of medically important antimicrobials sold in the United States in 2015 were used in food-
animals [6]. On the other hand, it is not a simple process to investigate the connection between 
antibiotic use in the food-animal production system and its subsequent effects on human health 
[65]. For example, it is necessary to investigate whether the use of antibiotics in animals 
increases the number of resistant bacteria in animals (and for how long after treatment ceases), 
how resistant bacteria are transferred to carcasses, to meat products, and to prepared food, and 
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the effects of environmental contamination with antibiotics and resistant bacteria on surface and 
ground water and row crops such as leafy greens and other vegetables and fruits [65].  
2.2.3 Resistant bacteria in human and animal populations 
Through the development of advanced molecular techniques, we are gaining a deeper and 
broader perspective on antibiotic resistance. In 2012, Mather et al. used novel ecological and 
epidemiological methods to compare the phenotypic resistance profiles of Salmonella 
Typhimurium DT104 isolates derived from cattle and human populations collected from 1990 to 
2004 in Scotland [66] Later genotypic resistance profiles and phylogenetic relations of the same 
isolates were compared [67]. Although some similar resistance profiles were found to be shared 
among cattle and humans, uniquely distinguishable phenotypic resistance profiles in the cattle 
and human populations were observed and maintained within the respective populations. Among 
the similar resistance profiles, more profiles were observed earlier in the human population.  
A similar study was conducted on Salmonella isolates derived from cattle and humans from 
2004 to 2011 in Washington State by Afema et al. [68]. The phenotypic antimicrobial resistance 
profiles of the dominant serotypes (Typhimurium, Newport, and Montevideo) were not shared 
among cattle and human-derived isolates. Isolates derived from the human population had more 
diverse phenotypes than the cattle isolates. The bacterial population that enters the human 
population through food animals are those from healthy animals and not the animals exhibiting 
clinical symptoms. Most Salmonella infected cattle do not typically show clinical symptoms. 
These results suggest that among the resistant Salmonella, even though some are shared between 
human and cattle populations, many unique isolates circulate only within their own species. 
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2.3 Salmonella description 
2.3.1 Salmonella taxonomy 
Karl Joseph Eberth isolated a bacillus bacterium, suspected to be the cause of typhoid fever, 
from the spleen and mesenteric lymph nodes of a patient who died from the disease. The 
bacterium was later discovered to be Salmonella Typhi. Theobald Smith isolated a bacillus from 
a hog with hog cholera, which was considered the likely pathogen causing the disease in 1885; 
instead, this bacterium turned out to be S. Choleraesuis and not the causative agent of hog 
cholera which turned out to be a virus. Unfairly, Salmonella was named after Smith’s chief 
scientist, Daniel Elmer Salmon, a veterinarian at the United States Department of Agriculture 
(USDA) who claimed the credit [69].  
Salmonella belongs to the Enterobacteriaceae family and is Gram-negative bacillus with 
flagella for motility. Two Salmonella species are known: Salmonella enterica and Salmonella 
bongori. Salmonella enterica is further classified into 6 subspecies: enterica (I), salamae (II), 
arizonae (IIIa), diarizonae (IIIb), houteniae (IV), and indica (VI). Most of the human cases of 
salmonellosis are caused by serotypes of Salmonella enterica subsp. enterica (referred to as 
Salmonella enterica henceforth; or abbreviated further to Salmonella and its serotype). The host 
of the other subspecies are cold-blooded animals such as reptiles. Salmonella enterica is a 
facultative anaerobe and biochemically tests positive for dulcitol, sorbitol, L(+)-tartrate, g-
glutamyltransferase, mucate, and additionally is lysed by phage O1 [70]. Biochemically, 
Salmonella enterica are also lactose negative, oxidase negative and catalase positive. For b-
glucuronidase, it is only positive in subsp. diarizonae in general and different reactions are given 
for different serotypes in other subspecies [70]. Salmonella can survive dehydration and low 
temperatures, but not extremely high temperatures [71]. They can adapt down to pH 3.3 [72].  
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2.3.2 Host relation of Salmonella 
Within the serotypes of Salmonella enterica, non-typhoidal Salmonella is the major food-
borne pathogen causing salmonellosis, while Salmonella Typhi (S. Typhi), S. Paratyphi A, S. 
Paratyphi B, and S. Paratyphi C are typically pathogenic only to humans and cause variations of 
typhoid fever. Three types of host specificities are known for Salmonella serotypes; host 
restricted (S. Typhi to human, S. Abortusequi to horse), host unrestricted (S. Typhimurium, S. 
Enteritidis), and host adapted which may cause severe illness (S. Dublin to cattle, S. Choleraesuis 
to pigs) [73]. The symptoms of salmonellosis are nausea, diarrhea, fever, abdominal pain, and 
vomiting with symptoms presenting 12 to 72 hours after ingesting contaminated food or water. 
Infectious doses vary from <101 to 109 CFU in humans; however, this varies by serotype. 
Salmonella often is shed intermittently. Some animals infected with host-adapted and host-
restricted serotypes become high-shedders or super-shedders.  These are defined as individuals 
shedding over 108 CFU / gram feces in mice with S. Typhimurium infection, or 103-105 CFU / 
gram feces in cattle with S. Dublin infection [74].  
2.3.3 Salmonella infection 
Salmonella have adaptations that allow them to evade and escape from the host immune 
system. Salmonella infect the host cell by utilizing the specialized antigen-sampling membranous 
epithelial (M) cells of the host intestine epithelium and translocation of proteins within the Type 
III Secretion system encoded by the Salmonella pathogenicity Island 2 (SPI-2) (Figure 2) [75]. 
Invasion by Salmonella induces an inflammatory response in the host, in which macrophages, 
neutrophils, and lymphocytes migrate to the site of invasion. Following the host immune 
response, more than 90% of Salmonella are destroyed by phagocytic cells [76]; however, 
Salmonella can also survive within the engulfed macrophages and escape the host immune 
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response. Further, Salmonella can disseminate through the lymphatic system and cause systemic 
infection. From the neutrophils that migrate into the intestinal lumen, reactive oxygen species 
(ROS) are released which target the invading bacteria. However, Salmonella can utilize 
tetrathionate, a respiratory electron acceptor produced by the oxidation of thiosulfate, which is 
the byproduct of the release of ROS [77]. Therefore, inflammation caused by a Salmonella 
infection can be advantageous to Salmonella and they utilize the tetrathionate to outgrow the 
other competing microbes in the intestine [78]. Salmonella Typhimurium infection itself can 
disrupt the microbiota by causing acute enteritis and diarrhea; further, they can increase their 
invasiveness requiring SPI1 and SPI2 type 3 secretion systems in mice [79]. Alterations are often 
caused by host’s diarrheal response rather than the presence of pathogen itself. In published 
studies, the host lost Eubacterium rectale/Clostridium coccoides 1 week after Salmonella 
infection. However, the microbiota recovered to normal after 1 month after the date of infection 
[79].  
The interaction between antibiotic use, host microbiota, and Salmonella has been studied 
previously in mice [80, 81]. A study showed that Salmonella can use the indole produced by E. 
coli to increase its antibiotic tolerance by mediating oxidative stress response and phage shock 
response [82]. Recent studies have shown that antibiotic administration can reduce diversity of 
microbiota and induce diseases in human and mice [44, 80, 81]. Antibiotic administration 
decreased the complexity of healthy microbiota and induced elevation of host derived fucose and 
sialic acid levels in the gut lumen of mice [80, 81]. Ng et al. used gnotobiotic mice that carry 
only Bacteroides thetatiotaomicron (Bt) as a simplified model microbiota mimicking the 
disrupted microbiota after antibiotic treatment. Bt encodes sialidase which is required to 
consume the liberated sialic acid, while Salmonella Typhimurium lacks the sialidase but have the 
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catabolic pathway (nan operon). Under the presence of Bt, Salmonella can catabolize the 
liberated sialic acid and further colonize the host [80, 81]. These studies have shown that 
Salmonella exhibit tolerance under stressed conditions caused by antibiotic treatments. Further, 
they can take advantage of host responses against their infection itself and changes to the 
microbiota to proliferate under such conditions. Because of the complexity of microbiota in 
ruminants compared with mice and humans, these previous results are unlikely to be directly 
applicable to cattle. In the current study, we explore the effects of antibiotics on the quantity of 
susceptible and resistant Salmonella in fecal populations by performing qPCR from total 
community DNA and by direct spiral plating. 
 
 
 
Figure 2. Schematic illustration of Salmonella infection (Adapted from Thiennimitr et al. [78]) 
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2.4 Methods for identification and characterization of Salmonella 
2.4.1 Isolation methods for Salmonella 
Enrichment procedures and selective broths and media are necessary for the isolation of 
Salmonella from samples containing abundant microbes, such as feces and soils. These selective 
broths and agars were developed based on the biochemical specifications of Salmonella, and 
were designed to inhibit the growth of other organisms, while promoting the growth of 
Salmonella. In the current study, tetrathionate broth and Rappaport-Vassiliadis (RV) broth were 
used, respectively, followed by plating onto brilliant green agar (BGA). Tetrathionate broth is 
composed of sodium thiosulfate, calcium carbonate, pancreatic digest of casein, peptic digest of 
animal tissue, and bile salts. Additionally, it is necessary to add iodine-iodide solution 
immediately before adding the samples, in order to initiate the formation of tetrathionate.  
Salmonella carry tetrathionate reductase, which allow Salmonella to use the tetrathionate as a 
respiratory electron acceptor, produced during inflammation (Figure 2), to grow and outcompete 
other coliforms [77, 78].  
The bile salts included in the tetrathionate broth inhibit the growth of Gram-positive bacteria 
and other coliforms. Pancreatic digest of casein and peptic digest of animal tissue provide 
nutrients for the Salmonella growth. Calcium carbonate absorbs toxic materials produced during 
the amplification. Rappaport-Vassiliadis broth is composed of soy peptone, sodium chloride, 
potassium phosphate, magnesium chloride, and malachite green. Malachite green inhibits the 
growth of other organisms. Magnesium chloride increases the osmotic pressure of the broth, 
which promotes the growth of Salmonella because they can survive dehydrating conditions when 
compared with other intestinal bacteria [83, 84]. Together with malachite green the low pH (5.2 
± 0.2), allows for the selection of Salmonella. Several selective agars are available for the 
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identification and isolation of Salmonella, including BGA, xylose lysine deoxycholate agar 
(XLD agar), xylose lysine tergitol-4 agar (XLT agar), Salmonella-Shigella agar (SS agar), and 
Hektoen enteric agar.  
In our study, BGA was used for the isolation of Salmonella, which was first reported by 
Kristensen in 1925 and modified by Kauffman in 1935. BGA is composed of brilliant green dye 
to suppress the growth of Gram-positive bacteria and other Gram-negative bacilli, including S. 
Typhi and S. Paratyphi. Lactose, sucrose, and yeast extract are included to provide nutrients for 
Salmonella growth. The color of uninoculated BGA is brownish-orange due to the addition of 
phenol-red dye. The growth of Salmonella changes the surrounding agar to pink with the change 
of pH level (original pH is 6.9 ± 0.2). Salmonella colonies are identified by a transparent, light 
red-pink coloration. Lactose-fermenting bacteria such as E. coli colonies grow as yellow-green 
colonies due to acid production by lactose/sucrose fermentation and are therefore easy to 
distinguish from Salmonella on BGA. The concerns of using enrichment methods are the 
possibility of selecting only certain serogroups or serotypes, which thus may bias the serotype 
results [85, 86]. A few Salmonella do not carry the gene encoding tetrathionate reductase, and 
thus may not proliferate in tetrathionate broth. 
Gorski examined the bias caused by enrichment processes in Salmonella isolation [86]. The 
growth of Salmonella enterica isolates from 4 serogroups, B, C1, C2, and E, including 13 
serotypes, and 19 isolates in RV broth and Rappaport-Vassiliadis soya peptone broth (RVS) were 
compared. RV broth is routinely used by the U.S. FDA following their Bacterial Analytical 
Methods manual [87]. Gorski prepared 8 sets of mixtures containing 4 strains from each 
serogroup having similar growth kinetics. She compared the ratio of these 4 isolates after 24-
hour enrichment at 35 °C in tryptic soy broth (TSB), and then enriched in RV or RVS broths at 
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42 °C for 24 hours, and finally plated on XLD agar. Even though TSB is a non-selective broth, 
there was clearly biased growth. However, the dominant serogroups seen in RV and RVS were 
not necessarily reflecting the dominant strains after TSB enrichment. In one mixture, serogroup 
C1 was approximately 10% after TSB enrichment but increased to 90% after RV enrichment. In 
the same mixture, serogroup B was dominant after RVS enrichment. In the other 4 mixtures, 
serogroup E was not dominant in TSB culture but become dominant after RV enrichment. The 
ratio of serogroups after RVS enrichment were more equivalent and similar to that of TSB than 
after RV enrichment; however, serogroups C2 and E were more dominant in 6 of the 8 tested 
groups after RVS enrichment.  
Gorski [86] also examined the bias caused by the background microbiota of cattle feces by 
mixing these Salmonella strain mixtures with cattle fecal samples that were not detected as 
having Salmonella. RVS had a more equivalent distribution of serogroups compared with RV, 
similar to those without background microbiota. However, in some mixtures, serogroup B grew 
better than Salmonella only mixture, which suggests the presence of fecal microbiota may favor 
the growth of serogroup B. Serogroup B consists with serotypes that are highly pathogenic to 
humans including S. Typhimurium. The bias caused by an enrichment process will affect 
interpretation of results of surveillance, but less so during outbreaks, and clinical diagnosis 
where a single strain is expected to dominate. The fact that serogroup B strains were less 
dominant after RV enrichment, which is the routine broth used in most surveillance systems, 
may be problematic since they are more pathogenic. On the other hand, RV broth has been used 
as a standard broth because of the balance between growth of desired bacteria and suppression of 
competing bacteria such as Proteus. Gorski’s study also showed that the dominance of serogroup 
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C2 and E is consistent with dominance of S. Newport and S. Kentucky in surveillance as shown 
by the CDC.  
A similar concern was raised by Singer et al. that enrichment may bias the results of current 
surveillance system [85]. In fact, many healthy food animals are not infected with a single 
serotype, but multiple serotypes and at different ratios [88]. Therefore, it is important to consider 
the methods used in the surveillance system, outbreak analysis, and experimental studies. 
Caution is needed when comparing the results from different studies. Conducting multiple 
enrichment using different broths, or not conducting any enrichment may reduce such bias. 
Additionally, next-generation sequencing may help to overcome this culture bias by extracting 
the total genomic DNA from microbiota and examine the Salmonella serotypes as they are found 
in situ [89]. 
2.4.2 Typing of Salmonella 
2.4.2.1 Traditional serotyping 
Traditionally, Salmonella enterica has been classified based on serotypes. Salmonella 
consists of diverse serotypes; however, around 80% of cases of salmonellosis in humans in the 
U.S. are accounted for by 20 serotypes of Salmonella enterica. Within Salmonella enterica 
species, there are approximately 2,500 serotypes and 1,500 serotypes within subspecies enterica, 
which are classified following the White-Kauffman-Le Minor scheme. The White-Kauffmann-
Le Minor scheme is curated by the Pasteur Institute, a World Health Organization (WHO) 
collaborating center [70]. Salmonella serotypes are determined by the expression of the somatic 
(O) and flagellar (H) antigens. The O-antigen is formed by chains of oligosaccharides on the 
lipopolysaccharide outer-membrane (LPS) [90]. This sugar chain is composed of 3 to 8 different 
combinations of core oligosaccharides, which are determined by the rfb gene cluster [90, 91]. 
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There are seven known pairs of O-antigens that are common between Salmonella and E. coli. 
Recent discoveries are of E. coli O11 / S. enterica O16 and E. coli O21 / S. enterica O38 [92]. 
Therefore, when serotyping is performed by the agglutination of antisera, misclassification may 
occur.  
H-antigens are biphasic and Salmonella express either the phase-1 or phase-2 antigen to 
escape the host immune system via the phase variation system; in turn, these are coded by fliC 
and fljB genes [93]. The expression of fljB gene is controlled by a repressor fliA, which is known 
for its inverted sequencing [93]. The majority of Salmonella serovars can express both antigens 
(diphasic), some serovars have a 3rd flagellar antigen, and some serovars have only one phase 
(monophasic) [94]. Serotyping based on O-antigens and H-antigens has been the standard 
method for classification of Salmonella for the past 75 years. Currently, serotypes are typically 
named after the location where the first isolate derived. The serotype is not italicized, and the 
first letter of the name is capitalized (e.g. S. Typhimurium). Traditional serotyping is conducted 
via the antisera-antigen reaction. It is rapid for determining common serotypes, but labor 
intensive and time consuming for rare serotypes; further, good quality antisera is expensive and 
with a limited shelf-life. In the United States, clinical isolates often are sent to the USDA, 
National Veterinary Services Laboratories (NVSL) for expert reference laboratory serotype 
determination.  
2.4.2.2 Whole genome sequencing (WGS) based serotyping 
Through the advancement of WGS technologies, England and the United States have 
transitioned to WGS based serotyping methods [95]. Currently, two in silico serotyping methods 
to determine serotypes via the rfb gene clusters encoding O-antigens, flippase (wzx), polymerase 
(wzy) and H-antigens (fliC and fljB) have been developed: SeqSero and SISTR (Salmonella in 
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Silico typing resource) [96, 97]. In addition to serotypes, SISTR determines multi-locus sequence 
type (MLST), ribosomal MLST (rMLST), and core genome MLST (cgMLST) using 330 genes 
to increase the specificity. The accuracy and possibility using WGS based in silico serotyping to 
replace traditional serotyping were reviewed by Yachison et al. [98]. All three methods, 
SeqSero, SISTR, and MLST have high match rates of 94.8, 88.2%, and 88.3% with traditional 
serotyping. However, all methods have the possibility of errors. For example, in monophasic 
Salmonella, where the second flagellar antigen is not expressed phenotypically, the gene may 
still be present. As a result, inconsistency occurs between traditional antisera serotyping and in 
silico-based serotyping. SeqSero accepts both FASTQ and FASTA file formats, while SISTR 
accepts only FASTA files from draft assemblies.  
Accepting the FASTQ file format is advantageous because of the assessment of the 
sequencing quality and quick return of serotype. Additionally, FASTQ based raw reads use wzx 
and wzy for O group identification, which have more discriminatory power than using the rfb 
gene clusters that are available in FASTA and used in SISTR. The rfb gene clusters can end in 
two separate contigs after assembly. SeqSero overcomes this problem by further flanking the rfb 
cluster into four contigs and BLASTing with the rfb database, whereas SISTR often returns false 
results [96, 97]. Yachison et al discussed that the rfb gene clusters which determine the O-
antigen, can be fragmented and removed during library preparation using Illumina Nextera XT 
library preparation kits [98]. This problem can be overcome by using different library 
preparation kits or else skipping the filtering procedure. Since assembly is required for SISTR, a 
certain level of assembly quality is required and genes encoding the O-antigen and H-antigen 
may be fragmented into separate contigs; thus, incorrect serotypes may be returned.  
 
 25 
Based on our study, submitting raw FASTQ files from Illumina runs have higher return rates 
of serotypes in SeqSero, further described in Chapter V. Yachison et al. only used FASTA files 
as input files for the comparison of SeqSero and SISTR, and may have obtained better results in 
SeqSero by using FASTQ files as input files. In spite of the advancement of bioinformatics 
methods, traditional serotyping remains a continuously important method and resource in 
countries where WGS is too expensive to conduct due to equipment and reagent costs. 
Additionally, WGS requires bioinformatics and computing resources. In such cases, international 
collaboration on WGS can be a potential solution to allow for uniformity of the methods and 
meaningful comparisons between countries. Such collaborations are important, especially given 
food-borne pathogens are spread through travelers and imported/exported foods.  
2.4.2.3 Multi-locus sequence types (MLST) 
Multi-locus sequence types (MLST) are classified based on the sequence of 7 housekeeping 
genes. Housekeeping genes are amplified by PCR (450-500bp) and allele sequences of each 
fragment are determined and assigned distinct allele numbers. The pattern of the 7-integers 
defines its allelic profile and a sequence type (ST) is assigned to a strain. The variation within 
these housekeeping genes are sufficient enough to provide many alleles per locus and 
differentiate 20 billion multi-locus genotypes with an average of 30 alleles per locus specific to 
each bacterial species (see for example: MLST.net; http://beta.mlst.net/Instructions/default.html). 
The seven housekeeping genes designated for Salmonella are aroC, dnaN, hemD, hisD, 
purE, sucA, and thrA. As of April 2018, 4,127 MLST profiles are defined on the PubMLST 
website. Through the development of whole-genome sequencing (WGS) technology, MLST can 
now be conducted in silico. WGS has allowed for using more than the 7 housekeeping genes for 
MLST classification. Seven housekeeping genes, ribosomal MLST (rMLST), core-genome 
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MLST (cgMLST) or whole-genome MLST (wgMLST) have been developed for MLST based 
typing [97, 99-101]. STs are further classified into eBurst Groups (eBGs), which Achtman et al. 
defined as a group of STs that share six of the seven alleles that define a ST [99, 102]; however, 
eBGs can be user-defined. Most of the serotypes with multiple STs are classified into the same 
eBGs, while polyphyletic serotypes are in separate eBGs even by cgMLST. The rMLST method 
is more conserved than methods using housekeeping genes, and Achtman et al. found eBGs were 
similar between MLST and rMLST. Achtman et al. recommended replacing traditional 
serotyping with MLST for epidemiological studies because MLST reflects more of the genetic 
relatedness. Despite a broad belief that serotyping reflects genetic relatedness, that may not 
always be true.  
It has been shown that horizontal gene transfer (HGT) and homologous recombination are 
important processes for the evolution and serotype diversity of Salmonella [103]. S. Heidelberg 
and S. Typhimurium share the same fliC alleles (Phase I flagellar antigen) but they are 
genetically very distinct [99, 104]. S. Lubbock and S. Mbandaka belong to the same ST 413 and 
have high genetic similarity, but the fliC gene of S. Lubbock is the same as S. Montevideo, 
suggesting a homologous recombination has occurred between S. Mbandaka and S. Montevideo 
[105]. Homologous recombination happens between two DNA regions that have homologous 
sequences. Therefore, serotyping does not necessarily reflect the evolutional relationships 
between the isolates. 
In addition, many serotypes have been discovered to be polyphyletic, in that even though 
they share the same O- and H- antigen formula, they have multiple evolutionary origins; 
including S. Newport, S. Kentucky, and S. Montevideo [106-110]. The polyphyletic serotypes, S. 
Newport and S. Kentucky have 49 STs and 5 STs, respectively. A detailed study on S. Newport 
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lineages showed 3 groups of S. Newport I, II, and III. The 3 groups have host, antibiotic 
resistance, and geographic differences [106]. It has been shown that the diversity within the 
Newport serotype accumulated by a mixture of mutation and homologous recombination. Sangal 
et al. have tested the ratio of recombination vs. mutation (R/M per site) in S. Kentucky, 
Enteritidis, Newport and Typhimurium. In S. Enteritidis and Typhimurium, the R/M per site 
ranged from 0.81 to 1.69, respectively. Meanwhile, S. Kentucky was >10.0, which suggests that 
recombination plays an outsized role in the diversity of that serotype. S. Newport was not as 
extreme as these serotypes, which ranged 7.08 to 8.14 in Newport-II. S. Enteritidis had a more 
clonal structure than S. Newport. The authors discussed that the diversity by serotypes may be 
due to their differences in response to phage infection, such as CRISPR systems, and defense 
mechanisms against genetic exchange. In case of the S. Newport example above, they have 
distinct geographical distribution, as Newport-I is found mainly in humans in Europe while 
Newport-II and -III are found across host species in North America [106]. Newport-II were more 
associated with animals and Newport-III isolates were associated with humans in North 
America. Therefore, even if a S. Newport outbreak happens at the same time in the United States, 
these isolates may have consisted of Newport-I and Newport-II, and possibily from different 
sources.  
Susceptibility to antibiotics was also significantly different between the lineages. In 
Newport-II and III, 60 to 80 % were pan-susceptible, whereas 40% of Newport-I were MDR. 
Approximately 30% of Newport-II were of the MDR-AmpC phenotype. To summarize, even 
within the same serotypes, there are distinct differences between the lineages. Determining the 
lineage of the polyphyletic serotypes is essential, especially in outbreaks to identify the source 
and distribution of the isolates. It is also essential to determine the lineages when examining the 
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dissemination of antibiotic resistant bacteria since antibiotic resistant profiles tend to be distinct 
between the lineages. Sangal et al. [106] also showed that MLST based eBG designations were 
distinct between the lineages, further illustrating the discriminatory power of MLST over 
traditional serotyping.  
2.4.2.4 Pulsed-field gel electrophoresis (PFGE) 
In addition to traditional serotyping, molecular typing of Salmonella is conducted in 
outbreaks to increase the discriminatory power of bacterial isolation and comparisons with 
contemporaneous and historical collections [111]. Pulsed-field gel electrophoresis (PFGE) has 
been the gold standard for typing of Salmonella in outbreaks by the Centers for Disease Control 
and Prevention (CDC). PFGE classifies Salmonella through the “fingerprinting” of the bacteria, 
which is performed through digestion of the DNA by specified restriction enzymes (i.e: XbaI) 
[112]. The PFGE type is classified based on the restriction pattern as designated by PulseNet 
methods. This technology is discriminative and especially useful in outbreak cases to cluster the 
bacteria and distinguish outbreak related and non-related strains. A study showed that PFGE is 
more discriminative than 3-gene-based MLST schemes and serotyping; however, in a few cases, 
two serotypes were classified into the same PFGE pattern [113]. Another study reported that 
PFGE was able to discriminate outbreak strains related to 5 serotypes attributed to Roma 
tomatoes occurring in Pennsylvania and surrounding states in 2004 [112]. The PulseNet database 
is maintained by the CDC to compare PFGE patterns and is now adopted worldwide as PulseNet 
International [114]. In an era of international food trade and travel, PulseNet International is 
helping to network national and regional laboratories to track the spread of global food-borne 
infections.  
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Even though PFGE has strong discriminatory power, there are still several disadvantages. 
Some strains cannot be typed by PFGE, and a single nucleotide change in a restriction site may 
change the PFGE banding pattern. Additionally, PFGE is time-consuming, labor intensive, and 
requires specific equipment, and thus may not ideal for labs with small budgets or small staffing 
capacity. Despite the multiple-day effort to create the banding pattern, this pattern provides no 
additional genomic information; further, no virulence or antibiotic resistance genes can be 
identified. Similar to serotyping and MLST, a shift towards WGS based typing for molecular 
typing has been occurring in national laboratories around the world including the United States 
[115]. In fact, a number of studies have shown that WGS have a higher resolution for Salmonella 
enterica classification than PFGE [116-120]. The U.S. FDA has been developing the 
GenomeTrakr Network with regional and national labs from multiple U.S. states and countries 
[121]. As of 2017, more than 100,000 Salmonella genomes have been collected in the database. 
It is expected that GenomeTrakr will function as PulseNet in the near future and help to 
harmonize the methodologies and bioinformatic analysis pipeline for rapid and accurate 
identification of outbreak bacterial strains among regions and countries.  
2.4.2.5 Phylogenetic relationships of Salmonella 
Multiple methods of phylogenetic analyses are available for whole-genome based analysis. 
Using the sequence data from outbreak cases, pan-genome single-nucleotide polymorphism 
(SNP), core-genome SNP, and MLST methods have been explored in multiple studies [102, 116, 
119, 122, 123].  
The core-genome is characterized by the genes that are shared among strains at the same 
taxonomic level; i.e., genus, species, subspecies, serotype. As the taxonomic rank goes higher, 
the pool of core-genome gets smaller and vice versa [122, 124]. The pan-genome contains the 
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core-genome and accessory genes, such as phages, plasmids, transposons, and Salmonella 
pathogenicity islands (SPIs) [125, 126]. The size of the pan-genome increases as more genomes 
are included in the analysis, often because more accessory genes are included. A study by Laing 
et al. reported the sizes of strict core-genome and pan-genomes of Salmonella enterica 
subspecies ranging between 1.5Mbp and 25.3Mbp, respectively, among 4939 genomes including 
all 6 subspecies and 28 S. enterica subsp. enterica serotypes downloaded from the National 
Center for Biotechnology Information (NCBI) GenBank [127]. Conserved core genes of 3.2Mbp 
were found in 96% of the genomes. Within S. enterica subsp. enterica, 404 Salmonella species-
specific regions were found. S. Enteritidis had the highest average number of species-specific 
regions and S. Typhi had the most diverse genome among the tested serotypes, which is 
consistent with the previous study by Leekitcharoenphon et al. [124]. Fu et al. defined 3,846 
genes as the core-genome of S. Typhimurium, while the Salmonella enterica subsp. enterica 
core-genome was 2,882 genes [122, 124].  
Based on these core-genomes and the pan-genome, phylogenetic trees were constructed in 
the studies by Laing et al. and Leekitcharoenphon et al. The concordance between the 
phylogenetic trees constructed by the core-genome SNPs and presence/absence among the pan-
genome were high in both Laing et al. and Leekitcharoenphon et al. studies. The inclusion of the 
accessory genome (pan-genome tree) increased the bootstrap values in many of the branches; 
however, a pan-genome tree requires high-quality assembly and computer power [124]. Overall, 
phylogenetic trees constructed with the core-genomes were valid for evolutionary analysis. 
Interestingly, core-genome SNP analysis showed 3 novel Salmonella enterica subspecies in 
addition to 6 existing subspecies by including 297 representative genomes from ribosomal eBGs 
in subspecies enterica and 593 isolates from ribosomal ST in S. enterica and S. bongori [102].  
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A WGS analysis classified Salmonella enterica subsp. enterica into at least 2 lineages [107, 
108, 124]. A study by den Bakker et al. and Timme et al. showed 2 lineages: clade A and clade 
B in subspecies enterica. Most of the serotypes in clade A were negative for β-glucuronidase, 
SPI-18, and CdtB-islet, while clade B serotypes were positive for these genes [107]. Clade A was 
divided into 3 subclades consisted of a Typhi clade, an Agona clade, and the remainder of the 
clade A serovars. This result is consistent with the other study by Timme et al. [108]. Timme et 
al. divided clade B into 4 subclades based on strong bootstrap values [108]. Further, den Bakker 
et al. found clades A and B differed based on the presence of fimbrial operons, which suggests 
differences in their adhesion abilities. Other differences were in the genomic regions involved in 
nitrogen and carbon metabolism. The β-glucuronidase operon was found in clade B but not in 
clade A. The authors discussed that this may be associated with vertebrate host adaptation, since 
β-glucuronides are found in the gall bladder and gut of vertebrate hosts [107]. These 
phylogenetic analyses are useful tools to reveal the evolution and the host adaptation of 
Salmonella by analyzing SNP differences between the isolates or clades and identifying 
important gene differences.  
In many outbreaks, high discrimination between isolates within a serotype is necessary 
because the isolates are mostly clonal except for outbreaks associated with multiple strains. A 
number of retrospective studies have reported the discriminatory power of WGS-based 
phylogenetic tree construction by SNPs, presence/absence of genes in pan-genome, and k-mer 
phylogenetic trees utilizing outbreak strains [109, 117-119, 122, 123, 128]. Among several 
methods for the genome comparison, SNP analysis has been shown to have high discriminatory 
power in S. Typhimurium, S. Enteritidis, and S. Montevideo, which are common outbreak 
serotypes. Both reference genome-based and de novo genomic variance-based methods showed 
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the same tree structure in a study by den Bakker et al. [129]. To acquire high-quality SNPs, a 
minimum sequence depth of 20x is required in Salmonella [117, 123]. Further, high-quality 
scores of the reads and removal of recombination sites and indels is necessary [117, 118, 123, 
129].  
Leekitcharoenphon et al. showed that a pan-genome tree with presence/absence of genes 
failed to form accurate clusters in outbreak strains; however, the pan-genome tree formed 
meaningful clusters for the phage types. They discussed that this may be because prophages were 
included in the pan-genome-based analysis. In the same study, the nucleotide difference tree (ND 
tree) and SNP tree were able to cluster the outbreak isolates at 100% accuracy in S. 
Typhimurium. Very small numbers of SNP differences between the isolates are found in most 
outbreak studies, typically ranging from 2 to 12, while one outbreak had 3 to 30 SNP differences 
[118, 123]. Further, no SNP differences or else temporal associations were observed in these 
outbreaks even during a 27-month long outbreak [118]. As of now, SNP-based phylogenetic tree 
construction is one of the most commonly used and accurate methods to classify the isolates in 
an epidemiological outbreak study.  
Recently, the MLST-based tree construction method has also been used. A recent study from 
the research group of Acktman et al. compared the analysis of cgMLST (3,002 Loci) and 
wgMLST (21,065 Loci) with core-genome SNP analysis [102]. Core SNP and cgMLST 
classified outbreak and non-outbreak strains in a similar structure correctly, while wgMLST 
classified strains similar to that of PFGE, which was classified incorrectly at the time of an 
outbreak in 2005. Even though the authors recommend using cgMLST over core-genome SNPs, 
and MLST over traditional serotyping, determining the best phylogenetic methods may change 
as more data are collected and the methods mature. Pearce et al. also compared a Salmonella 
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Enteritidis outbreak in Europe by cgMLST and SNP analysis, and showed high congruence 
between the two methods [130]. The cgMLST method may be more reproducible and easier to 
implement across laboratories since it is a gene-to-gene based analysis with less variability [130].  
Fast, accurate, and easy to execute methods are preferred for bioinformatic analyses. 
Reproducibility and comparable data are necessary for comparison of analyses across 
laboratories and research groups. Since the population of users with bioinformatics skills, 
knowledge, and training are limited and as the sequencing technique is becoming more and more 
affordable, user-friendly tools are required to support the growing sequencing community. Web 
servers from Center for Genomic Epidemiology at the Technical University of Denmark, 
PATRIC from University of Chicago, and the Galaxy project are resources available for 
researchers or scientists who are developing bioinformatics skills. 
2.4.3 Antimicrobial susceptibility testing and genotyping of resistance genes in Salmonella 
2.4.3.1 Phenotypic resistance 
Antimicrobial susceptibility testing is commonly performed on bacterial culture to determine 
the minimum inhibitory concentration (MIC) of each of several antibiotics. The MIC is the 
lowest concentration of an antimicrobial where the growth of a bacterial isolate is inhibited. 
Common methods are by agar disk diffusion and broth micro-dilution. The microbroth dilution 
system is a commercialized and partially automated system developed and marketed by TREK® 
Sensititre® that is routinely used in diagnostic laboratories. The acquired MIC data are utilized 
to determine the appropriate treatment regimens for clinical patients. The MIC is compared to 
breakpoints established by Clinical and Laboratory Standards Institute (CLSI), which determines 
susceptible, intermediate, and resistance phenotypic breakpoints in addition to the MIC values 
[131]. The epidemiological cutoff value (ECOFF in European Committee on Antimicrobial 
 
 34 
Susceptibility Testing (EUCAST)) is different from breakpoints, in that they are upper limit 
values that distinguish a wild-type population of bacteria from the population with acquired 
resistant traits that exhibit higher MIC values [132]. When the breakpoint is not set for a 
particular bacterium and antimicrobial combination, consensus interpretive criteria set by the 
U.S. National Antimicrobial Resistance Monitoring System (NARMS) are used.  In our study as 
is common in other studies, we also rely on these consensus breakpoints [35, 133]. Even though 
antimicrobial susceptibility testing is widely used and breakpoint values are established, 
inconsistency in breakpoints between researchers and changes in the CLSI interpretive criteria 
over time causes difficulty in interpreting the results among published articles. Additionally, 
antimicrobial susceptibility testing is labor intensive and time-consuming. Thus, ensuring that 
the original MIC values are recorded and maintained is essential. 
2.4.3.2 Genotypic resistance 
Genotypic resistance data acquired by WGS matches with the phenotypic resistance data 
with high accuracy for most antibiotics in foodborne pathogens [134-136]. Among Salmonella, 
8,872 out of 8,960 isolates had genotypic and phenotypic agreement (99.0%) in a study by 
McDermott et al [136]. Overall sensitivity was 98.8%, in which phenotypic resistance was set as 
the gold standard. Sensitivities of 90.0% to 100.0% were reported for most of the antibiotics 
including aminoglycosides, ampicillin, cephalosporins, sulfisoxazole, azithromycin, 
chloramphenicol, ciprofloxacin, and tetracycline. The sensitivity of trimethoprim-
sulfamethoxazole and nalidixic acid were 86.4% and 86.7%, respectively [136]. Streptomycin 
had 98.8% sensitivity but a specificity of 90.8%, which was the lowest specificity of the 
antimicrobials tested. The disagreement for streptomycin occurred in isolates that were 
phenotypically susceptible but carried resistance genes. The MIC for streptomycin is not defined 
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by CLSI because streptomycin is not intended to be used for the treatment of enteric bacteria. 
The NARMS consensus breakpoint is >= 64 mg/L, while the MIC values of many isolates 
carrying resistance genes falls in the range of 32 mg/L [137]. Therefore, recently the consensus 
breakpoint of streptomycin has been changed to >= 32 mg/L in NARMS and EUCAST for 
Salmonella.  
Chromosomal mutations in quinolone resistance-determining regions (QRDRs) of gyrA, 
gyrB, parC, and parE genes and plasmid-mediated quinolone resistance (PMQR) genes are 
common resistance mechanisms for quinolones. Even if the bacteria carry qnr genes on 
plasmids, additional chromosomal mutations in QRDR are needed for bacteria to be 
phenotypically resistant to nalidixic acid or ciprofloxacin based on CLSI breakpoints.  
It is important to investigate both acquired resistance genes and chromosomal mutations to 
determine the genotype of the bacterium. Databases including ResFinder, ARG-ANNOT, and 
CARD are major databases for the detection of acquired resistance genes [138-142]. Recently, 
PointFinder has become available in the Center for Genomic Epidemiology (CGE) web server at 
the Danish Technical University (DTU), which identifies chromosomal mutations encoding 
resistance to quinolones, polymyxins, rifampicin, macrolides, and tetracyclines [143].  
In accordance with the recent advancement in sequencing technology, there is an effort by 
NARMS to develop genotypic cutoff values [132]. The authors compared over 20,000 MIC 
values with resistance determinants from WGS for 1,738 non-typhoidal Salmonella to establish 
“genotypic” cutoff values (GCVs) for 13 antimicrobials against Salmonella. GCV is defined as 
“the highest MIC of isolates in a population devoid of known acquired resistance mechanisms.” 
[132]. In the study by Tyson et al., only 0.36% of mismatch between phenotypic MIC values and 
GCVs were found. In amoxicillin-clavulanic acid (AMC), MIC values were compared among the 
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isolates without resistance genes, isolates carrying beta-lactamase genes (ESBLs: blaCTX-M and 
blaTEM-1) but not predicted to confer resistance to AMC and isolates with expected resistance 
genes (blaCMY-2). Interestingly, MIC distribution clearly separated into 3 groups in that isolates 
with MIC < 2 mg/L were all without genes, between 4 to 16 mg/L were carrying ESBL genes, 
and isolates with blaCMY-2 genes were >= 32 mg/L. All the isolates with ESBL genes had slightly 
higher MIC values than isolates lacking any beta-lactamase encoding genes, but not so elevated 
as to be phenotypically resistant per CLSI. The authors proposed to set the GCVs for AMC at  < 
2 mg/L with a note that isolates with MIC values >= 32mg/L may have distinct resistance genes.  
The benefits of GCVs are to set the breakpoints for drugs that do not have established 
breakpoint or cutoff values by CLSI or EUCAST. The limitation of this study that the authors 
did not compare the MIC values of isolates with multiple resistance genes, which would have 
higher MIC values, with those isolates with a single resistance gene. Even though phenotypes 
and genotypes have high concordance resistance genes are not always expressed, or else may 
have variants that result in lost ability to confer resistance. In the former case, only an exposure 
to antibiotics may trigger the expression of the resistance gene. Also, as different countries or 
regions are distributed with different resistance genes, it is possible to have different GCVs 
among countries. Comparison of more MIC and genotypic information will help further to 
establish the GCVs, which may eventually lead to a situation where it is no longer needed to 
conduct antimicrobial susceptibility testing from culture. A comprehensive study comparing the 
presence of resistance genes and MIC breakpoints provided by CLSI and EUCAST has not been 
previously reported. 
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2.5 Salmonella epidemiology and antibiotic resistance in humans and cattle 
2.5.1 Salmonella epidemiology in humans 
Approximately 1.2 million cases and 450 deaths attributed to Salmonella are estimated to 
occur every year in the United States [19]. Salmonella can colonize or infect a wide range of 
hosts, such as reptiles, poultry, wild animals, pigs, cattle, horses, humans, fish, dogs and cats. 
Human infections often are caused by consumption of undercooked meat, raw eggs, 
contaminated vegetables, spices, person-to-person contact (fecal-oral), often exacerbated during 
international travel, or via direct contact with infected animals. It is not recommended to treat 
mild salmonellosis with antibiotics because empirical treatment may not be effective against all 
likely Salmonella strains, and this may allow the resistant Salmonella population to expand. 
Symptoms of salmonellosis are diarrhea, fever, abdominal cramp, and vomiting. Usually the 
infection is self-limiting and patients recover within 4-7 days with oral rehydration or 
intravenous fluids. However, in severe cases in adults fluoroquinolones or azithromycin may be 
used for treatment. Infants, children, and immunocompromised people may require antibiotic 
treatment with cephalosporins such as in cases of bacteremia and meningitis.  
When severe cases of salmonellosis are caused by antibiotic-resistant Salmonella, there are 
fewer therapeutic options and treatment failures may occur. Medalla et al. estimated the 
incidence of resistant Salmonella infections as 0.51/100,000 person-years for ceftriaxone and 
ampicillin resistance [144]. In 2014, 72% of S. Typhi were resistant to nalidixic acid, 5% were 
resistant to ciprofloxacin, and 11% were MDR [145]. Among Paratyphi A, 80% were resistant to 
nalidixic acid. Since typhoid fever is treated with antibiotics such as quinolones, this is 
problematic due to reduced treatment choices and may lead to treatment failure. Importantly, 
human infection with these serotypes is not associated with animals or food. 
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Among the 831 foodborne outbreak cases recorded in 2012, 106 were caused by Salmonella 
according to the CDC. The food sources of Salmonella infection included vegetables, eggs, 
poultry, beef, and pork, among others. Beef is attributed to have caused 7.3% of the Salmonella 
infections from 1998 to 2008 [146]. Multiple retail meat associated outbreaks have been reported 
by the CDC. From 2011 to 2013, outbreaks related to ground beef were reported every year; 
however, no deaths were reported. A beef outbreak from 2011 caused by S. Typhimurium 
resulted in 20 infections and 8 hospitalizations. Isolates recovered from leftover food implicated 
beef and both these and the human isolates were of an MDR phenotype. A beef outbreak from 
2012 was caused by S. Enteritidis and infected 46 people resulting in 12 hospitalizations. The 
company that sold the product recalled 29,339 pounds of fresh ground beef. An outbreak from 
2012 caused by S. Typhimurium infected 22 people who ate a raw ground beef dish called 
kibbeh. All the isolates were pan-susceptible; in the end, the company recalled 500 pounds of 
ground beef.  
2.5.2 Antibiotic resistant Salmonella in humans 
The National Antimicrobial Resistance Monitoring System (NARMS) is a collaborative 
program run by the U.S. FDA, CDC, and USDA. The surveillance system launched in 1996 with 
testing of non-typhoidal Salmonella and E. coli O157:H7 isolated from humans. The animal 
component was launched in 1997 with testing of regulatory Salmonella isolates from chicken, 
turkey, swine, and cattle.  
A retrospective study of 2,149 Salmonella isolated from humans by the CDC showed that the 
proportion of antimicrobial resistant Salmonella increased during the period from1948 to 1995 
[147]. Among all Salmonella, 20% of the isolates were resistant to more than one antibiotic and 
there was increase in MDR isolates since 1950.  They also found a significant increase in 
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resistance to older drugs such as ampicillin, chloramphenicol, streptomycin, sulfamethoxazole, 
and tetracycline [147]. The top 5 serotypes were S. Enteritidis, Typhimurium, Newport, 
Heidelberg, and Saintpaul. Salmonella Typhimurium often exhibited resistance to more 
antibiotics than the other serotypes, while S. Enteritidis was typically the least resistant. In S. 
Typhimurium, tetracycline and streptomycin resistance rose from 0% to 42.6% from pre-1960 to 
post-1989. MDR isolates increased from 0% to 16.9%. Isolates with resistance to tetracycline 
was the most common phenotype observed, especially together with streptomycin or 
sulfamethoxazole resistance. No resistance to ceftiofur, ceftriaxone, and ciprofloxacin was 
detected [147]. However, this study only contained isolates up to 1995, when cephalosporins 
were not yet widely used in food-animals.  
A powdered cephalosporin requiring reconstitution (NAXCELÒ) was first approved in 1988. 
Later, a sterile suspension form (EXCENELÒ) was approved in 1998 by the FDA for food 
animal use. More recent NARMS data, including 24,903 non-typhoidal Salmonella isolates, 
reported the same distribution of serotypes as the study mentioned above; however, the 
proportion of MDR isolates decreased between 1996 to 2009, which was largely attributed to the 
decline in S. Typhimurium isolates [148]. In contrast to the study from 1948 to 1995, isolates 
with resistance to ceftriaxone increased from 0.2% in 1996 to 3.4% and resistant or intermediate 
susceptibility to ciprofloxacin increased from 0.4% to 2.4%.  
The most recent data from the 2015 NARMS Integrated Report show a decline in tetracycline 
and streptomycin resistance from 52.1% to 18.7% in S. Typhimurium from 1996 to 2015, 
respectively [32]. However, there was an increase in nalidixic acid resistance from 0.3% to 4% 
and ceftiofur resistance from 0% to 4%. Interestingly, S. Dublin isolates are showing a markedly 
significant increase in ceftiofur resistance, which was 0% until 2003 versus 66.7% as of 2015 in 
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human isolates. Tetracycline and streptomycin resistance were around 25% in 1998 and 
increased to 83.3% in 2015 in S. Dublin. S. Dublin is a host-adapted serotype commonly found in 
cattle. Human cases involving this serotype are rare; however, when they do occur they tend to 
cause severe illness in humans often resulting in bloodstream infections, which require antibiotic 
treatment and hospitalization.  
2.5.3 Salmonella epidemiology and antibiotic resistance in feedlot cattle 
The prevalence of Salmonella in feedlot cattle varies by region, season, and method of 
sampling [149-153]. Prevalence at the feedlot level, pen level, and sample level were 60.3%, 
35.6%, and 9.1%, respectively in a USDA APHIS 2014 study [154]. Southern regions have a 
higher prevalence than northern regions and a higher prevalence is found in the summer months 
compared to the winter [149, 155, 156]. Higher temperatures may be more suitable for the 
survival and propagation of Salmonella outside the host. One study showed that the thermal 
environment is associated with fecal shedding of Salmonella in dairy cattle, which suggests that 
thermal stress can be a factor for increasing the prevalence in southern regions or during the 
summer months more generally [156].  
Prevalence of Salmonella in cattle at slaughter has been studied extensively, typically 
because Salmonella contamination of meat products often occurs at the slaughterhouse. Samples 
collected from hides, lymph nodes, or carcasses at harvest tend to have a higher prevalence of 
Salmonella than in the same animals’ feces [157-160]. Barham et al. showed that transportation 
of the cattle from farm to the abattoir is a potential stressor and causes animals to shed more 
Salmonella. In fact, the prevalence of Salmonella before transportation was 6% and 18% on 
hides and in feces at the feedlot. The prevalence increased to 89% on hides and 46% in feces 
upon arrival at the abattoir [157]. Fluckey et al. also observed a similar increase on hides from 
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before to after shipping cattle to a commercial abattoir [158]. Salmonella was identified in 33.9% 
of the fecal samples and on 37.3% of the hides before shipping; however, at the abattoir, 
Salmonella was identified from 84.2% of hides [158].   
A study by Kunze et al. reported that the prevalence of Salmonella at abattoirs recovered 
from hides was 69.6%, while feces was 30.3% [159]. This may be due to stress shedding of 
Salmonella and cross-contamination of the external surface of multiple animals during the 
transport [158]. The concentration of Salmonella was also higher on hides (1.82 log10 /100cm2) 
compared with feces (0.75 log10/g feces). However, Kunze et al. discussed the likelihood of bias 
caused by the sampling size of hides versus feces (1,000cm2 vs. 150g feces), where 
approximately 6 times a difference in dilution factors may occur. In addition, Salmonella within 
fecal samples may not uniformly distributed. To compare more accurately the prevalence of 
Salmonella between hides and feces before and after transportation, it is important to sample 
from multiple hides and enough fecal material. Due to inconsistent methods and difficulties of 
back calculation between hides and feces, it may not be appropriate to directly compare the 
concentration of Salmonella between hides and feces.  
Most often, Salmonella infections in cattle are subclinical, but the Salmonella shed by 
subclinical cattle can infect cattle within the same pen or herd. Salmonella Typhimurium, 
Newport, and Dublin are serotypes that are commonly pathogenic for cattle. Additionally, these 
serotypes are commonly MDR and can cause severe salmonellosis in humans, as mentioned 
above [160-163]. The recent increase in S. Dublin with resistance to cephalosporins in humans is 
a very serious concern [164]. Although the serotypes reported from feedlot cattle vary, the most 
common serotypes reported are S. Typhimurium, Anatum, Agona, Kentucky, Montevideo, 
Mbandaka, Muenster, Cerro, and Newport [150, 151, 153, 159].  
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Approximately 70% of Salmonella isolated from feedlot cattle feces are pan-susceptible to 
the panel of antibiotics tested in many studies [150, 153, 165, 166]. The most common antibiotic 
resistance reported is to tetracycline (21.7%) and then to sulfisoxazole (12.4%) [150, 153, 159].  
Resistance to 3rd generation cephalosporins are reported to be around 0.5% [152] and rarely, 
Salmonella with reduced susceptibility to nalidixic acid was reported [166]. Often serotypes and 
antibiotic resistance profiles are associated in Salmonella isolates [159, 167]. In the cattle 
population, ceftiofur resistant Salmonella Newport isolates rapidly increased in the United States 
from 1998 to 2003. This increase in resistance was more than any other reported resistance in 
food-animals, according to CDC. This rise in S. Newport with resistance to ceftiofur coincided 
with the approval of ceftiofur in liquid form, EXCENELÒ in 1998 and later the longer-acting 
formula, EXCEDEÒ in 2003 for use in cattle (Figure 3).  
A study in humans, retail meat, and food animal-derived ceftriaxone-resistant non-typhoidal 
Salmonella from 1996 to 2013 showed that 2.9% of human-derived isolates were resistant to 
ceftriaxone [168]. Among the total isolates tested from different sources, 26.2% of retail chicken, 
9.0% of ground turkey, and 13.5% of ground beef-derived isolates were ceftriaxone resistant. 
The common ceftriaxone-resistant serotypes were Newport (40%), Typhimurium (26%), and 
Heidelberg (12%). Although ceftriaxone-resistant S. Newport increased in humans and cattle, 
peaking around 2001 in humans and 2005 in cattle, the percentage of ceftriaxone resistance 
isolates was not correlated. In addition, S. Newport was not frequently detected in retail ground 
beef; however, resistance pattern profiles correlated significantly with isolates from humans and 
cattle [168]. On the other hand, antimicrobial resistance among S. Typhimurium isolates from 
cattle and chickens was higher than in human isolates [168]. Ceftriaxone resistance in S. 
Typhimurium correlated significantly between humans and cattle, while no correlation was 
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found between human and chicken isolates. Further, no correlation was found between retail 
meat and human or animal isolates. Resistant S. Heidelberg has recently been rising and 
ceftriaxone resistance is highly correlated between isolates from humans, chicken, and turkey in 
that serotype [168].  
Although the study by Iwamoto et al. [168] only showed correlations between ceftriaxone-
resistant Salmonella in food-animals and humans, and did not establish any causality, it provides 
evidence that food-animals may be a source of ceftriaxone-resistant Salmonella in humans or 
perhaps even vice versa. The data derived from NARMS including the study by Iwamoto et al. 
and others listed in this chapter need to be interpreted with caution because the isolates used in 
NARMS study may be biased by the differing sampling methods. For example, the human 
isolates were collected through passive surveillance at the state level until 2003. The human 
isolates also were only collected from clinical samples and do not including healthy individuals. 
Clinical samples derive from patients who are sick enough to visit the hospital and are more 
likely to have received antibiotic prescriptions or have taken antibiotics by themselves. Isolates 
from such patients are therefore more likely to be resistant. This can bias the distribution 
estimate of antibiotic resistant bacteria. To estimate overall distribution of antibiotic resistant 
bacteria among the healthy population, it is necessary to include healthy human derived isolates, 
though current dogma suggests that humans are not typically asymptomatic carriers of 
Salmonella. The sampling program of food-animal isolates is part of the USDA in-plant HACCP 
monitoring and changed in 2006 from a random selection of slaughter establishments to those in 
non-compliance. These biases have to be taken into consideration in evaluating NARMS data, 
though recently the sampling has further changed to that of an active surveillance using cecal 
sampling [169].  
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Since the partial ban on extra-label use of cephalosporins in 2012 [170], the NARMS 
Integrated Report from the USDA shows that ceftriaxone resistance in Salmonella has declined 
from all nonhuman sources including beef cecal, dairy cecal, and other cattle samples (HACCP); 
this may be because of the improvements in the judicious use of antibiotics [164]. The decline of 
Salmonella isolates with cephalosporin resistance genes has also been observed in retail chickens 
and ground turkey, as reported in the FDA portion of the NARMS study [32]. However, in retail 
ground beef Salmonella isolates carrying cephalosporin resistance genes increased from 2012 
until 2014 and then declined in 2015 [32]. In the human derived isolates, ceftriaxone resistant 
Salmonella has been declining since 2003, according to the CDC [171]. The differences on 
detection of resistant Salmonella isolates among USDA, FDA, and CDC might be explained by 
the variation in detected serotypes of Salmonella.  
Host specificity, resistance phenotype and genotype, and pathogenicity differ among 
serotypes of Salmonella. For example, the recent increase of cattle derived resistant Salmonella 
is likely explained by the increase of MDR S. Dublin, which is a cattle-adapted serotype. Since S. 
Dublin infection in human tends to be severe, this may be problematic. On the other hand, 
increased resistance in ground beef samples may be due to rare serotypes that are not highly 
pathogenic to humans, and thus may not be problematic. Data from CDC derived from clinical 
cases which may be from severe cases often are narrowed to serotypes that are pathogenic to 
humans. For example, monophasic S. Typhimurium tends to be MDR and pathogenic to humans, 
and therefore may more often be more detected from human isolates. As mentioned previously, 
in a polyphyletic serotype like S. Newport, host and antibiotic resistance differs within the 
serotype. Although the NARMS data will show the tendency of antibiotic resistant populations in 
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each section, which are food animal, retail meat, and human, careful investigation per serotype is 
always necessary. 
 
 
Figure 3. Ceftriaxone-resistant Salmonella from food-animals (2015 NARMS Integrated 
Report [32]) 
 
 
2.5.4 Comparison of resistant bacteria in human and animal populations 
Through the development of advanced molecular techniques, we are gaining a broader 
perspective on antibiotic resistance. In 2012, Mather et al. used novel ecological and 
epidemiological methods to compare the phenotypic resistance profiles of Salmonella 
Typhimurium DT104 isolates derived from cattle and human populations collected from 1990 to 
2004 in Scotland [66]. Although some similar resistance profiles were found between cattle and 
humans, unique distinguishable phenotypic resistance profiles in the cattle and human 
populations were observed and maintained within the population. Among the similar resistance 
profiles, more profiles were observed earlier in the human population. A similar study was 
conducted on Salmonella isolates derived from cattle and humans from 2004 to 2011 in 
 
 46 
Washington State by Afema et al. [68]. The phenotypic antimicrobial resistance profiles of the 
dominant serotypes (Typhimurium, Newport, and Montevideo) were not shared among cattle and 
human-derived isolates. Isolates derived from the human population had more diverse 
phenotypes than the cattle isolates. They also observed that non-clinical cattle were carrying less 
diverse resistant bacteria than clinical cattle. The bacteria that enter the human population 
through food animals more often are those from healthy animals and not the animals exhibiting 
clinical symptoms. Most Salmonella infected cattle do not show clinical symptoms.  These 
results suggest that among the resistant Salmonella, even though some are shared between 
human and cattle population, unique isolates are circulating mostly within their own species. 
2.6 Control of Salmonella 
As of the time of writing, Salmonella is not considered as an adulterant by the USDA Food 
Safety and Inspection Service (FSIS) [172]. If Salmonella are isolated from raw meat, the 
product can still be sold legally in the market. It is highly recommended to properly cook each 
food item to reach the recommended temperature to kill Salmonella (e.g. 62.8°C for raw meat, 
71.1°C for ground meat and egg dishes, 73.9°C for poultry) [173]. Manufacturers voluntarily 
recall a contaminated batch if Salmonella are detected in multiple tests. On the other hand, 
Salmonella detected in ready-to-eat meats are considered an adulterant and legal action (such as 
issuance of a recall notice) can be taken by the FDA. That may happen, for example, when 
ready-to-eat meat is not cooked properly or a spice was rubbed on that was contaminated with 
Salmonella.  
The FSIS implemented the 1996 Pathogen Reduction/HACCP Systems Final Rule, which 
required establishments that slaughtered animals or prepared meat to meet Salmonella 
performance standards [174]. The performance standards of Salmonella were set to the 
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prevalence of 7.5% for ground beef. Standards for market hogs, cows, and steers were 
discontinued in 2011. The standard for ground chicken was set to 44.6% in 2011 and in 2015 it 
was proposed to reduce the standard to 25%. By setting these standards, meat and poultry 
producers adopted various internal testing programs to reduce Salmonella contamination. 
Product recalls because of bacterial contamination negatively impact the producers financially 
and commercially; therefore, reducing the risk of contaminationis a priority for industry. In the 
outbreak case of Foster Farms related to S. Heidelberg from chicken in 2013 to 2014, a 5-year-
old child suffered serious brain damage from Salmonella infection. The lawsuit filed against 
Foster Farms returned a verdict of $6.5 million with 30% of the fault attributed to Foster Farms 
and 70% to the family who improperly handled the chicken 
(https://www.businesswire.com/news/home/20180312005082/en/Pritzker-Hageman-Wins-6.5-
Million-Verdict-Landmark).  
A petition was prepared by a consumer group in 2014 in order to declare four antibiotic-
resistant Salmonella serotypes (S. Hadar, Heidelberg, Newport, and Typhimurium) as 
adulterants. The petition was rejected by the USDA FSIS because there was not enough 
scientific evidence that antibiotic resistant Salmonella are more heat resistant and more virulent 
than susceptible strains of Salmonella [172]. As Salmonella are often subclinical and commonly 
exist in food-animals, recalling all meat contaminated with Salmonella may not be the best 
solution from an industry stand-point. From a scientific stand-point, determining the serotypes 
and antibiotic resistance profiles of Salmonella is more laborious than simply detecting 
Salmonella. It takes approximately one week to isolate Salmonella using standard enrichment 
and culturing techniques. Declaring only certain serotypes and antibiotic resistance profiles as 
adulterants is also not realistic, because different pathogenic serotypes emerge in humans (e.g. 
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increase of S. Dublin and monophasic S. Typhimurium) and antibiotic resistance is not 
necessarily linked to pathogenicity.  
A metagenomics approach to detect Salmonella and determine serotypes may be one possible 
solution for this controversial issue. For example, samples can be lightly enriched in Salmonella 
selective broth and the enrichment broth can be used for further metagenomic analyses. On the 
other hand, E. coli O157:H7 and 6 serotypes of Shiga-toxin producing E. coli (STECs) are 
considered adulterants in ground beef because infective doses are very low and the infections 
caused by E. coli O157:H7 are often severe and life threatening; that is, leading to tragic 
outcomes such as kidney failure, hemorrhagic colitis, and death. Outbreaks caused by E. coli 
O157:H7 and the “big six” non-O157 Shiga-toxin producing serotypes, following their 
declaration as adulterants in ground beef, have been reduced by half. The success was possible 
because of a rapid diagnostic test system and the mandated regulatory requirement and fears of 
the costs associated with recalls.  
Salmonella contamination of meat from food-animals can occur at multiple stages such as 
transportation to the slaughterhouse and during the slaughter process from hides and feces [152, 
157]. Fecal, hide, and lymph-node contamination are believed to be the main sources of carcass 
contamination [152, 175]. Rinse water or improper handling of the meat are also potential 
sources of contamination. However, overall contamination levels can be decreased if Salmonella 
can be reduced pre-harvest in cattle and the environment. Moreover, proper use of antibiotics 
during the finishing period in feedlot may help reduce antibiotic-resistant Salmonella. Schmidt et 
al. followed the occurrence of resistant E. coli and Salmonella in feces and on hides from feedlot 
to processing plants and until the final carcasses were refrigerated and stored [152]. In that study, 
E. coli and Salmonella population existed in feces and hides at the feedlot and during processing. 
 
 49 
Salmonella was not detected on the final carcass. However, cephalosporin resistant E. coli 
concentrations on hides during processing were correlated with the contaminant concentration on 
the final carcass [152]. Interestingly, even though the prevalence of cephalosporin resistant 
Salmonella was only 2.8% in feces at one of the feedlots, prevalence on hides was 55.6%. 
Samples from an additional two feedlots were only detected with Salmonella from 8.1% of hides 
at the feedlot; however, 100% of hides at processing were detected with Salmonella. Moreover, 
1.4% were resistant to cephalosporins. These are alarming results, since antibiotic resistant E. 
coli and Salmonella derive from feedlots where intervention will be needed to reduce the 
concentration of resistant bacteria. 
As mentioned above, Salmonella prevalence in the feedlot varies by region and season. 
Antibiotics are not labeled nor typically used to control Salmonella infections in cattle. 
Vaccinations are available for chickens, pigs, and cattle for common host-adapted serotypes, 
such as S. Newport and S. Dublin; however, vaccination is not a common practice. Some of the 
obstacles to control Salmonella in the feedlot are that Salmonella infections often are subclinical 
and Salmonella is shed intermittently [74]. Mechanisms of intermittent shedding are 
complicated. Stress conditions of the animal can induce shedding, such as transportation or 
antibiotic treatments. Even though Salmonella was not detected before sending an animal to the 
slaughterhouse, animals may shed during transportation, which may increase the risk of 
contamination of hides during shipment and the carcass at the slaughterhouse [157].  
Ivanek et al. modeled that the fecal shedding and immune responses in pigs are strongly 
dependent on the serotype and dose of infection [176]. They experimentally infected pigs with 
low (0.65x106 CFU/pig) or high (0.65x109 CFU/pig) doses of Salmonella using 4 different 
serotypes, Salmonella Typhimurium, Derby, Yoruba, or Cubana. They examined the fecal 
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shedding of the pigs and classified the pigs into 4 shedding stages; latent, continuous shedding, 
intermittent non-shedding and intermittent shedding. The pigs infected with high doses of 
Salmonella Typhimurium or Salmonella Derby, which are more invasive and pig-adapted 
serotypes, were likely to enter an intermittent non-shedding state after continuous shedding 
rather than recovering. Although their shedding time was shorter during continuous shedding and 
the intermittent shedding state, they were more likely to re-enter into intermittent non-shedding 
state as well. Therefore, in total, pigs infected with Typhimurium or Derby tend to shed 
Salmonella for a longer duration and at a higher rate than the pigs infected with Yoruba or 
Cubana. The study suggests that serotypes of Salmonella are an important factor in shedding, 
which ultimately affects the dissemination to other animals within the pen.  
Quantification of Salmonella has been conducted at multiple stages for risk assessment 
purposes from pre-harvest to post-harvest stages [177, 178]. The probability of illness from 
Salmonella Enteritidis contamination in eggs was predicted from a dose-response curve by the 
FAO [177]. Even low doses of contamination in retail meat can multiply to harmful levels due to 
inappropriate storage conditions; typically, an inadequate cold chain and other ambient factors 
[178]. The prevalence and quantity of Salmonella have been reported in cattle and pigs from 
hides, lymph nodes, and feces at the feedlot and slaughterhouse to assess the risk of 
contamination in the food chain and to identify high-shedding cattle [159, 165, 179-182]. 
Accurate quantification of Salmonella is a challenging task, especially from fecal samples with 
large amount of background microbiota. Kunze et al. reported the concentration of Salmonella in 
feces was 1.03 most-probable number (MPN)/g in feedlot cattle with desirable weight for harvest 
and 0.48 MPN/g in poor productivity cattle. The concentrations of Salmonella from hide swabs 
at the abattoir were 2.32 MPN/g in feedlot cattle and 1.24 MPN/g in dairy cattle. The prevalence 
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or concentration of Salmonella in fecal samples and hides differs by the sampling methods and 
sampling sites; therefore, caution needs to be exercised when comparing the results.  
For example, in fecal samples E. coli or Salmonella may locate in one part of the voided 
feces, or in the fecal sample, but not be included in the part used for isolation [182]. Similarly, 
environmental samples may require multiple samplings from different sites. Agga et al. 
evaluated fecal grab (FG) and recto-anal mucosal swab (RAMS) sampling methods for 
enumeration of Salmonella in feedlot cattle. Fecal samples were collected from eight different 
commercial feedlots approximately 90 days pre-harvest. Fecal grab samples and RAMS were 
directly spiral plated for enumeration. Detection of Salmonella from FG samples were 
significantly higher than from RAMS, and overall Salmonella prevalence was high in this study 
(89.6% of RAMS and 98.8% of FG). The mean Salmonella concentration was 3.04 log CFU/ml 
by RAMS and 3.15 log CFU/ml by FG. Kappa agreement was 0.2 and classified as low. This 
was because the the Kappa calculation depends on the prevalence of the disease. In this 
experiment, the prevalence of Salmonella was 99% by FG, which adversely affected the Kappa 
calculation. The authors used PABAK (prevalence-adjusted bias-adjusted kappa) and obtained 
0.82 agreement between these two sampling methods. The authors classified cattle shedding 
more than 2.7 log CFU/ml as high-shedders. PABAK agreement between FG and RAMS for 
identifying high-shedding cattle was 86.3%. The mean concentration of Salmonella for the 
samples that were detected by FG (but not with RAMS) was log 1.07 CFU/ml. This may be due 
to the heterogeneous distribution of Salmonella within the feces. Therefore, the authors 
suggested RAMS as the best method for enumeration and detection of Salmonella and for 
identifying high-shedding cattle. However, because the prevalence of Salmonella in this study 
was very high, RAMS may not be applicable for the farms with a low prevalence of Salmonella 
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or cattle infected with different serotypes of Salmonella. The Agga et al. study did not identify 
the serotypes of the Salmonella and these Salmonella concentrations may not be applicable to 
other serotypes.  Since many cattle are subclinical and shed intermittently, frequent RAMS 
sampling may be necessary.  
Hide sampling also differs by sampling site and sampling multiple locations is necessary for 
accurate test results. Kalchayanand et al. tested hide samples from the left and right shoulders, 
left and right ribs, back, and belly for the prevalence of E. coli O157:H7 and Salmonella [183]. 
The belly was identified as the site most likely to be naturally contaminated by both bacteria. At 
one sampling from 64 carcasses, the Salmonella prevalence for back samples was 9.4%, while 
the belly was 54.7%. Therefore, it is recommended to test multiple sites for accurate estimation 
of the prevalence.  
Utilizing different enumeration methods also makes it difficult to compare the Salmonella 
concentrations between studies. There are a number of reported enumeration methods, such as 
most probable number (MPN), immunomagnetic isolation methods, spiral plating (or serial 
dilution) methods, and quantitative real-time PCR (qPCR). Each method has advantages and 
disadvantages in the sensitivity, specificity, labor intensity, accuracy, reproducibility, and 
repeatability. The advantage and disadvantage of MPN method and qPCR were compared in a 
mini-review by Malorny et al. [178]. The quantitation limit for the MPN method is 1.8 MPN/g 
and takes 4-5 days, while qPCR can detect as low as 1 cell in 10g of food and can be automated. 
In addition, studies use different back calculations and units to present the results, and a 
consensus unit may be required for comparison between studies.  
Multiple steps can be taken to control Salmonella entering into the food supply. However, to 
reduce antibiotic resistant Salmonella, prudent use of antibiotics at the feedlot is key because this 
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is the final environment in which the cattle reside and may receive antibiotic treatment. Several 
strategies were proposed to combat antimicrobial resistance by controlling the use of antibiotics 
in the food-animal production system. In Europe, the Precautionary Principle, which was 
justification for banning the growth promotion use of antimicrobials in food animals, was 
adopted in 2006 based on the assumption that the cause of antimicrobial resistance in humans is 
due to growth promoter use of antibiotics in food animals [184, 185]. On the other hand, in the 
United States the use of medically important antibiotics for growth promotion purposes 
effectively disappeared in 2017 when their labels were withdrawn by the drug sponsors. Also, 
the judicious use of antimicrobials has been promoted, where judicious use is defined as “drug 
use practices aimed at maximizing therapeutic efficacy while minimizing the selection of 
resistant microorganisms” by the FDA. This judicious use policy consists of 1) limiting 
medically important antimicrobial drugs to uses in food-producing animals that are considered 
necessary for assuring animal health, and 2) limiting medically important antimicrobial drugs to 
uses in food-producing animals to those that include veterinary oversight or consultation, which 
are discussed later.  
2.7 Antibiotics and Antibiotic Resistance Mechanisms 
2.7.1 Antibiotics and antibiotic resistance 
Different classes of antibiotics are available for both human and animal use. Antibiotics are a 
subclass of antimicrobials, originating from a microbial source, and tend to specifically target 
bacteria (i.e., are antibacterial). The WHO has categorized medically important antimicrobials 
into three categories via two criteria [186]. The first criterion (C1) is “The antimicrobial class is 
the sole, or one of limited available therapies, to treat serious bacterial infections in people”. The 
2nd criterion (C2) is that “The antimicrobial class is used to treat infections in people caused by 
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either: (1) bacteria that may be transmitted to humans from non-human sources, or (2) bacteria 
that may acquire resistance genes from non-human sources.” Critically important antimicrobials 
are those meet both C1 and C2. Highly important classes meet either C1 or C2 and lastly, 
important classes are those used in humans that meet neither C1 nor C2. Critically important 
antimicrobials include carbapenems, 3rd and higher generations of cephalosporins, gentamicin, 
ciprofloxacin, vancomycin, and others. Highly important antimicrobials include 
chlortetracycline, sulfamethoxazole, trimethoprim, 1st and 2nd generation cephalosporins, and 
others [186].  There are only 3 classes of antibiotic that the WHO does not classify as medically 
important for human medicine. 
In general, multiple mechanisms for antibiotic resistance are known; 1) modifications of 
the antimicrobial molecule by production of enzymes that can degrade or inactivate the drug, 2) 
prevention to reach the antibiotic target by decreasing antibiotic penetration and by efflux 
pumps, 3) change and/or bypass the target site, 4) and global cell adaptations [187]. Antibiotic 
resistance can be transmitted both inter- and intrabacterially via transformation (chromosomal), 
conjugation (plasmid), transduction (phages), and also via transposons and integrons [188]. 
Along with plasmids, these latter factors are called mobile genetic elements, which often contain 
antibiotic resistance genes and contribute greatly to the evolution of prokaryotes and the 
dissemination of antibiotic resistance [189].  
2.7.2 Cephalosporins and their resistance mechanisms 
Cephalosporins are in the class of b-lactam antibiotics first isolated from a fungus 
Cephalosporium acremonium, now named Acremonium chrysogenum, and found in a sewer in 
1948. Cephalosporins have a similar structure to penicillin and inhibit bacterial cell wall 
synthesis by disrupting the synthesis of the peptidoglycan layer by binding to the penicillin-
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binding protein (PBP). Penicillin-binding proteins are transpeptidases, which facilitate the 
transpeptidation step in cell wall synthesis. PBP binds to b-lactam antibiotics because of the 
chemical structure similarities to D-alanyl-D-alanine, which forms the peptidoglycan layer. This 
binding process is irreversible and is how cephalosporins act as bactericidal antibiotics.  
Cephalosporins became commercially available in 1964 for human use and since then the 
consumption of cephalosporins has continuously increased [190]. In 2015, cephalosporins were 
ranked the top 3rd of oral antibiotic classes and agents prescribed for outpatients in the United 
States [191]. Currently, five generations of cephalosporins have been developed. The spectrum 
and coverage of Gram-positive and Gram-negative bacteria differ by the generation of 
cephalosporin used. Third generation and higher cephalosporins are classified as the highest 
priority within the critically important antimicrobials by the WHO [186]. Critically important 
cephalosporins have the possibility of “transmission of Enterobacteriaceae, including E. coli and 
Salmonella, from non-human sources” [186]. Third generation cephalosporins, such as 
ceftriaxone are one of the few choices for the treatment of invasive salmonellosis in children or 
immunocompromised people. Fluoroquinolones and azithromycin are other antibiotic options for 
salmonellosis treatment in adults. Fluoroquinolones are not used for children because of the 
increased risk of musculoskeletal disorders [24]. Ceftriaxone is effective against Gram-negative 
and Gram-positive bacteria, and extended-spectrum cephalosporins, more tolerate to b-lactamase 
produced by the bacteria.  Ceftriaxone has a long half-life, which makes it a favorable antibiotic 
for the treatment of community-acquired infectious diseases, Lyme disease, and sexually-
transmitted diseases. Cephalosporins are time-dependent antibiotics, which means they are 
effective when they are at a concentration higher than the minimum inhibitory concentration 
(MIC) for a requisite amount of time.  
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Ceftiofur and cephapirin are the only cephalosporins approved for food-animal use by the 
FDA. Ceftiofur is in the same class as ceftriaxone and used for the treatment and control of 
bovine respiratory disease in beef cattle caused by Mannheimia haemolytica, Pasteurella 
multocida, and Histophilus somni and for foot rot and metritis. Cephalosporins are estimated to 
encompass only <1% of the mass of antimicrobials sold for food-animal production purposes, 
around 31,010 kg in 2016 [6]. However, it is estimated that in 2016 80% of cephalosporins 
marketed for food-animals were intended for use in cattle [6]. Multiple formulas of ceftiofur are 
available: in powdered form (NAXCELÒ, approved 1988), as a sterile suspension (EXCENELÒ 
RTU EZ, approved 1998), and in a long-acting suspension (EXCEDEÒ, approved 2003) 
marketed by Zoetis. EXCEDEÒ or ceftiofur crystalline-free acid (CCFA) is a long-acting 
formula used in beef cattle, dairy cattle, horses, and pigs. A one-time subcutaneous injection at 
the base of the ear is required by the label for the treatment or control of BRD in cattle. Ceftiofur 
metabolizes into desfuroylceftiofur within 10 minutes after injection and this metabolite is 
equally as effective as ceftiofur for 7 days per label instructions. Withdrawal time for beef cattle 
is 13 days prior to slaughter following a single injection.  
Bacteria most often become resistant to cephalosporins by acquiring b-lactamase producing 
genes. b-lactamases are enzymes that can break the b-lactam structure through hydrolysis. b-
lactamase enzymes are traditionally divided into 4 classes, A, B, C, and D (Ambler 
classification) based on the protein sequence (Figure 4) [192]. In 2009, Bush & Jacoby updated 
the Ambler classification into 3 groups based on the enzymatic function to aid clinicians and 
laboratory microbiologists in clinical decision-making (Figure 4). Relating the Bush and Jacoby 
clasification to the Ambler classification: group 1 consists of classes A, C, and D which utilize 
serine to hydrolyze b-lactams, and group 2 consists of class B metalloenzymes that require 
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divalent zinc ions for the hydrolysis process. An added functional classification separates class C 
(including AmpC) from classes A and D in that they are more active on cephalosporins than 
benzylpenicillin [192].  
AmpC proteins are resistant to inhibition by clavulanic acid and active on cephamycins (2nd 
generation cephalosporins), although a few exceptions exist in Klebsiella pneumoniae derived 
AmpC. AmpC expression is inducible by exposure to certain b-lactams in many bacteria. When 
large quantities of group 1 enzymes are produced, they confer resistance to carbapenems [187]. 
A Salmonella Wien with porin loss and the blaCMY-4 gene was resistant to imipenem reaching 
MIC values of 32 µg/ml [193]. As of 2009, 890 b-lactamases have been discovered; including 
blaCMY-2 in group 1, and blaCTX-M, blaSHV, blaTEM extended spectrum b-lactamase (ESBL) in 
group 2. Group 3, or class B, enzymes are functionally and structurally unique because they 
require a zinc ion at the active site (so-called metallo-beta-lactamases) and are not inhibited by 
clavulanic acid, but by metal ion chelators, such as EDTA.  
 
 
 
 
 
 
 
 
 
 
Figure 4. Schematic illustration of b-lactamases according to the Ambler 
classification scheme (Adapted from Munita and Arias, 2016 [187]) 
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2.7.3 Transmission of cephalosporin resistance via blaCMY-2 gene 
Until recently, in the United States the blaCMY-2 gene was the leading ceftiofur/ceftriaxone 
resistance gene discovered in food-animal production and in humans infected with foodborne 
Salmonella. The blaCMY-1 gene encoding beta-lactamase enzyme is the oldest cephamycinase 
discovered. The blaCMY-2 gene belongs to AmpC enzyme group. These genes can hydrolyze 
cephamycins including cefoxitin and cefotetan, and oxyiminocephalosporins such as 
ceftazidime, cefotaxime, and ceftriaxone, and monobactams such as aztreonam. Clavulanic acid 
does not have much effect on AmpC b-lactamases. The blaCMY-2 gene originated from the 
chromosome of Citrobacter freundii [194]. Plasmid borne blaCMY-1 was first reported in 1989, 
which rapidly spread in hospital and animal-derived Salmonella isolates. No chromosomally 
coded AmpC genes have been reported in Salmonella spp., Klebsiella pneumoniae, Klebsiella 
oxytoca, Proteus mirabilis and multiple other species until that time [193]. Currently, blaCMY-2 
genes are mainly found on large plasmids such as the IncA/C plasmid (>140 kbp), which 
encodes for multiple resistance genes in Enterobacteriaceae.  
A study from Canada showed that blaCMY-2 in E. coli and Salmonella was found on five types 
of plasmids (IncA/C, IncI1, IncK, IncFIB, and unidentified plasmid) isolated from poultry, cattle, 
swine and related food products [195]. All of the IncA/C plasmids isolated from Salmonella 
were multidrug resistant (ACSSuT-Cef). Transmission of ceftiofur and ceftriaxone resistant 
Salmonella carrying blaCMY-2 genes between humans and food-animals (cattle, chicken) have 
been reported [28, 196]. In 2001, it was shown that blaCMY genes are transferrable between E. 
coli and Salmonella by transconjugation, which suggested that the blaCMY-2 genes were 
disseminated intra-bacterially with the animal microbiota acting as a reservoir [197]. However, 
in these studies, the transconjugation results were assessed by phenotypic resistance profile 
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changes and PCR. Also, the incompatibility types of plasmids were not determined. Later studies 
showed that IncA/C plasmid carrying MDR genes have a diverse backbone and E. coli have a 
more diverse backbone than Salmonella [198]. A similar backbone of a MDR IncA/C plasmid 
(113,320bp) to that of Salmonella Newport (pSN254, 176,473bp) was discovered in Yersinia 
pestis (pIP1202, 182,913bp) and Yersinia ruckeri (pYR1, 158,038bp) isolates from fish, which 
would imply natural transfer between species [198].  
Many resistance genes on IncA/C plasmids are encoded between two transposons, Tn21 and 
Tn10. The pSN254 plasmid carried duplicate copies of the blaCMY-2 genes, while the other two 
plasmids from Yersinia carried none. The pIP1202 and pSN254 plasmid carried the mercury 
resistance operon, while the pYR1 did not. This mercury resistance operon is a hallmark of the 
Tn21-transposon family [198]. While Welch et al. demonstrated that IncA/C plasmids from 70 
Salmonella strains (e.g. S. Typhimurium, Kentucky, Dublin, Heidelberg) were transferable to Y. 
pestis, none of the IncA/C plasmids derived from S. Newport from multiple food-animals were 
transferable. It is possible that environmental factors or antibiotic pressure may be needed to 
have a higher success rate of plasmid transfer for this particular serotype.  
Heider et al. examined the genetic homology of blaCMY-2 genes from E. coli and Salmonella 
isolated from humans, cattle, swine, beef, pork, turkeys, and sewage from 7 states [199]. They 
found that Salmonella blaCMY-2 genes have more alleles than E. coli. Although the alleles were 
synonymous mutations, based on the study by Call et al. (2006) it was found that plasmids in 
Salmonella are more likely to be transmitted between Salmonella, while plasmids in E. coli are 
transferred from E. coli and Salmonella. They postulated that evolution of the blaCMY-2 gene first 
occurred in Salmonella. They also found the same alleles of blaCMY-2 from different serotypes of 
Salmonella derived from humans and turkey meat, suggesting the occurrence of conjugation, 
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intergron/transposon, or homologous recombination under some selective pressure [199]. Later, 
Daniels et al. studied the effect of ceftiofur use on the horizontal transfer of blaCMY-2 plasmids 
among E. coli and Salmonella in dairy cattle treated with ceftiofur. Dairy calves were infected 
with donor bacteria carrying blaCMY-2 plasmids and recipient bacteria. The transfer of plasmids 
between the bacteria was detected at a low frequency under ceftiofur selection pressure; 
however, no difference was observed between calves treated with ceftiofur and those without 
ceftiofur treatment [30].  
Call et al. conducted a comparative genomics study of IncA/C plasmids derived from two 
geographically distinct cattle sources of E. coli (Washington and Illinois) and a human-derived S. 
Newport strain (pAM04528, Kansas).  Using plasmid pSN254 as a reference, they showed that 
the IncA/C plasmids were genetically distinct from Y. pestis and Photobacterium damselae 
derived IncA/C plasmids [200]. The phylogenetic tree analysis of these IncA/C plasmids showed 
three distinct subgroups represented by plasmids from E. coli and S. Newport, and those from Y. 
pestis and P. damselae, and lastly Y. ruckeri plasmid. Interestingly, genomic comparisons of 
blaCMY genes derived from bacterial isolates of the 1920s, before the antibiotic era, and recent 
plasmid blaCMY genes showed that blaCMY from the 1920s were closely related (Figure 5) [194]. 
Therefore, use of antibiotics may have pressured the dissemination of plasmid borne blaCMY 
genes, but did not contribute to the evolution of the gene. Although single nucleotide 
polymorphisms are discovered in blaCMY genes, it has not evolved for resistance to carbapenems 
or ESBLs, which may be because the blaCMY gene has evolved to its maximum capacity [194].  
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Cfre6879 and Cfre8454 are AmpC genes from Citrobacter isolates from 1920, before the 
antibiotic era, locate at the middle and tip of the tree, respectively (Adapted from Barlow et al. 
2002 [194]). 
 
 
Other common resistance genes for cephalosporins are blaTEM, blaSHV, and blaCTX-M. Some of 
the blaTEM and blaSHV genes along with the blaCTX-M are extended-spectrum beta-lactamases 
(ESBLs), and show phenotypic resistance to third and fourth generation cephalosporins but not 
to cefoxitin (cephamycin) and carbapenems. Until recently, blaTEM had been the major beta-
lactamase gene found in the United States; however, it recently has been replaced by blaCTX-M. 
The blaCTX-M gene was the most common ESBL found in Europe from humans and animals; 
however, the gene was not reported in animals in the United States until 2010 when blaCTX-M 
gene was found on a IncN plasmid in E. coli from dairy cattle and then feedlot cattle in 2013 
[201, 202]. Wittum et al. screened 2,034 Salmonella isolates from NVSL submitted from 
Figure 5. Bayesian consensus phylogenetic tree of Citrobacter freundii AmpC allele. 
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October 2010 and June 2011 for the blaCTX-M gene. They found the blaCTX-M gene in 6.8% of 
turkey, 0.1% of swine, and 3.5% of equine Salmonella isolates originating from Texas [203]. 
However, the blaCTX-M gene was not detected in the 58 cattle, 83 chicken, and 198 other source 
derived Salmonella isolates. Most recently, NARMS reported an increase in the blaCTX-M-65 gene 
in S. Infantis from various sources including humans, and cecal contents of dairy cattle and 
chickens at slaughter facilities from North Carolina and California collected in 2015 [204].  
2.7.4 Tetracycline and resistance mechanism 
Tetracycline is a highly important antibiotic per the WHO and one of the oldest antibiotics 
used in animals and humans [186]. Tetracycline was approved by the FDA for human use in 
1948. Tetracyline was discovered by Dr. Benjamin Minge Duggar from Streptomyces 
aureofaciens, which was referred to as “ultra-mold” from the soil of the University of Missouri 
campus [205]. Originally, it was named aureomycin and is now known as chlortetracycline. 
Currently, chlortetracycline, oxytetracycline, and tetracycline are approved for use in food-
producing animals [205]. Tetracyclines are broad-spectrum antibiotics, with a chemical structure 
that consists of a four or “tetra” hydrocarbon ring. Tetracycline inhibits bacterial protein 
synthesis by binding to the bacterial 30S ribosome and work in a bacteriostatic manner by 
preventing the aminoacyl-tRNA from binding to the 30S ribosome [206]. Tetracyclines have a 
broad range of activity against Gram-positive, Gram-negative bacteria, and other organisms 
including Chlamydiae, Mycoplasmas, Rickettsiae, and protozoan parasites such as Anaplasma 
marginale.  
Until 2017, it was a common practice to use tetracyclines as in-feed antibiotics for both 
disease prevention and growth promotion in food-animal production in the United States 
(subtherapeutic use). In 2016, among all the domestic sales of antimicrobials approved for use in 
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food-animals, tetracyclines accounted for 70%, with 49% of the tetracycline class intended for 
use in cattle [6]. Approximately 5.8 million tons of tetracycline were sold in 2016 but sales 
decreased by 15% from 2015 [6]. Nowadays, tetracycline resistant bacteria have been widely 
reported in animal and human-derived bacterial populations. In 2015, around 30% of cattle 
(HACCP) derived Salmonella isolates and 10% of human clinical isolates were resistant to 
tetracycline [32].  
The major mechanisms of tetracycline resistance are by traversing membrane systems (efflux 
proteins) and modifying the ribosomal binding mechanisms. Currently, more than 50 tetracycline 
resistance genes have been identified. The genes tet(A) through tet(E), tet(H) through tet(J), 
tet(Z), tet(30), tet(31), just to list a few, encode for efflux proteins [206]. The tet(M), tet(O), 
tet(S), tet(W) genes, and others encode for ribosomal protection. In Gram-negative bacteria, 
tet(A), tet(B), tet(C), tet(D), tet(E), and tet(G) are most commonly found. The tet(B) gene is the 
most common resistance gene reported in Gram-negative bacteria.  
In Gram-negative bacteria, efflux mechanisms are encoded with two genes, one for the efflux 
protein and another for the repressor protein, each of which is regulated by tetracycline itself 
[206]. When tetracycline is absent, the repressor protein blocks the transcription of both the 
repressor and efflux protein. However, when the tetracycline-Mg2+ complex enters the cell, it 
binds to the repressor protein, and the repressor protein no longer controls the transcription of 
these genes. Then, the efflux protein is produced and tetracycline resistance is expressed. While 
this is well recognized in Gram-negative bacteria, this mechanism has not been found in Gram-
positive tet(K) or tet(L) genes.  
Tetracycline resistance genes are transmitted widely through plasmids. In Salmonella 
enterica, tet(A), tet(B), tet(C), tet(D) and tet(G) are commonly found [207, 208]. Many 
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Salmonella isolates that are resistant to tetracycline are co-resistant to other antibiotics such as 
streptomycin. Commonly, they exhibit a penta-resistance phenotype, which includes resistance 
to ampicillin, chloramphenicol, streptomycin, sulfonamides, and tetracycline (ACSSuT). The 
ACSSuT phenotype is mainly located on a class-1 integron forming a gene cassette on the 
plasmid. This gene cassette is similar to that of the Salmonella Genomic Island 1, which was 
likely transferred to the IncA/C plasmid. The integron is bounded by insertion sequences (IS) 
and mobilizable elements. The most common plasmids harboring tetracyline resistance are 
IncA/C followed by IncI1, IncF, and IncH.  
2.7.5 Effect of ceftiofur on Salmonella and E. coli in feedlot cattle 
Several experimental and observational studies have been conducted to analyze the effects of 
ceftiofur on Gram-negative bacteria in feedlot cattle [29, 30, 35, 209-211], dairy cattle [212-
214], and swine [215-217]. Many studies have shown that the treatments transiently increase the 
resistant bacteria but may not have a long-term effect. In this section, each study will be critically 
reviewed. 
A cross-sectional study to examine the association between ceftiofur use and E. coli with 
reduced susceptibility to ceftriaxone was conducted on dairy farms [212]. Fecal samples were 
collected from 1,266 dairy cows on 18 farms in Ohio. E. coli with reduced susceptibility to 
ceftriaxone were isolated from 12 out of 18 herds. At the individual level, 436 (34.4%) out of 
1,266 E. coli isolates had reduced susceptibility to ceftriaxone. If more than one cow was 
isolated with ceftriaxone resistant E. coli, the herd was classified as positive. Associations 
between the use of ceftiofur and reduced susceptibility to ceftriaxone was highly significant at 
the herd level (odds ratio, 25.0; p = 0.01); meanwhile, it was not significant at the individual 
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level within farm (adjusted odds ratio, 1.01; p = 0.83). The authors suggested that to reduce the 
ceftiofur resistance on dairy farms, intervention strategies are most effective at the herd level.  
This was an observational study and convenience samples were used; therefore, the results 
could be biased by the age of the cow, feed, lactation stages, housing pens, mixture with treated 
cows, and other environmental factors that were not taken into consideration. The records for 
antimicrobial treatment were obtained for a 6-month period prior to sample collection, which is a 
long period during which microbiota normalization could occur post-treatment. Cows might 
either have received the treatment 6 months before sampling, or else have received the treatment 
the day before the sample collection. The resistant bacteria population would be high if the 
treatment was performed right before the sample collection. This could be adjusted by collapsing 
the 6-month period into groups at week or months level. Herd level significance may be due to 
certain herd’s use of ceftiofur more frequently, which can increase the resistant E. coli 
population. Ceftiofur use in dairy cattle has a short-term effect and would not require milk to be 
discarded or withheld from the market. Ceftiofur formulas used in dairy cattle often are different 
from those used in the feedlot, which typically uses a long-acting formula. Therefore, the results 
from this study might not be applicable to feedlot cattle. 
A longitudinal experimental study design reported by Lowrance et al. examined the effects of 
different concentrations and repeated doses of ceftiofur crystalline-free acid (CCFA) on the 
antimicrobial susceptibility of E. coli populations in feedlot cattle [209]. The study was 
conducted for 28 days and fecal samples were collected 8 times. The administrated doses and 
concentrations of CCFA differed as follows: a one-time full-dose regimen (6.6 mg/kg on day 0), 
a one-time 2/3-dose regimen (4.4 mg/kg on day 0), and a three-time full-dose regimen (6.6 
mg/kg on days 0, 6, and 13).  Ceftiofur treatment cohorts consisted of 10 steers (5 steers/pen), 
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and 5 or 6 untreated steers were mixed within each cohort pen at a 1:1 ratio. The MIC values of 
the isolated E. coli were tested by microbroth dilution for 15 antimicrobials. The total amount of 
E. coli and of ceftiofur-resistant E. coli were enumerated. In total, 1,441 isolates were recovered 
and subsets of 953 isolates were subjected to biochemical confirmation of E. coli, which 952 
were confirmed as E. coli.  
There were 986 (68.4%) resistant isolates and the most common resistance observed was to 
sulfisoxazole, tetracycline, and streptomycin. Ceftiofur resistance was found in 289 (20.1%) 
isolates with perfect agreement to the ACSSuT penta-resistance phenotype. Ceftiofur resistance 
was more prevalent in the 3-dose regimen followed by the single 2/3-dose regimen (4.4 mg/kg), 
followed by the single full-dose regimen (6.6 mg/kg). In the 3-dose cohort, the proportion of 
ceftiofur resistant E. coli was significantly higher on days 13, 16, and 20 compared with the 
control cohort. In the single full-dose cohort and single 2/3-dose cohort, days 2, 6, 9, and 16 were 
significantly high for ceftiofur resistant E. coli compared with control cattle (p = 0.03). However, 
no significant differences in ceftiofur resistance were found between the single full-dose and 
single 2/3-dose cohorts. The authors argued that the variation between the single 2/3- and full-
dose cohorts were likely associated with the with-in pen effects rather than ceftiofur selection 
pressure. The selection pressure of ceftiofur allowed for the expansion of resistant E. coli but the 
population of resistant E. coli returned to baseline levels after 2 weeks. This may indicate that 
susceptible E. coli had a greater fitness then the resistant E. coli in the tested feedlot. The 
concentration of E. coli decreased significantly in all treatment groups 2 days after initial 
treatment. Three-dose cohorts remained low until day 20 and showed recovery on day 28. In all 
other groups, concentration was not significantly different on day 13. These results show that the 
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effects of ceftiofur treatment were transient on both the proportion of ceftiofur resistant E. coli 
and the concentration of total E. coli. 
As a follow-up of Lowrance et al., Alali et al. [29] studied the quantity of the blaCMY-2 gene 
in the total community DNA extracted from 469 fecal samples from the same feedlot cattle 
population. Total community DNA represents all the bacterial, viral, archaeal, and eukaryotic 
community within the feces. Quantification of the blaCMY-2 gene using community DNA reflects 
the entire gene pool and helps in understanding the dynamics of antimicrobial resistance genes in 
the population. However, it will not provide information regarding from which bacteria the gene 
is derived. The authors extracted community DNA from the fecal samples derived from cattle 
treated with 3 different doses of ceftiofur, as mentioned above in the Lowrance study. 
Quantitative real-time PCR was conducted for the blaCMY-2 gene which is the primary gene 
responsible for ceftiofur and ceftriaxone resistance in the United States. They also quantified the 
16s rRNA gene, which allows for the quantification of total bacterial genes in the community 
DNA and for standardization purposes. While the CCFA treatment regimens increased the 
quantity of the blaCMY-2 gene significantly compared with control groups without 
standardization, the differences were lowered after the standardization with 16s rRNA. This 
result showed that the treatment decreased the overall bacterial concentration in addition to the 
quantity of the blaCMY-2 gene. Compared with the Lowrance et al. study that measured the 
number of samples with ceftiofur-resistant E. coli, a significant increase of blaCMY-2 genes was 
detected in different sampled days. These two studies show that E. coli can be used as an 
indicator to measure the resistant bacteria but measurement of total bacterial numbers is equally 
important.  
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Singer et al. and Boyer et al. observed the effect of ceftiofur on E. coli isolated from 5 dairy 
cows that were treated for Leptospira infection for 32 days [210, 218]. An additional 5 cows 
from the same cohort were selected randomly as controls. The dairy cows were treated 
intramuscularly with 2.2mg/kg of ceftiofur once daily for 5 days. Fecal samples were collected 
prior (days -1, 0) during (day 2, 4) and after (days 5, 11, 14, 18, 25, and 32) treatment. Three E. 
coli isolates from each cow on each day (total 468 isolates) were tested for antibiotic 
susceptibility. The quantity of E. coli was manually counted and the presence of the blaCMY-2 
gene in the fecal samples was identified by multiplex PCR. The E. coli were genotyped with 
repetitive element PCR (Rep-PCR).  
The total E. coli load significantly decreased from days 0 to 2 and day 2 to 4 in the treated 
cows compared with the controls. The authors calculated an antibiotic resistance index (ARI) by 
dividing the sum of number of antibiotics that each isolate was resistant to by number of isolates 
in the population and multiplied by number of antibiotics tested. ARI is a quantitative 
measurement of the level of antibiotic resistance in a bacterial population, which is used to make 
comparison among populations within a single study. The ARI of E. coli in the treatment group 
significantly increased on days 4, 5, and 6. Both the E. coli load and ARI gradually returned to 
the base level around day 8. Among 203 E. coli isolates, the blaCMY-2 gene was detected by PCR 
in 12 isolates. Interestingly, the blaCMY-2 gene was detected from all the sampled days from both 
treatment and control groups from the community DNA. Even though it cannot be determined 
that these genes were derived from E. coli, it implies that resistant bacteria populations reside in 
the microbiota before the antibiotic treatments.  
They also found that the genotype of susceptible E. coli was different from that of resistant E. 
coli, which implies little to no horizontal gene transfer occurred between the E. coli in the 
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presence of the antibiotic pressure. Additionally, no resistant strains were isolated from the 
untreated cows even though they were located in the same cohort and most likely share a 
common microbiota. These may be due to low sensitivity and a small sample size. As the authors 
discussed, using agar containing ceftiofur would have helped to detect resistant E. coli in 
untreated cows. The sample size used in the study was small and is not appropriate for the 
generalization of results between treatment groups. However, they analyzed 10 isolates per 
animal for genotypic analysis to compare the genomic diversity per animal, which helped to 
conclude that the horizontal gene transfer between resistant and susceptible isolates likely did not 
occur as a result of antibiotic pressure.  
Benedict et al. studied the effect of routine exposure of feedlot cattle to five antibiotics on 
non-type specific E. coli (NTSEC) over 3 years by 2-point sampling; in total, enrolling over 
10,000 animals [219]. Cattle were exposed to two in-feed antibiotics (macrolides and 
tetracycline) for the prevention of live-abscesses. In addition, 44.6% (412/923) of the cattle 
received macrolides and tetracycline treatments parenterally. Less than 2% of the cattle received 
beta-lactams, phenicols, quinolones, or sulfonamide treatments parenterally. The first set of 
samples were collected upon arrival to the feedlot and the second set of samples were collected 
during the feeding period, which ranged from 33-202 days on feed (DOF), with an average of 
95.5 DOF. The majority of pens housed at least one animal that was treated with antibiotics 
before the second sampling. In the first sampling set, 79.8% of NTSEC were pan-susceptible, 
while 21.9% were pan-susceptible in the second sampling set.  
The most common resistance phenotype was single resistance to tetracycline and additional 
resistance to streptomycin and sulfisoxazole was also observed. Individual parenteral tetracycline 
exposure significantly increased the odds of recovering tetracycline and trimethoprim-
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sulfamethoxazole resistant isolates. In-feed tetracycline exposure also increased the odds of 
recovering resistance to tetracycline. Interestingly, parenteral exposure to beta-lactams decreased 
the streptomycin resistance. Pen-level exposure to these antibiotics was associated with recovery 
of resistant NTSEC isolates. This study provided abundant information on antibiotic use, which 
many previous observational studies have lacked. Even though this study included more than 
10,000 animals in total, there were few NTSEC isolates that were resistant to medically 
important antibiotic; therefore, the significance of antibiotic use on such resistance could not be 
assessed as the authors had anticipated. The fact that beta-lactam exposure was associated with 
decreased streptomycin resistance shows the complexity of resistance mechanisms in bacteria.  
In contrast, Platt et al. showed a protective effect of chlortetracycline treatment against 
ceftiofur resistant E. coli, while Kanwar et al. showed the opposite results and found that 
chlortetracycline use increased ceftiofur resistance [34, 35]. As Benedict et al. and Kanwar et al 
discussed, indirect selection of NTSEC that were susceptible to streptomycin or tetracycline but 
resistant to beta-lactams may have replaced the NTSEC that were resistant to streptomycin or 
tetracycline, respectively. However, since genotypes were not examined in the Benedict study, 
the mechanisms remain unknown. The temporal relationship between antibiotic use and 
resistance is not shown in this study since only two-point sampling was conducted and the period 
ranged from 33-202 DOF. The effects of antibiotics may vary by the days after the treatment, 
which were not reported in their study.   
In contrast with previous studies, Schmidt et al. did not find a significant increase of 
extended-spectrum-cephalosporin-resistant E. coli (ESCr) following therapeutic ceftiofur 
treatment at the herd level in 763 feedlot cattle over a 10 months study. However, the fecal 
prevalence of ESCr  E. coli in the feces of 50 cattle from 3-8 days post-treatment of ceftiofur, 
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significantly increased from 8.2% to 92.0% at an individual level. No significance was found in 
the hide prevalence at slaughter. The study was conducted at the U.S. Meat Animal Research 
Center (USMARC) feedlot, where the cattle were born and raised on pasture at USMARC. 
Samples were collected six periods during the study for 10 months. Prevalence of ESCr E. coli 
upon arrival at the feedlot was 3.9% in feces and 15.0% in hides. The fecal concentration of 
ESCr E. coli was >2.00 log CFU/swab for 85.2% post-ceftiofur injection, while only 1.6% of the 
samples remained at this level at subsequent periods. All ESCr E. coli were detected with blaCMY-
2 gene and ACSSuTCfCtCx phenotype. PFGE genotypes of ESCr E. coli isolates were also 
studied and 26 unique PFGE genotypes were identified, in which 12 of them were isolated at 
multiple sampling time points. This suggests a clonal expansion of ESCr E. coli carrying blaCMY-
2 gene but not a horizontal gene transfer between the isolates with different PFGE genotypes. 
Most prevalent plasmid replicons were IncA/C plasmid followed by IncY plasmid. Overall 
results showed that ceftiofur transiently increase ESCr E. coli at an individual level, but not at the 
herd level in the long-term. 
2.7.6 Effects of chlortetracycline and ceftiofur on E. coli in feedlot cattle 
Previously, the effects of ceftiofur and chlortetracycline were examined in E. coli isolated 
from the same cattle that were studied in this dissertation [35, 220]. In a 2008 study by Platt et 
al., chlortetracycline treatment transiently increased E. coli with reduced susceptibility to 
tetracycline but also reduced phenotypically ceftiofur resistant E. coli in cattle [34]. Platt et al. 
administered in-feed chlortetracycline to 10 steers at the concentration of 22 mg/kg for 3 
separated 5-day periods with a 1-day interval. Another 10 steers served as controls (without 
treatment). Fecal samples were collected every 2 to 4 days and three E. coli were isolated from 
each sample and tested for antibiotic susceptibility. Among 525 E. coli isolates, 24.4% were 
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pansusceptible and 75.6% were resistant to one or more antimicrobials. Tetracycline resistant 
isolates were 294 (56.4%) of the total and 37 of the total (7.1%) were resistant to ceftiofur. Those 
isolates resistant to ceftiofur always were co-resistant to ampicillin, chloramphenicol, 
streptomycin, sulfamethoxazole, and tetracycline (or ACSSuT). In the control cohort, 42.3% 
were resistant to tetracycline with 68.8% in the treatment cohort (p=0.03). In contrast, the 
proportion of ceftiofur resistant isolates was significantly lower (p=0.01) in the treatment cohort 
(2.9%) than control cohort (8.6%).  
This observation led to the follow-up study by Kanwar et al. in 2009 to utilize 
chlortetracycline to reduce ceftiofur resistant E. coli in feedlot cattle following treatment with 
CCFA [35]. Unexpectedly, in the Kanwar et al. study chlortetracycline contributed to an 
increased prevalence of ceftiofur resistant E. coli isolates. To be more specific, Kanwar et al. 
enrolled 176 steers in the study, randomized into two replicates with 11 steers per pen (16 pens). 
In half of the pens, ceftiofur crystalline-free acid (CCFA) was administered to one out of the 11 
steers and mixed in the pen to observe the effect of mixing with steers not treated with CCFA, to 
test the hypothesis that mixing with steers that were not treated with antibiotics may restore the 
microbiota of treated steer. In the other half of the pens, all 11 steers received CCFA treatment. 
The CCFA treatment was followed by in-feed 5-day chlortetracycline treatments for three times 
with 1-day in between the treatments (that was the same as described above in the Platt et al. 
study).  
Three non-type specific E. coli were isolated from the fecal samples on days 0, 4, 12, and 26, 
and tested for antibiotic susceptibility and genotyped for tet(A), tet(B), and blaCMY-2 genes. 
Among the 1,050 E. coli isolates collected, 32.4% were pansusceptible and 67.6% were resistant 
to at least one antibiotic. Most common resistances were to tetracycline (61.1%) followed by 
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ampicillin and sulfisoxazole. Ceftriaxone-resistant isolates were 25.4%. In the treatment group 
with the least amount of antibiotic exposure, 55.1% of E. coli were pansusceptible and the 
number of antibiotics to which the isolates were resistant was right-skewed. In the pens with all 
animals receiving CCFA treatment, the number of antibiotic-resistant isolates were more 
uniformly distributed to the full range of MDR numbers (note: no pan-resistant phenotypes were 
observed in any group). Chlortetracycline treatment increased the number of isolates with higher 
MDR counts but tended to select more of the low MDR isolates than CCFA treatment. Animals 
in pens treated with both CCFA and CTC exhibited a profound effect of the chlortetracycline, 
where 3.0% of the isolates were resistant to 12 antibiotics.  
Among 1,050 isolates tested, 120 isolates were co-resistant with both tet(A) and blaCMY-2. 
The tet(B) gene was detected in 208 isolates and only 14 isolates harbored both tet(A) and tet(B) 
together. When phenotype and genotype were compared, the proportion of tetracycline-resistant 
isolates increased following the chlortetracycline treatment in the pens that received 
chlortetracycline but with CCFA given only to 1 out of 11 steers. These isolates were carrying 
tet(B) genes much more so than the tet(A) gene. While in the pens that all cattle received CCFA 
treatment or with additional chlortetracycline treatment, tet(A) was favored over tet(B).  
Unexpected from the Platt et al. study, chlortetracycline treatment was not associated with a 
decrease in ceftiofur resistance. With prior CCFA treatment, chlortetracycline treatment delayed 
the return of ceftiofur resistant isolates to baseline level. Many phenotypically ceftriaxone 
resistant isolates were not explained by the presence of the blaCMY-2 gene. In fact, 32.9% of 88 
steers in this cohort were detected with blaCTX-M-32 gene located on an IncN plasmid [202]. The 
genotyping results explain some of the differences between the Platt et al. study and Kanwar et 
al. study, where Platt et al. study showed a decrease of ceftiofur resistance following CTC and 
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Kanwar et al. showed an increase and delay of return to baseline level. In the Kanwar et al. 
study, the priming of the CCFA treatment may have selected E. coli with blaCMY-2, which also 
carry tet(A) gene. While in Platt et al., due to no prior CCFA treatment, tet(B) carrying E. coli 
may have been favored over tet(A) E. coli which led to a decrease of ceftiofur resistant E. coli 
when treated with CTC. In our study, we examined the Salmonella population from the same 
cattle population as Kanwar et al.   
2.7.7 Therapeutic and subtherapeutic CTC on Salmonella and E. coli in cattle and pigs 
Using similar antibiotics to Kanwar et al., but with experimental inoculation of nalidixic acid 
resistant S. Typhimurium in pigs, a study was conducted by Ebner et al [221]. Pigs were 
randomly assigned to four treatment groups after inoculation of S. Typhimurium orally and 
intranasally. Treatment started two days after Salmonella inoculation in four treatment groups as 
follows: 1) intramuscular injection of ceftiofur sodium (Naxcel) for 3 days followed by 100g/ton 
of oxytetracycline in-feed, 2) apramycin in-feed for 14 days followed by oxytetracycline, 3) 
carbadox in-feed until pigs reached 35 kg followed by oxytetracycline 4) no antibiotics (control).  
Salmonella prevalence reached its peak from 2 to 7 days post-inoculation (DPI); therefore, 
the authors considered 2 DPI as baseline for each assessment of variation. Apramycin treatment 
decreased the shedding pig prevalence the most, followed by ceftiofur sodium and carbadox 
treatments. They found significant interactions between treatment and days. Resistant isolates 
were the lowest on 4 DPI and peaked at the end of the study (70 dpi) among all treatment groups. 
However, the percentage of resistant isolates among treatment groups did not differ, except for 
the carbadox treatment group. This study showed the temporal association of antibiotic 
treatments and increased resistant isolates. Since pigs were fed with oxytetracycline throughout 
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the whole experimental period after each antibiotic injection, it is not directly comparable to our 
study as each injectable antibiotics cannot be assessed in the absence of the tetracycline.  
Delsol et al. reported the effects of therapeutic (15mg/kg) and sub-therapeutic (1.5mg/kg) 
doses of chlortetracycline on the Salmonella Typhimurium DT104 and E. coli populations in 
pigs [222]. They experimentally inoculated five strains of ACSSuT with nalidixic acid resistant 
Salmonella Typhimurium DT104 to pigs 48-hours before the treatment began and tracked the 
quantitative changes in the fecal samples up to 41-days post inoculation in three groups: 
therapeutic, sub-therapeutic, and control groups. Salmonella was isolated for 7-weeks after 
inoculation.  
Pigs treated with therapeutic doses shed higher numbers of Salmonella compared with the 
sub-therapeutic dose group up to 7-days post-treatment. However, the significant difference was 
observed only until 7-days post-treatment, while non-significant differences were found after 
that. After 41-days post-treatment, sub-therapeutic pigs were shedding higher numbers of 
Salmonella than therapeutic or control groups. The authors discussed that CTC treatment had an 
effect to establish the S. Typhimurium in the gut, which resulted in higher and longer shedding in 
the fecal samples post-treatment. However, the Salmonella in this study were collected from pig 
feces, which might reflect the shedding more than the establishment. Few studies showed that 
fecal shedding of Salmonella changes with the immune response via inflammation in the gut and 
may change by stress [74]. Therefore, pigs in the therapeutic treatment groups may have shed 
higher number of Salmonella due to antibiotic treatment stress or due to change in the 
composition of microbiota; further, it is not clear if the CTC treatment significantly affected the 
establishment of Salmonella population in the gut flora. Experimental inoculation may not be an 
ideal method to examine the long-term effects of antibiotic treatments on farms. This is because 
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variations, such as inoculation concentration, inoculation methods, serotypes, time to start and 
antibiotic treatments, are introduced. More time to comingle the pigs after Salmonella 
inoculation may be needed to uniform the infections and establish the microbiota among pigs 
may needed to reproduce natural farm environment.  
Naturally infected pigs may be infected with multiple serotypes, while experimental 
inoculation has more control to observe the differences to the response to antibiotic treatments. 
There was no difference in the MIC of S. Typhimurium DT104 after CTC treatment. In E. coli, 
these authors observed a higher tetracycline resistant population in the therapeutic dose treatment 
group until after 1-2-weeks post-treatment. Since there were 2% of E. coli population with MIC 
of > 50mg / L before treatment, it implies that these populations were selected by CTC 
administration. Those resistant isolates were carrying tet(A), tet(B), and tet(C) genes, and 
isolates with tet(B) genes had a higher MIC value (256mg / L) than isolates with tet(A) or tet(C) 
genes (32 to 128mg / L). Interestingly, some isolates with tet(C) genes were susceptible to CTC, 
which raises a question to the function of tet(C) genes. These authors are recommending 
extending the withdrawal time of CTC so that less resistant bacteria would enter the human 
population through a food chain, which is an important insight to determine the risk of using 
antimicrobials in food animals.  
Funk et al. [223] studied the effects of subtherapeutic doses of chlortetracycline on 
Salmonella prevalence and antimicrobial susceptibility of Gram-negative flora in pigs. Treatment 
dosage was 50g of CTC per ton of feed for the entire finishing period following the labeled 
indication. Gram-negative isolates were collected from those that grew on a MacConkey agar 
plate. The fecal samples derived from three different farms that were willing to alternate their 
feed and antibiotics. The overall prevalence of Salmonella was 0.7% (15/2,112). The 
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chlortetracycline-fed group had a higher prevalence (1.3%) than the non-fed group (0.09%), but 
no statistical significance was detected. All the Salmonella isolates were derived from one farm. 
All isolates were ACSSuT-ceftiofur-cefoxitin resistant, but susceptible to ceftriaxone (whose 
CLSI breakpoint at the time of the research was >= 64 mg / L) and the serotypes were Agona and 
Ohio. Since the prevalence of Salmonella was very low in this study, the effect of subtherapeutic 
CTC on Salmonella prevalence cannot be determined.  
However, the authors also tested the antimicrobial resistance of around 76,500 Gram-
negative bacteria isolates. In both CTC treatment and control groups, tetracycline resistance was 
the most common phenotype. In total 97.5% were resistant to tetracycline in the treatment group 
and 84.3% in control group. Ceftriaxone resistance (that is, with extremely high MIC) was found 
in 0.7% of samples from the CTC treatment group and 0.3% in control. The odds-ratio of being 
tetracycline resistant between a CTC fed and a non-fed farm was 7.2, and that of ceftriaxone 
resistance was 2.4. These results show that subtherapeutic dosages of CTC in feed can select 
both tetracycline and ceftriaxone resistance in Gram-negative bacteria in swine. In this study, the 
sampling was conducted only once at the end of the finishing period, which the temporal relation 
of CTC use and antibiotic resistant bacteria emergence could not be examined. Even though the 
authors confirmed the presence of Salmonella in the tested farm prior to initiating the study, the 
prevalence was very low, which may be due to the intermittent shedding pattern requiring more 
sampling days.  
Sharma et al. reported a study on the effects of the subtherapeutic use of chlortetracycline (T) 
alone or in combination with sulfamethazine (TS) on the diversity and distribution of E. coli in 
feedlot cattle in Canada [224]. Chlortetracycline was given at 350 mg per head per day 
(approximately 0.5 mg/lb per day), and so was sulfamethazine: both are common antibiotics used 
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in Canadian feedlots. Control pen animals were not treated with antibiotics. Each pen consisted 
of 50 steers. The study was continued until slaughter and fecal samples were collected 9 times 
based on their diet because the T and TS are both top dressing feed additives; diets were as 
follows, background silage-based diet (period A to C), diet transition to grain (D), finishing 
grain-based diet (E to H), and off antimicrobials (I). The E. coli was tested by PCR. E. coli that 
grew on plain MacConkey agar, MacConkey agar with ampicillin (32 µg/ml), and MacConkey 
agar with TE hydrochloride (16 µg/ml) were enumerated. Antimicrobial susceptibility was tested 
for each isolate and genotyped for the presence of ampicillin, tetracycline, and sulfamethoxazole 
resistance genes. Genetic diversity was determined by PFGE analysis.  
The authors mainly compared the distribution of resistant E. coli at period A (day 0) and 
period H (day 197). Both tetracycline and ampicillin resistant E. coli numbers were higher in 
period H. They also found continuous detection of both resistant E. coli in control group at 
period H, which suggests other factors contributing such as change in animal diet from forage to 
grain. The diversity of phenotypical resistance decreased as the trial proceeded. It was showing 
11 antibiograms at period A, while only 3 antibiograms were found during period H, irrespective 
of the treatments. Common resistant patterns were resistance to both trimethoprim-
sulfamethoxazole (SX) and tetracycline (19.2%), or tetracycline alone (26.7%) in period A and 
increased to 47.5% and 31.7%, respectively in period H. The authors also showed by PFGE 
analysis and phylogenetic tree analysis that the genetic diversity of E. coli decreased at period H 
even in control groups. Since the structure of the pens used in this study does not allow direct 
animal contacts between different treatment groups, the authors concluded that the resistant E. 
coli were spread in the environment at the feedlot and then among cattle. The overall results 
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indicated that the use of chlortetracycline and sulfamethazine increase tetracycline resistance 
among E. coli.  
Agga et al. conducted a randomized control study in 300 weaned calves divided into 2 
treatment groups: 1) 5 consecutive days of in-feed prophylactic CTC (22mg/kg; 150 calves), and 
2) no CTC treatment (150 calves). Calves were divided into 5 pens with 30 calves per pen and 
each occupied pen was separated by an empty pen from other occupied pens. Fecal swab and pen 
surface, feed, and water were collected five times: upon arrival, 5 days post-treatment (5-DPT), 
27-DPT, 75-DPT, and 117-DPT. The concentrations of generic E. coli, cefotaxime-resistant E. 
coli (3GCr), and tetracycline-resistant E. coli (TETr) were enumerated by spiral-plating on plain 
CHROMagar E. coli, CHROMagar E. coli supplemented with 2mg / L cefotaxime, and 
CHROMagar E. coli supplemented with 32mg / L tetracycline. Concentrations of generic and 
TETr E. coli were approximately 4.8 log10 CFU/swab and 3.2 log10 CFU/swab, respectively, 
upon arrival in both groups. On 5-DPT, generic E. coli in CTC group was 4.7 log10 CFU/swab, 
which was not different from upon arrival. Interestingly, generic E. coli concentration decreased 
in the control group on 5-DPT (3.51 log10 CFU/swab). The concentration of generic E. coli was 
higher in CTC groups on 5-DPT but the differences between the groups diminished after 27-
DPT. TETr E. coli increased by CTC treatment to 4.25 log10 CFU/swab on 5-DPT, which was 
higher than control group (1.86 log10 CFU/swab); however, the differences between the groups 
diminished after 27-DPT.  
The concentrations of generic E. coli and TETr E. coli increased in both treatment groups on 
75-DPT and 117-DPT compared with that of day upon arrival. However, the concentration did 
not differ between the two groups on both days. The concentration of cephalosporin-resistant E. 
coli were not enumerable. Prevalence of cephalosporin resistant E. coli increased from <10% 
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upon arrival to >70% after 75-DPT in both groups. Generic and TETr E. coli concentration on the 
pen surface was around 1.2 log10 CFU / g upon arrival and increased to 5-6 log10 CFU / g on 
117-DPT in both pens, except for in the empty pens. These results showed that the effect of CTC 
treatment was only seen on 5-DPT by increasing tetracycline resistant E. coli concentrations. The 
concentration of generic E. coli and tetracycline-resistant E. coli increased in spite of the 
treatment group, which suggests other undetermined environmental factors affected the 
concentration. The authors discussed that the deposited manure in occupied pens increased the 
tetracycline and cephalosporin-resistant population, for which further study will be needed. The 
increase of tetracycline resistance agrees with the Sharma et al. study in that resistant isolates 
increased at the end of the study period regardless of the treatment group; that said, Sharma et al. 
were using subtherapeutic doses of CTC. The consideration of environmental variables is 
necessary when conducting similar experiments in near future. 
2.8  Strategies to tackle antimicrobial resistance derived from animal 
2.8.1 Precautionary principle (Ban the growth promoter use) 
The Swann report was published in 1969 by U.K. parliament, which was the first formal 
warning of increased antimicrobial resistant infections in humans due to the use of antibiotics for 
growth promotion and feed efficiency in food animals in the UK [225]. The Swann report 
specifically warned of the increase of chloramphenicol resistant Salmonella. The first ban on 
antibiotic use as growth promoters started in the U.K. for tetracycline, penicillin, and 
streptomycin in 1972 [185]. Sweden was the first country to ban the use of all antibiotics for 
growth promotion in 1986. Denmark followed and worked with industry to also ban the use of 
antibiotics for prophylactic purpose in 1995. At the same time, Denmark started the monitoring 
system called the Danish Integrated Antimicrobial Resistance Monitoring and Research Program 
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(DANMAP) [226]. The EU banned growth promoter use of all the antimicrobials in 2006. In the 
UK, vancomycin-resistant enterococci (VRE) were first reported in food animals in 1993, which 
led to the ban of avoparcin for all purposes in Sweden; later, in the entire European Union (EU) 
in 1997. Avoparcin has a similar chemical structure as vancomycin (both are glycopeptides), 
which is a critically important class of antibiotics for use in humans [186]. In the US, avoparcin 
was never approved for use in animals. The ban in Denmark reduced the overall use of 
antibiotics but increased the antibiotic use for disease treatment [10]. It is not yet clear whether 
the ban reduced resistance in human health. In the United States, prudent or judicious use of 
antimicrobials is promoted at multiple levels. A partial ban on the extra-label use of 
cephalosporins in animals was announced in 2012, and the voluntary withdrawal of growth 
promotion labels by product sponsors led to a de facto ban on the use of medically important 
antimicrobials in the U.S starting in 2017.  
In 2007, Phillips reviewed the effect of the European ban on growth promoters for human 
health outcomes using Enterococcus and Campylobacter as examples. The ban of antibiotics as 
growth promoters in 2006 in the EU had eliminated the use of antibiotics for that purpose, 
however, the infection of ciprofloxacin resistance Campylobacter infections in the human 
population increased according to Phillips [227]. However, this was disputed later by 
Hammerum and colleagues from Denmark, who claimed that one-third of Campylobacter 
infections in Denmark were due to travel [228]. Hammerum and colleagues further noted that 
67% of poultry meat imported in Denmark was contaminated with Campylobacter, while only 
17% was contaminated in domestic poultry meat. Further, 17% of Danish chicken-derived 
Campylobacter jejuni were resistant to ciprofloxacin, compared to 49% in imported chicken 
[228]. Chickens were imported from Germany, Sweden and United Kingdom to Denmark for 
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several years. The latest 2015 DANMAP show that ciprofloxacin-resistant Campylobacter jejuni 
from broiler and broiler meat has been increasing since 2006 reaching 27% in 2015. However, 
this rate is far lower than the EU average of 66% [229]. Additionally, the importation of chicken 
to Denmark has increased from $10.2M in 2006 to $23M in 2014 [230], which may partially 
explain the increase of ciprofloxacin resistance even though fluoroquinolone were not used in 
broiler production since 2009. Among Enterococcus spp., Phillips claims that the ban of 
avoparcin in 1997 in EU and virginiamycin (streptogramin) in 1998 in Denmark had little effect 
on humans because cases of vancomycin-resistant Enterococcus (VRE) were rare from the 
beginning. In the United States, avoparcin was never allowed for use in animals due to its 
purported carcinogenic effects. However, VRE cases are high in the human population in the US, 
which is probably because of the high vancomycin use in hospitals. Phillips also claimed that 9% 
of E. faecium that were submitted to European Antimicrobial Resistance Surveillance System 
(EARSS) were VRE in 2004 and increased to 14% in 2005. Hammerum commented that since 
the EARSS report included both vanA (animal origin) and vanB (human) gene cases, this cannot 
be used to explain this paradox. Ironically, the 2015 DANMAP reported that the cases of VRE in 
human have been increasing, and a 5-times increase was observed from 2012 to 2013. More than 
90% of the VRE isolates are Enterococcus faecium vanA type, which has a sequence type (ST) 
that is not of animal origin [229, 231]. Since these E. faecium vanA type occurrences have 
regional differences, Hammerum et al. suspect that these may be due to the use of vancomycin 
for C. difficile treatment in hospitalized patients. Interestingly, the authors also mentioned that 
the use of cephalosporins can help to transmit vanA gene to E. faecium in mice [231].  
Both conclusions from Phillips and Hammerum et al are based on DANMAP data but are 
interpreted in vastly differently ways. The differences between Phillips and Hammerum et al. 
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comes from the different focus on the final purpose of the growth promotion ban. Phillips 
focused on the effect on human health, which is an ultimate goal, while the current ban policy in 
EU focuses on reducing the resistant population derived from animal production system [185]. It 
might be true as Phillips stated that the contributions of animal food production on human 
resistant bacterial infection were not as large as initially feared in the Swann report, but it 
remains true that food-borne pathogens are one of the major causes of infection by resistant 
bacteria. These illustrate the difficulty of controlling the use of antimicrobials and then 
measuring the effects on the intervention. 
2.8.2 Judicious use principles in the United States 
In the United States, the FDA proposed the withdrawal of subtherapeutic uses of two 
important antibiotics in human medicine, penicillin and tetracyclines, in 1977. However, due to a 
lack of sufficient scientific evidence to approve this proposal, Congress directed FDA to 
continue the study on the effects of the subtherapeutic use of antimicrobials in animals on human 
health. Even after this attempt, when the National Academy of Sciences reported the study on the 
effect of antimicrobial use in animals, the FDA did not make a decision [170]. In 2008, the FDA 
announced a prohibition of extra-label cephalosporin use in food-animal production. However, 
critics claimed that this was too broad of a prohibition and cited concerns over negative 
consequences, and a lack of scientific evidence, which resulted in the FDA delaying the final 
order.  
In April 2012, the FDA Center for Veterinary Medicine (CVM) issued an order of 
prohibition, which generally prohibits the extra-label use of cephalosporin (excluding 
cephapirin) in cattle, swine, chickens, and turkeys, with notable exceptions. As long as the use 
adheres to the labeled regimens, it is approved to be used for treatment and control of labeled and 
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extra-labeled disease indications. Later that same year, judicious use of antibiotics (or voluntarily 
withdrawing the use of medically important antibiotics for animal growth promotion use) was 
announced by the FDA in the Guidance for Industry (GFI) #209 in seeking public comment 
[170, 232]. The process in reaching this recommendation is summarized in GFI #209 [170]. The 
GFI #209 is following the two principles. The first principle is “The use of medically important 
antimicrobial drugs in food-producing animals should be limited to those uses that are 
considered necessary for assuring animal health”, which indicates that as long as the use of 
antimicrobials for disease prevention is considered necessary by the veterinarian, it is considered 
judicious use. The second principle is “The use of medically important antimicrobial drugs in 
food-producing animals should be limited to those uses that include veterinary oversight or 
consultation”, which indicates that use of medically important antimicrobials requires the 
supervision of veterinarian [232]. In 2017 January, GFI #213 was put into full implementation by 
FDA. Chlortetracycline in feed changed from over-the-counter to the Veterinary Feed Directive 
in 2017 as mentioned in GFI #213 (effective October 2015).  
2.9 Summary of literature review 
Salmonella has been studied extensively, although not to the same degree as commensal E. 
coli, because of its unique pathogenicity towards humans and other animals. Salmonella resides 
in multiple hosts including food-animals, which ultimately can infect humans as a foodborne 
pathogen. Although most of the Salmonella found in food-animals are pan-susceptible, specific 
serotypes of Salmonella are highly MDR. It is crucial to use antibiotics prudently at the feedlot 
to reduce antibiotic resistant Salmonella. There have been no studies conducted to compare the 
effects of ceftiofur and chlortetracycline on the Salmonella populations in feedlot cattle. Studies 
from pigs and dairy cattle are not directly applicable to the feedlot cattle population. This is 
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because pigs and dairy cattle have different farm operation styles, metabolisms, and antibiotic 
use protocols. Moreover, Salmonella prevalence and serotypes distribution are different among 
hosts, geographical locations, and seasons.  
Multiple studies on the effects of antibiotics on E. coli populations in feedlot cattle have been 
conducted, largely because E. coli are commensal bacteria and readily found in all mammalian 
enteric samples. E. coli tends to acquire plasmids, including plasmids carrying resistance genes, 
from other bacteria. In multiple studies, antibiotic treatments have increased antibiotic resistant 
E. coli transiently. Some studies have shown that farm management is more important than the 
use of antibiotics for causing an increase in antibiotic resistant E. coli. Even though E. coli and 
Salmonella belongs to same Enterobacteriaceae family, they have different biology, microbial 
ecology and genomic backgrounds. E. coli has more diverse phenotype and pathogenicity within 
host species, while Salmonella is uniformly more pathogenic, especially to humans. In 
Salmonella, serotype and antibiotic resistance are highly associated. This may be due to 
serotypes specializing in the response to horizontal gene transfer or recombination. Therefore, 
the antibiotic response in E. coli is rarely directly comparable to that of Salmonella.  
In the United States, judicious use of antibiotics at the pre-harvest level is adopted to 
reduce the population of antibiotic resistant bacteria that can contaminate meat at slaughter or 
escape from the farm via environmental means such as water, dust, or soil. The effects of 
antibiotic use on the quantity of antibiotic resistant Salmonella are not well known. In our study, 
we have isolated the Salmonella in the feedlot cattle population for 26 days following injection 
of CCFA and administration of in-feed CTC in a randomized control study. The effects of 
antibiotics were assessed from multiple aspects:1) the prevalence and quantitative dynamics of 
Salmonella by treatment and day, 2) antibiotic resistance by antibiotic phenotype and genotype 
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by WGS, and 3) genomic dynamics of Salmonella by antibiotic treatments. As the advancement 
of WGS technology proceeds and the opportunity to conduct WGS and bioinformatic analysis 
within our laboratory expanded, the detailed genomic study of isolates derived from the same 
population was enabled. Few studies have been conducted to compare the genomics of 
Salmonella collected from different host populations (human versus cattle) or geographically 
separated populations. However, no study has been reported as of yet comparing isolates from a 
single feedlot cattle population experimentally treated with antibiotics. Moreover, Salmonella 
isolates collected in our study are wild-type populations, not those experimentally challenging 
farm animals as orally administered laboratory cultured strains, which induce more variables by 
inoculation methods, concentration, and serotypes [233]. Our research project will show the 
effects of CCFA and CTC on feedlot cattle from multiple aspects, which fills the research gaps 
of current research on antibiotic resistant Salmonella in feedlot cattle. 
*Reprinted with permission from “Population dynamics of enteric Salmonella in response to 
antimicrobial use in beef feedlot cattle” by Ohta N, Norman KN, Norby B, Lawhon SD, Vinasco 
J, den Bakker H, et al., 2017 Scientific Reports, 2017;7(1):14310., Copyright 2017 by Creative 
Commons licences. 
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CHAPTER III 
POPULATION DYNAMICS OF ENTERIC SALMONELLA IN RESPONSE TO 
ANTIMICROBIAL USE IN BEEF FEEDLOT CATTLE* 
 
3.1 Introduction 
Foodborne salmonellosis is estimated to cause more than 1.2 million illnesses annually in the 
United States, requiring 23,000 hospital admissions and resulting in 450 deaths [19]. 
Salmonellosis is usually self-limiting, and even severely affected patients generally recover in 5 
to 7 days if given rehydration fluids. Antimicrobial treatment options for adults include 
ceftriaxone, a medically important third-generation cephalosporin, and fluoroquinolones. There 
are potential side effects of fluoroquinolones for pediatric patients, and hence the first choice of 
treatment is ceftriaxone [234-236]. Because fewer treatment options are available for 
antimicrobial-resistant Salmonella, infections with these strains are potentially more life 
threatening [237]. Use of antimicrobials can cause unintentional selection pressure for 
antimicrobial resistance in the gut microbiota of animals, and therefore can potentially lead to 
more severe cases of salmonellosis [238-240]. 
The National Antimicrobial Resistance Monitoring System (NARMS) has previously 
reported an increase in ceftriaxone resistant Salmonella carrying the blaCMY-2 gene, a class C 
beta-lactamase and the chromosome encoded ampC gene, in human cases of salmonellosis [193, 
241, 242]. The blaCMY-2 gene also confers resistance to ceftiofur, a third-generation 
cephalosporin approved for veterinary use, as well as ampicillin, amoxicillin-clavulanic acid, 
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cephalothin, and cefoxitin [193, 241]. Observed increases in ceftriaxone resistant Salmonella in 
humans may be due, at least in part, to the increased use of third-generation cephalosporins in 
food animals [28, 169]. This is considered a high public health risk since ceftriaxone and 
ceftiofur belong to the same class of 3rd generation cephalosporins, which the World Health 
Organization (WHO) has classified as critically important for human medicine. A variety of risk 
management strategies have been employed to help maintain antimicrobial efficacy for human 
medicine and to reduce the spread of antimicrobial-resistant bacteria derived from food animals 
[243]. In 2008, the U.S. Food and Drug Administration (FDA) announced a plan to prohibit the 
extra-label use of all cephalosporins in food animals (with no exceptions); later, this was revoked 
due to concerns about overly broad restrictions and the potential for unintended negative 
consequences [244]. Following re-examination by the FDA, extra-label use of cephapirin, some 
extra-label uses for indications involving the same route of administration, dose, and duration, 
and the use in minor food-producing species were excluded from the 2012 prohibition on extra-
label use of cephalosporins in food-producing animals [244]. The FDA also promoted judicious 
use of antimicrobials of importance to human medicine, by working to remove growth promotion 
labels as of January 1, 2017 [31, 245]. The effects of such strategies on reducing human 
infections with resistant bacteria have yet to be determined [10, 185, 227]. In the current study, 
we investigated treatment strategies involving a 3rd generation cephalosporin and 
chlortetracycline in fed beef cattle and their effects on intestinal Salmonella enterica populations. 
In the recent past, several studies have been conducted to investigate the selection of resistant 
E. coli and Salmonella with the use of ceftiofur in cattle, both in experimental and observational 
settings [30, 35, 209-213]. In one study, ceftiofur administration in beef cattle transiently 
increased ceftiofur-resistant E. coli; however, the bacterial population returned to the before-
 
 89 
treatment level after 2 weeks [209]. Daniels and others showed that ceftiofur use in a dairy herd 
was not associated with the occurrence of ceftiofur-resistant Salmonella and E. coli [30]. Singer 
and others reported that the therapeutic use of ceftiofur in dairy cattle opened the “window” to 
detect resistant E. coli, but it was not concluded that such use resulted in the emergence or 
expansion of resistant E. coli [210]. Another dairy farm study reported that ceftiofur use and E. 
coli with reduced susceptibility to ceftriaxone are associated at the herd level, but not at the 
individual cow level [212]. A 10-month long study by Schmidt et al. showed that ceftiofur use in 
feedlot cattle did not increase the extended-spectrum cephalosporin resistant E. coli [211]. These 
studies suggest that the therapeutic use of ceftiofur can transiently increase the detection of 
cephalosporin resistant E. coli; however, the susceptible bacterial population returns after a 
suitable washout period. Since E. coli and Salmonella both belong to the Enterobacteriaceae 
family, it would seem likely that Salmonella would exhibit a similar response to ceftiofur as E. 
coli; however, it is not yet known since studies involving Salmonella require consistent presence 
at the high prevalence of pathogen like commensal bacteria. An observational study investigating 
varying levels of ceftiofur use and an association with resistant Salmonella isolated on swine 
farms, showed that the barns with rare and common ceftiofur use had 4.1% and 6.0% recovery of 
Salmonella carrying the blaCMY gene, respectively, while only 0.15% recovery occurred in the 
barns with moderate uses of ceftiofur [215]. The results suggest that other factors, such as farm 
management or environmental factors may have a greater impact than ceftiofur use on resistant 
Salmonella. 
Chlortetracycline (CTC) is a common feed additive used to treat and control bacterial 
pneumonia (bovine respiratory disease complex) in feedlot cattle; this is in addition to 
vaccination used to prevent respiratory disease and other injectable antimicrobials used for 
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disease control purposes [45]. In previous work reported from our group by Platt et al., CTC 
treatment paradoxically reduced the prevalence of ceftiofur resistant E. coli [34]. However, 
contradictory results were found in a subsequent study by Kanwar et al. in which CTC treatment 
increased ceftiofur resistance, most likely due to co-selection [35]. In a longer-term study, the 
effects of prophylactic use of CTC on antimicrobial-resistant E. coli in beef cattle were studied 
for 117 days by Agga et al.; their findings showed an increased level of tetracycline resistant E. 
coli on Day 5 post-treatment, but not on Days 27, 75, and 117 [63]. Additionally, prevalence of 
cephalosporin-resistant E. coli remained the same among CTC and control groups throughout the 
study period [63]. We have further investigated the antimicrobial resistance profiles of the 
Salmonella population dynamics in response to both ceftiofur and chlortetracycline 
administration in the very same cattle studied by Kanwar et al. [35].  
A randomized controlled study concerning the use of CTC and ceftiofur use and antibiotic 
resistant Salmonella enterica in feedlot cattle, has not previously been reported. 
The current study is focused on the effects of ceftiofur crystalline-free acid (CCFA) and CTC 
on the prevalence of Salmonella in feedlot cattle, and on changes in the profile of antimicrobial 
susceptibilities of Salmonella resulting from the selective pressures of CTC and CCFA. 
Furthermore, we investigate and report on the temporal dynamics of the Salmonella population 
in response to the use of antimicrobials.  
 
3.2 Materials and Methods 
3.2.1 Experimental design 
A randomized, controlled, longitudinal field trial was conducted involving two sequential 26-
day replicates in an experimental feedlot at West Texas A&M University in Canyon, Texas, 
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USA. The first replicate began in early August 2009 and a second replicate began in the middle 
of September. The cattle were owned by a third party and been purchased from a single 
operation in the far western United States. The cattle were shipped directly to the experimental 
feed yard one month before the trial started. The cattle were yearling steers that were 
predominantly of the Angus breed. The cattle were fed diets typical of regional feedlots; that is, a 
flaked-corned based diet with added roughage, protein, vitamins and minerals. Any cattle that 
became sick and required antibiotic treatments were excluded from the study. In each replicate, 
88 steers were assigned into 8 pens (n = 11 cattle) to distribute the body weights among the 
pens evenly, in a two-by-two factorial design with four treatment regimens (Figure 6), as 
described in a previous paper by our group [35].  
Across both replicates, in 8 pens all 11 steers received 6.6 mg/kg of CCFA (Excede®, 
Zoetis Animal Health, Florham Park, NJ) subcutaneously at the base of the ear (“All-CCFA & 
CTC” and “All-CCFA / no CTC” in Figure 6; group metaphylaxis model), and in the 
remaining 8 pens, a single steer treated with CCFA on day 0 was co-housed (mixed) with 10 
non-treated steers. Repeated across both replicates, four of the pens receiving “All-CCFA” 
and four of the pens receiving “1-CCFA” treatment later received three 5-day pulses of 
22 mg/kg CTC (Aureomycin®, chlortetracycline complex equivalent to 220.5 g/kg of 
chlortetracycline, Alpharma, Bridgewater, NJ). The CTC was top-dressed in feed with a one-
day break between each 5-day pulse. The CTC feeding occurred during the period from day 4 
until day 20 (“All-CCFA & CTC”, “1-CCFA & CTC”). The remaining 8 pens across both 
replicates did not receive CTC i.e., (four each of “All-CCFA / no CTC” and “1-CCFA / no 
CTC”). Fecal samples were collected every other day per rectum as described previously [35]. 
These samples were mixed with glycerol at a 1:1 ratio and preserved at −80 °C.  
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The animal experiments were approved by the Amarillo-Area Cooperative Research, 
Education, and Extension Triangle Animal Care and Use Committee (Protocol No. 2008-07), 
and by the Clinical Research Review Committee at Texas A&M University (CRRC # 09–35). 
All experiments were performed in accordance with institutional and the United States 
Department of Agriculture (USDA) guidelines and regulations governing the oversight and 
conduct of experiments involving food producing animals in the U.S. The Texas A&M 
University Institutional Biosafety Committee approval # IBC 2014-043 permitted the 
microbiological laboratory experiments involving Salmonella enterica isolates. 
 
  
 
Figure 6. Study design.  Four pens were allocated to each treatment over two replicates. 
Samples were tested from the circled days on the arrow (0, 4, 8, 14, 20, and 26). Un-circled 
numbers represent the days when ‘pulsed’ CTC was added back into the feed bunks for five 
days. 
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3.2.2 Salmonella isolation from fecal samples 
A total of 1,040 fecal samples obtained across days 0, 4, 8, 14, 20, and 26 were cultured for 
Salmonella. The maximum effect of CCFA treatment on multidrug resistant E. coli isolates was 
seen on day 4 in the previous study [35], and we expected to observe a similar trend for 
Salmonella. Days 8, 14, and 20 were chosen because these were the last days of each of the 5-
day CTC treatment pulses, and we predicted they would reflect the maximum effect on 
Salmonella prevalence. The study was completed on day 26.  
We isolated Salmonella by following a modified enrichment process as described previously 
[246] (see Tables 1-4 for media preparation instructions). Samples were thawed on ice and 
mixed thoroughly with a transfer pipette. In total, 500 mg of feces were pre-enriched in 5 ml of 
tryptic soy broth (TSB) (Difco, Becton Dickinson, Franklin Lakes, NJ) for 2 hours at room 
temperature, then incubated for 6 hours at 37 °C, and then kept at 4 °C for 14 hours. A 1 ml 
aliquot of the enriched feces in TSB was transferred into 9 ml of tetrathionate broth (Difco, 
Becton Dickinson) and incubated at 37 °C for 24 hours. After incubation, 100 µl of the 
tetrathionate broth culture was transferred into 10 ml of Rappaport-Vassiliadis R10 (RV) broth 
(Difco, Becton Dickinson) and incubated at 42 °C for 18 hours. The next day, 50 µl of RV broth 
was spiral-plated onto Brilliant Green agar (BGA) (Difco, Becton Dickinson) using an Eddy Jet 
2 spiral plater (Neutec Group Inc., Farmingdale, NY). A single presumptive Salmonella isolate 
was plated on tryptic soy agar (TSA) with 5% sheep blood agar (RemelTM, Lenexa, KS) for 
isolation and incubated at 37°C for 18 hours. Isolates were verified with Salmonella O-antiserum 
Poly A-I & Vi Factors 1–16, 19, 22–25, 34, Vi (Becton, Dickinson and Company, Franklin 
Lakes, NJ). Confirmed Salmonella isolates (n = 566) were preserved in cryobeads at −80 °C for 
further characterization.  
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Table 1.Tetrathionate broth formulas per liter purified water (modified from 
http://www.bd.com/europe/regulatory/Assets/IFU/HB/CE/BA/BA-257103.pdf  Becton 
Dickinson) 
 
BD Tetrathionate Broth Base 
Bacto™ Proteose Peptone 
5.0 g 
Provides nitrogen, carbon, vitamins and acids. 
Bacto™ Bile Salts 1.0 g Suppresses coliform bacteria and inhibits Gram-
positive organisms. 
Sodium Thiosulfate 30.0 g Suppresses commensal intestinal organisms. Forms 
tetrathionate by the addition of iodine solution. 
Salmonella carries the enzyme tetrathionate 
reductase and proliferates in the medium. 
Calcium Carbonate 10.0 g Neutralizes and absorbs toxic metabolites and 
provides a stable pH value. 
pH 8.4 ± 0.2  
 
Table 2 Iodine solution formula 
 
Iodine Solution 
Iodine 300.0 g 
Potassium Iodide 
250.0 g 
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Table 3 Rappaport-Vassiliadis broth (modified from 
http://www.bd.com/europe/regulatory/Assets/IFU/HB/CE/BA/BA-257257.pdf) 
BD Rappaport Vassiliadis Broth 
Bacto™ Tryptone 4.54 g Source of carbon and nitrogen for 
general growth requirements. 
Sodium Chloride 7.2 g  
Potassium Dihydrogen Phosphate 1.45 g  
Magnesium Chloride, Anhydrous 13.4 g Raises the osmotic pressure in the 
medium. Salmonella can grow at higher 
osmotic pressure, because they can 
survive dehydration. Inhibits the growth 
of Proteus spp. and Escherichia coli. 
Malachite Green Oxalate 0.036 g Inhibitory to organisms other than 
Salmonellae. Salmonella Typhi cannot 
grow under this concentration of 
Malachite Green. 
pH 5.1 ± 0.2 Inhibits the growth of other 
microorganisms. 
 
 
 
Table 4. Brilliant Green Agar 
BD Brilliant Green Agar 
Yeast Extract 3.0 g Nutrient 
Bacto Proteose Peptone 
10.0 g 
Nutrient 
Lactose 10.0 g Differentiation from lactose 
fermenters 
Sucrose 10.0 g Differentiation from sucrose 
fermenters 
Sodium Chloride 5.0 g  
Phenol Red 0.08 g Differentiation by color from 
lactose/sucrose fermenters; 
Salmonella do not produce acid.  
Agar 20.0 g Agar base 
Brilliant Green 12.5 mg Inhibit the growth of other 
coliform bacteria. 
pH 6.9 ± 0.2  
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3.2.3 Antimicrobial susceptibility testing  
Minimum inhibitory concentrations (MIC) of 14 antimicrobials (9 antimicrobial classes) 
for Salmonella isolates were determined by the broth microdilution method using the 
Sensititre® system (TREK, Thermo Scientific Microbiology, Oakwood Village, OH). 
Tested antimicrobials were ampicillin (AMP), amoxicillin/clavulanic acid (AUG2), 
azithromycin (AZI), cefoxitin (FOX), ceftiofur (XNL), ceftriaxone (AXO), chloramphenicol 
(CHL), ciprofloxacin (CIP), gentamicin (GEN), nalidixic acid (NAL), streptomycin (STR), 
sulfisoxazole (FIS), tetracycline (TET), and trimethoprim/sulfamethoxazole (SXT) (Table 5; 
Figure 7). Briefly, isolates were plated onto TSA with 5% sheep blood agar and incubated at 
37 °C for 18 hours. Then, 1 or 2 colonies were suspended in 4 ml of sterilized water adjusted 
to 0.5 McFarland standard and 50 µl of the culture suspension was transferred into 11 ml of 
Mueller-Hinton broth; thereafter, 50 µl of suspension was inoculated onto Gram-negative 
National Antimicrobial Resistance Monitoring System (NARMS) CMV3AGNF plates using 
the Sensititre® automated inoculation delivery system (TREK). Plates were incubated at 37 °C 
for 18 hours.  
Escherichia coli ATCC 25922, Escherichia coli ATCC 35218, Pseudomonas aeruginosa 
ATCC 27853, Staphylococcus aureus ATCC 29213, and Enterococcus faecalis ATCC 29212 
(American Type Culture Collection, Manassas, VA) were used as quality control strains for 
susceptibility testing. Plates were read on a Sensititre OptiRead™ (TREK, Thermo Scientific 
Microbiology). The results were interpreted as susceptible, intermediate, or resistant 
according to Clinical and Laboratory Standards Institute (CLSI) guidelines using SWIN 
software (TREK, Thermo Scientific Microbiology) [247]. When breakpoints were 
undetermined, we followed the consensus breakpoints established by NARMS for Salmonella. 
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Intermediate isolates were reclassified as susceptible for further statistical analysis. Isolates 
resistant to three or more classes of antimicrobials were considered multidrug resistant (MDR) 
as defined by NARMS.  
 
Table 5. MIC range and breakpoints for Salmonella spp. antimicrobial susceptibility testing by 
NARMS (2014) [26] 
 
Antibiotic Range Breakpoint 
Ampicillin 1 - 32 ≥ 32 
Amoxicillin/Clavulanic Acid 1/0.5 - 32/16 ≥ 32 / 16 
Azithromycin 0.12 - 16 ≥ 32 
Cefoxitin 0.5 - 32 ≥ 32 
Ceftiofur 0.12 - 8 ≥ 8 
Ceftriaxone 0.25 - 64 ≥ 4 
Chloramphenicol 2 - 32 ≥ 32 
Ciprofloxacin 0.015 - 4 ≥ 1 
Gentamicin 0.25 - 16 ≥ 16 
Nalidixic Acid 0.5 - 32 ≥ 32 
Streptomycin 2 - 64 ≥ 64 
Sulfisoxazole 16 - 256 ≥ 512 
Tetracycline 4 - 32 ≥ 16 
Trimethoprim/Sulphamethoxazole 0.12/2.4 - 4/76 ≥ 4 / 76 
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3.2.4 Salmonella DNA extraction for whole-genome sequencing  
Salmonella DNA was isolated in a QIAcube HT robot using the QIAamp 96 DNA 
QIAcube HT Kit (Qiagen, Valencia, CA). A single Salmonella colony was suspended into 
5 ml of TSB and incubated overnight at 37 °C. From the suspension culture, 1 ml was 
transferred into a 1.2 ml micro-collection tube and centrifuged at 4,000 rpm for 15 minutes at 
room temperature. After the supernatant was removed, the pellet was re-suspended in ATL 
buffer (Qiagen) and mixed with reagent DX (Qiagen). One tube of small pathogen lysis beads 
(Qiagen) was mixed with the suspension and disrupted with the Qiagen TissueLyser system 
(Qiagen) at 25 Hz, for 5 minutes. The tubes were briefly centrifuged and 40 µl of Proteinase K 
was added to each tube. The tubes were incubated at 56 °C for 1 hour at 900 rpm in a 
ThermoMixer (Eppendorf, Hauppauge, NY) followed by a heat shock for 10 minutes at 95 °C. 
The suspension was cooled to room temperature and 4 µl of RNAse A was added. The 
prepared samples were set in the QIAcube HT for DNA extraction using a modified protocol 
Figure 7. Trek Sensititre® CMV3AGNF plate design 
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provided by Qiagen. The quality of the DNA was determined by the 260/280 ratios on the 
FLUOstar Omega Microplate Reader (BMG LABTECH, Cary, NC). The DNA quantity was 
measured by fluorescence with the Quant-iT™ Pico Green® ds DNA Assay kit (Thermo 
Fisher Scientific) on the FLUOstar Omega Microplate Reader and the DNA was stored at 
−20 °C until future use. 
3.2.5 Whole-genome sequencing by Illumina MiSeq 
To determine the serotypes and genotypes of the Salmonella isolates, we conducted 
whole-genome sequencing (WGS) using the Illumina MiSeq platform (Illumina, San Diego, 
CA, USA) on 566 isolates as shown in Figure 8. Libraries for 32 Salmonella DNA samples 
were multiplexed and pooled per sequence run using the Illumina Nextera XT library 
preparation kit as per the manufacturer’s instructions and were run with the Illumina MiSeq 
600 cycle v3 Reagent Kit with paired-end 2 reads (Illumina).  
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Figure 8. Library preparation workflow with Nextera XT library preparation kits 
 
 
3.2.6 Illumina Sequencing data analysis 
3.2.6.1 de novo assemblies and gene annotations 
Obtained raw reads in fastq files were trimmed with Trimmomatic ver. 0.36 [248]. The 
quality of the reads was confirmed by FastQC software and de novo assembled by Spades ver. 
3.10 [249]. The assembly quality was assessed on the QUAST web server, which provided the 
number of contigs, total length of genome by bp, GC (%), N50, and L50 statistics [250]. When 
the number of contigs was over 1,000 in SPAdes 3.10, the contigs were reassembled on the 
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PATRIC web resource using SMART mode, which assembles with SPAdes, Velvet, and IDBA 
assembler. The best-assembled contigs were chosen for downstream analysis.   
Raw fastq files obtained from the forward and reverse reads were uploaded to the web-
based database SeqSero 1.0 to determine the serotypes from WGS data 
(http://www.denglab.info/SeqSero) [96]. Multi-Locus Sequence Type (MLST) of each of 
the Salmonella isolates was determined by the combination of 7 gene alleles 
(aroC, dnaN, hemD, hisD, purE, sucA and thrA) using the PubMLST database (30-Nov-2014) in 
the SRST2 pipeline in the Illumina® BaseSpace® Sequence Hub [251, 252]. The PlasmidFinder 
database (20-Feb-2017) [253] was used for plasmid determination on the Center for Genomics 
Epidemiology (CGE) web server. 
 
3.2.7 Statistical analysis 
3.2.7.1 Descriptive Statistics 
The proportion of Salmonella positive (binary outcome) fecal samples and the proportion 
of isolates resistant to greater than or equal to 3 classes of antimicrobials, or else pan-susceptible 
by sampling day and by treatment group were cross-tabulated in Stata® version 12.1 (StataCorp 
LLC, College Station, TX). Crude associations between the serotypes, sampling days, and 
treatment groups were initially tested via the Likelihood-ratio based Chi-Square test or the 
Fisher’s exact test for rare combinations. Graphics for descriptive statistics were created on 
Tableau Desktop Professional Edition 10.3.2. 
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3.2.7.2 Multivariable analysis 
Prevalence of Salmonella (a binary variable) was modelled using a multilevel mixed-
effects logistic regression model (-melogit- in Stata® ver. 15.1) considering replicate (2 
replicates), pen (16 pens) and animal identifier (176 animals) as potential clustering variables 
with repeated observations. Following initial assessment of these three potential sources of 
over-dispersion, all three variables were included as significant (P < 0.05) random effects in 
the final statistical model. A 3-way full factorial statistical model incorporating fixed effects 
for CCFA (mixing) and CTC antibiotic regimens and sampling day was built. 
The final model for the prevalence of MDR Salmonella (a binary variable) was similarly 
modelled using multilevel mixed-effects logistic regression (-melogit- in Stata® ver. 15.1). 
Replicate, pen, and animal identifier were considered as potential clustering variables. 
Following the initial assessment, replicate was instead included as a fixed effect in the final 
model since repeated observations within animal identifier was not significant in the presence 
of pen level effects. In addition to replicate, a statistical model incorporating the fixed effects 
for each of the CCFA and CTC antibiotic regimens, sampling day, and 2-way interactions 
between day and antibiotic regimens was built. Marginal mean estimates from the final 
models were produced and graphical representations of the temporal dynamics were plotted. 
3.2.8 Data Availability 
The datasets generated during and/or analyzed during the current study are not publicly 
available due to on-going sequencing analyses at the time of publication; however, they will 
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become available from the corresponding author upon request. The sequencing data will be 
publicly available on NCBI as a Bioproject upon completion of all publications. 
3.3 Results 
3.3.1 Descriptive statistics of Salmonella among fecal samples of feedlot cattle 
In total, Salmonella were recovered from 566 out of 1,040 fecal samples. The mean 
Salmonella prevalence before the antibiotic treatments began (day 0) was 75.0% (95% CI: 
67.9–81.2%), with 132 out of 176 samples testing positive. Among the two groups in which 
all cattle were treated with CCFA (All-CCFA / no CTC, All-CCFA & CTC), the prevalence 
of Salmonella was 34.1% (15 positive out of 44 samples) and 27.3% (12 positive out of 44 
samples) on day 4, respectively. By day 14, the Salmonella prevalence in cattle receiving no 
subsequent CTC treatment (All-CCFA / no CTC; 31 positives out of 43 samples, 72.1%) was 
similar to that of those steers with the least antibiotic exposure (1-CCFA / no CTC; 35 
positives out of 44 samples, 79.5%) as shown in Figure 9 (second row). When CTC treatment 
followed CCFA treatment, the prevalence dropped even further to 16.3% by day 14 (All-
CCFA & CTC; 7 out of 43 positive). By day 26, the prevalence in both CTC treatment groups 
(1-CCFA & CTC, All-CCFA & CTC) returned to 47.1% (40 out of 85 positive). By 
comparison, the overall mean prevalence among steers in those pens that received the least 
antibiotic treatment (1-CCFA / no CTC) was estimated at 72.7% (95% CI: 66.8–78.0%) 
throughout the study period.  
3.3.2 Descriptive statistics of Salmonella isolates resistant to antibiotics 
The total number of Salmonella isolates and the percentage of MDR Salmonella (defined 
as resistant to ≥ 3 antimicrobial classes) for each sampling day by antibiotic treatment groups 
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are shown in an inner circle of Figure 9. Among the steers with the least exposure to antibiotic 
treatment, the vast majority of isolates remained pan-susceptible throughout the study period, 
although 3.2%, 5.7%, and 3.8% of multidrug resistant Salmonella isolates were detected on 
days 4, 14 and 20, respectively (Figure 9, first row). Among the group in which all cattle were 
treated with CCFA on day 0, 26.7% of Salmonella isolates were MDR on day 4 and 22.7% 
were MDR on day 8; however, MDR prevalence thereafter declined by day 14 (Figure 9, 
second row). In the group treated with CTC (1-CCFA & CTC) starting from day 4, pan-
susceptible isolates decreased and MDR isolates increased (73.3%) on day 8 and further 
increased to 80% and 100% on days 14 and 20, respectively (Figure 9, third row). By the end 
of the study (day 26), 50% of the isolates in this latter group remained MDR. Among animals 
sequentially receiving both CCFA and CTC treatment, the pattern of MDR dynamics 
resembled that of the treatment groups receiving CTC (Figure 9, fourth row). 
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Figure 9. Total number of isolates and proportion of MDR isolates per day and treatment group 
The outer circle (grey) reflects the number of fecal samples tested per pen each sampling day 
(n = 42 to 44). The size of the inner circle corresponds to the number of Salmonella isolates 
obtained each sampling day. The green piece of the inner circle represents pan-susceptible 
Salmonella and the red piece represents resistance to 3 or more classes of antimicrobials 
(MDR). Total number of the Salmonella positive samples and total fecal samples tested are 
shown below each pie in the text box. Percentages of pan-susceptible and MDR isolates are 
shown inside the circle. 
 
 
3.3.3 Mixed effects logistic regression model of Salmonella prevalence and MDR 
Salmonella prevalence 
CCFA and CTC treatments were coded as binary variables, with 0 (no treatment) used as 
the referent category. Days were 0, 4, 8, 14, 20, and 26, with day 0 used as the referent. CCFA 
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treatment effects were highly significant on days 4 (p < 0.004) and 8 (p < 0.003). CTC 
treatment significantly decreased the prevalence of Salmonella on days 8 (p < 0.004), 14 
(p < 0.001), and 20 (p < 0.024) when compared to day 0 (Figure 10).  
 
 
Figure 10. Modelled marginal mean prevalence of Salmonella by day and treatment group.  
Modelled marginal mean prevalence of Salmonella and 95% confidence intervals in cattle 
fecal samples by sample day and treatment group.  
Solid lines represent treatment groups in which a single CCFA treated steer was mixed within an 
otherwise untreated group while dashed lines represent groups in which all steers received CCFA 
treatment. 
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The prevalence of MDR Salmonella was modelled similar to that of overall Salmonella 
prevalence, as above, except that day 4 was used as a referent category. This is because MDR 
isolates first appeared on day 4, yielding unstable model parameters for day 0. Interaction 
between CTC treatment and day was associated with an increase of MDR Salmonella from 
day 8 (p < 0.008) to day 26 (p < 0.041) (Figure 11). CCFA treatment on day 0 further 
increased MDR Salmonella probability on day 8 in the All-CCFA & CTC treated groups, 
compared with the group treated only with CTC. A slight increase of MDR Salmonella was 
seen on day 4 in the CCFA-only treated group, compared to the referent group (1-CCFA / no 
CTC); however, this was not significant (P = 0.159). 
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Figure 11. Modelled marginal mean prevalence of MDR Salmonella by day and treatment group. 
Modelled marginal mean prevalence of Salmonella and 95% confidence intervals in cattle 
fecal samples by sample day and treatment group. Solid lines represent treatment groups in 
which a single CCFA treated steer was mixed within an otherwise untreated group while 
dashed lines represent groups in which all steers received CCFA treatment. 
 
 
3.3.4 Identification of serotypes and MLST 
Salmonella serotypes were identified by whole-genome sequencing using the SeqSero 
pipeline [96], which determines the serotype based on the sequence of the O-antigen gene 
cluster and H1 and H2 antigens. Six serotypes were detected; the most common serotype was 
Salmonella Mbandaka (38.0%), followed by S. Give (19.1%), S. Kentucky (13.6%), S. 
Reading (15.2%), S. Montevideo (13.4%), and S. Anatum (0.7%) as shown in Table 6.  
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Table 6. Multi-Locus Sequence Type (MLST) and serotypes of the Salmonella isolates 
 
 
All serotypes and MLST data matched and no divergent serotypes were detected from any 
single MLST (Table 6). Salmonella Reading was detected starting on day 4, and the prevalence 
increased greatly by day 8 in the All-CCFA / no-CTC groups, and especially in the 1-CCFA & 
CTC and All-CCFA & CTC treatment groups (Figure 12), where its presence extended well past 
day 8. Five serotypes, except S. Reading, were identified on day 0. In the 1-CCFA / no CTC 
group, the diverse composition of serotypes remained similar throughout the study. The S. 
Reading isolate detected on day 4 in the 1-CCFA / no CTC group was derived from the single 
steer that received CCFA and was mixed in the group comprised of 10 other non-CCFA-treated 
cattle; however, the S. Reading isolates from day 14 and 20 were from steers that were not 
treated with antibiotics. In the All-CCFA/no CTC group, the susceptible serotypes (S. Anatum, 
Give, Kentucky, Mbandaka, Montevideo) decreased on day 4 while S. Reading was increasingly 
Serotype 
Number 
of isolates 
Antigenic profile from Seqsero 
MLST 
Gene Alleles 
O 
H1 
(fliC) 
H2 
(fljB) 
Predicted 
profile 
aroC dnaN hemD hisD purE sucA thrA 
Anatum 
4 
(0.7%) 
O-3,10 e,h 1,6 3,10:e,h:1,6 64 10 14 15 31 25 20 33 
Kentucky 
77 
(13.6%) 
O-8 i z6 8:i:z6 198 76 14 3 77 64 64 67 
Mbandaka 
215 
(38.0%) 
O-7 z10 e,n,z15 7:z10:e,n,z15 413 15 70 93 78 113 6 68 
Montevideo 
76 
(13.4%) 
O-7 g,m,s - 7:g,m,s:- 138 11 41 55 42 34 58 4 
Give 
108 
(19.0%) 
O-3,10 l,v 1,7 3,10:l,v:1,7 654 111 47 49 42 12 58 3 
Reading 
86 
(15.2%) 
O-4 e,h 1,5 4:e,h:1,5 1628 46 60 10 9 6 12 17 
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present. In the 1-CCFA & CTC group, all isolates were S. Reading on day 20; however, 
susceptible serotypes were once again detected on day 26. The All-CCFA & CTC group 
exhibited less serotype diversity and S. Montevideo was detected only on day 0 in this group. 
More S. Reading were isolated from the treatment groups that received CTC. Serotype 
distribution was similar between replicates 1 and 2, except that S. Anatum was identified only in 
replicate 1 (Figure 13). The most common serotype detected in the 1-CCFA / no CTC group 
was S. Mbandaka and S. Reading was the least detected serotype (Table 7). The most common 
serotype detected in All-CCFA & CTC group was S. Give followed by S. Reading. In the 1-
CCFA & CTC group, overall 33.1% were S. Reading. 
 
 
 
Figure 12. Number of Salmonella enterica isolates within serotypes by treatment group and 
sample day. Six serotypes (Anatum, Give, Kentucky, Mbandaka, Montevideo, and Reading) 
were found among tested fecal samples. Numbers shown in the bars are the number of isolates 
for each serotype by treatment group across both trial replicates. 
 
 
 111 
 
Figure 13 Distribution of Salmonella enterica isolates within serotypes by replicate and day of 
sampling across all treatment groups. 
 
 
For quality control purposes, 2 isolates randomly chosen from each of the 5 serotypes 
identified by whole-genome sequencing (WGS) were sent to the National Veterinary Services 
Laboratories for traditional serotyping. All traditional serotyping results matched exactly with 
sequence based serotyping results. 
3.3.5 Associations of phenotypic antimicrobial resistance profile and serotypes of 
Salmonella 
All isolates (n = 566) were tested against a standard NARMS panel that included 14 
antimicrobials arising from 9 antibiotic classes. Serotype and resistant phenotypes were 
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significantly associated (p < 0.05). All the S. Anatum, S. Give, S. Mbandaka and S. 
Montevideo were phenotypically pan-susceptible. Nearly all (96.5%) of the S. Reading 
isolates had at least the penta-resistant profile, ACSSuT (resistant to ampicillin, 
chloramphenicol, streptomycin, sulfonamides, and tetracycline), with additional resistance to 
the 3rd generation cephalosporins, ceftiofur and ceftriaxone (Table 7). The other 3.5% of 
Reading isolates detected from the 1-CCFA & CTC group were not resistant to sulfonamides. 
The S. Reading resistance profiles were AMP-AUG2-AXO-FOX-TIO-STR-CHL-TET for 8 
antimicrobials and AMP-AUG2-AXO-FOX-TIO-FIS-STR-CHL-TET for 9 antimicrobials. 
One S. Kentucky isolate from the 1-CCFA & CTC group was resistant to 3 antimicrobials: 
STR, FIS, and TET (Table 7). No resistance to azithromycin, ciprofloxacin, gentamicin, or 
nalidixic acid was detected. 
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Table 7. Proportion of Salmonella serotype and AMR phenotype by treatment group 
 
 
 
 
3.3.6 Serotype pattern per individual animal 
Salmonella serotypes that were detected in the same animal from different sampling days 
were aggregated to identify the serotype patterns (Figure 14). In one steer, 5 serotypes (S. 
Give, Kentucky, Mbandaka, Montevideo, and Reading) were detected across the different 
sampling days. In 4.5% (8 steers) of animals, 4 serotypes with different combinations were 
Serotype 
Serotype per Treatment Group 
   AMR Phenotype 1-CCFA /   
no CTC 
1-CCFA  
& CTC 
All-CCFA /   
no CTC 
All-CCFA 
& CTC 
Anatum 
(n=4) 
0.0% (0) 1.7% (2) 1.2% (2) 0.0% (0)    Pansusceptible: 100.0% (4) 
Give 
(n=108) 
17.5% (33) 14.0% (17) 14.9% (24) 35.8% (34)    Pansusceptible: 100.0% (108) 
Kentucky 
(n=77) 
20.1% (38) 13.2% (16) 10.6% (17) 6.3% (6) 
   Pansusceptible: 98.7% (76) 
   STR-SUL-TET: 1.3% (1) 
Mbandaka 
(n=215) 
42.9% (81) 27.3% (33) 48.4% (78) 24.2% (23)    Pansusceptible: 100.0% (215) 
Montevideo 
(n=76) 
17.5% (33) 10.7% (13) 15.5% (25) 5.3% (5)    Pansusceptible: 100.0% (76) 
Reading 
(n=86) 
2.1% (4) 33.1% (40) 9.3% (15) 28.4% (27) 
   AMP-AUG2-AXO-FOX-TIO-SOX-STR-CHL-
TET: 96.5% (83) 
   AMP-AUG2-AXO-FOX-TIO-STR-CHL-TET: 
3.5% (3) 
Total 
(n=566) 
100.0% (189) 100.0% (121) 100.0% (161) 100.0% (95) 
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detected. Three serotypes were detected from 20.5% (36 steers) of animals and 2 serotypes 
were detected from 38.6% (68 steers) of animals. A single serotype was detected from 34.7% 
(61 steers) of animals. No steers were detected with S. Reading alone; that is, it was always 
detected with other serotypes across different sampling days (Figure 15). Four steers were 
classified as not harboring any Salmonella throughout the study period.  
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Figure 14. Total number of animals harboring each serotype pattern across all sampling days. 
Serotype patterns were clustered per treatment group across different sampling days. Darker blue 
indicates more animals with specific serotype patterns; conversely, lighter blue shaded serotype 
combinations had fewer animals.
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Figure 15. Salmonella serotypes detected per individual animal per day and treatment group 
Red: Kentucky; orange: Give; green: Montevideo; teal blue: Mbandaka; yellow: Reading; dark blue: Anatum 
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3.4 Discussion 
This randomized, controlled, longitudinal field trial has clearly demonstrated that the use 
of antibiotics shifts the antibiotic resistance status of the Salmonella population by selecting 
for MDR Salmonella and against the pan-susceptible Salmonella serotypes that are highly 
prevalent in beef cattle in this region of the USA. Since resistance phenotype and Salmonella 
serotype are so strongly associated, this effectively means that antibiotic use selects for 
particular serotypes. Chlortetracycline treatment alone, or with prior treatment with a 3rd 
generation cephalosporin, decreased the overall prevalence of Salmonella; further, each of 
these treatments increased the proportion of MDR Salmonella that remained. Ceftiofur 
treatment alone did reduce the prevalence of Salmonella; however, the reduction was 
relatively transient. The MDR phenotypic pattern was virtually identical among the S. 
Reading isolates (Table 7). Six Salmonella serotypes, which have commonly been reported in 
feedlot cattle and the feedlot environment, were detected in the fecal flora of these cattle [153, 
254-256]. As a point of reference, Salmonella Anatum, Montevideo, and Kentucky accounted 
for 50.4% of the serotypes detected in the National Animal Health Monitoring Systems 
(NAHMS) Feedlot 2011 study [256]. 
We found a high prevalence of Salmonella in the feces of feedlot cattle prior to antibiotic 
treatment. Previous attempts to determine the dynamics of Salmonella in experimental studies 
were likely not successful due to a low prevalence overall, and of resistant Salmonella, in the 
study population; thus, requiring a vast number of animals on trial to have enough power for 
the analyses [209, 213]. Even in large-scale observational studies, the prevalence can vary a 
great deal, illustrating that in many U.S. locations the prevalence is very low. The NAHMS 
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Feedlot 2011 study reported that the overall pen-level prevalence of Salmonella in feedlot 
cattle across the United States was 35.6%, with 9.1% sample (cattle)-level prevalence [154]. 
Our study successfully showed that the Salmonella population changes in response to 
antibiotic treatments, in part due to the high prevalence at the beginning of the study (i.e., 
70 + %). Some of the factors explaining the high initial prevalence in our study include 
geography (southern United States) and season (August-October). Several studies have shown 
a seasonal variation in Salmonella prevalence, such that sampling during the summer months 
yields the highest percentage of Salmonella positive samples [155, 156, 159, 257]. One study 
from North Dakota found 62.2% prevalence of Salmonella in the tested herd during spring 
months, but only one serotype S. Typhimurium var. Copenhagen was isolated from the entire 
herd [258]. It is possible that if our study had been conducted during the colder months of the 
year, such an obvious change in the Salmonella population might not have been observed. 
The Salmonella prevalence and serotype populations differ by region, country, and 
ambient environment which implies that the resistance phenotype will vary at the same time 
[154]. Therefore, our results may not necessarily be generalized to feedlots at other 
geographic locations. Sampling only from fecal grabs might not be an ideal method to 
determine the overall prevalence in feedlot cattle. One study showed that a combination of 
samples from perineum swab and fecal grab samples increased the prevalence of Salmonella 
to 88% from 50% versus when only fecal grab was tested for the prevalence [259]. We 
collected the fecal samples only by fecal grabs, which may return false negative results if 
Salmonella are distributed unequally within the feces.  
Several observational and experimental studies have explored the association between 
antimicrobial use (including ceftiofur) and the temporal dynamics of resistant E. coli and 
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Salmonella in cattle and pigs [30, 209, 211, 214-217, 260, 261]. One-time CCFA treatment 
(as is typically used to control respiratory disease in beef feeder cattle) on day 0 reduced the 
overall prevalence of Salmonella in feces. CCFA is not labeled for the control of Salmonella 
in cattle; however, its broad-spectrum nature, presence in multiple tissues, and effectiveness 
against Gram-negative bacteria appears to result in a temporal decrease of Salmonella 
prevalence immediately following treatment. The dose of CCFA (6.6 mg/kg) used in the 
current study was for the treatment and control of bovine respiratory diseases, such that the 
serum concentration is maintained over the minimum inhibitory concentration (0.2 µg/ml) for 
up 10 days following a single-dose administration. A previous study illustrated that an extra-
label regimen of ceftiofur (5 mg/kg, intramuscularly) decreased the detection and quantity of 
Salmonella and effectively treated salmonellosis in neonatal calves [262].  
In our study, CCFA treatment also increased the proportion of MDR Salmonella on days 4 
through 8. Despite only receiving a single dose of CCFA, by the end of the study (day 26) 
12.5% of isolated Salmonella remained multidrug resistant (Figure 9). With the follow-up of 
CTC treatment to earlier CCFA treatment, MDR isolates increased further to 75% of total 
Salmonella by day 14. We chose to explore day 14 to examine the status of antibiotic resistant 
Salmonella in cattle feces on the first day post-treatment that the animals were eligible to be 
sent to slaughter based on residue avoidance; that is, because the labelled slaughter 
withholding time of CCFA is 13 days. Our findings indicate that at the point at which this 
compliance requirement is met, MDR Salmonella prevalence persists far above the baseline 
starting values, a finding that has not been previously reported. However, we are well aware 
that such a scenario is highly unlikely in real feedlot settings; that is, CCFA treatment at the 
whole pen level is extremely unlikely to occur anytime close to when cattle are sent to 
 
 120 
slaughter. Typically, fed cattle would instead be sent to slaughter at least 6 months post-
arrival. To understand longer-term dynamics, additional studies are needed to further 
investigate the effects of CCFA and CTC treatments from treatment in the early feeding 
period through to slaughter. 
While CTC has been used for many decades in animal agriculture for prevention and 
growth promotion purposes, the effects of therapeutic doses of CTC on the prevalence and 
resistance of Salmonella in cattle have not been studied extensively. CTC was added to the 
feed (as a top-dress) for 3 pulses of 5 continuous days, with a one-day interval in between. 
This regimen was designed to observe the maximum effect of CTC, to follow the product 
label in the U.S., and to be consistent with a previous study published by Platt et al. [34]. 
CTC treatment alone reduced Salmonella prevalence to the same levels as cattle first injected 
with CCFA and then subsequently treated with CTC. This further suggests that the initial 
CCFA treatment did not have a significant long-term effect on Salmonella prevalence. It is 
possible that the initial CCFA may have selected for MDR Salmonella, which will be 
discussed later.  
The effects of CTC given at therapeutic or sub-therapeutic doses on pathogens including 
Salmonella have been reported in pigs [15, 263]. Although not statistically significant, pulsed 
CTC feeding during the finishing period lowered Salmonella prevalence in pigs [263]. Wells 
et al. have shown that CTC supplemented in the diet reduced the prevalence of both 
Campylobacter and Shiga-toxin producing E. coli [15]. Prevalence of Salmonella was at a 
negligible level in their study. A study by Agga et al. found that one-set of 5-day CTC in-feed 
treatments transiently increased tetracycline resistant E. coli concentration in the fecal swabs 
of feedlot cattle. Importantly, generic E. coli concentrations in the CTC treatment group 
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remained the same, thus indicating that tetracycline resistant E. coli effectively replaced the 
susceptible E. coli population [63]. 
Previous work by our group illustrated an inexplicable and paradoxical reduction of 
ceftiofur resistant E. coli via CTC treatment (despite mechanistic potential for co-location via 
tet(A) and blacmy-2 genes housed on a single IncA/C plasmid in many E. coli). We explored 
the potential that this might serve as a potential intervention to reduce ceftiofur resistance by 
instead favoring singly resistant E. coli strains harboring the tet(B) gene on the bacterial 
chromosome [34, 35]. In our current study, three pulsed (intermittent) CTC treatments 
displayed a stronger selection pressure on MDR Salmonella than CCFA treatment alone, 
which was completely the opposite of the previous published work exploring the effects of 
these same regimens in E. coli populations [35]. In that study, fecal E. coli from CCFA 
administrated pens showed more resistance to a full range of antibiotics than in cattle from the 
pens administered only CTC (the latter effect was negligible) [35]. As mentioned, while Agga 
et al. showed that a 5-day single-pulsed CTC treatment increased tetracycline resistant E. coli 
in fecal swabs of beef cattle at 5 days-post-treatment, no differences in cephalosporin resistant 
E. coli were found [63]. It is possible that the resistant E. coli population were different 
between these two studies. Comparatively, phenotypic resistance patterns and sequence type 
(or PFGE patterns) of E. coli in earlier studies of food animals are often diverse, while 
Salmonella are often either pan-susceptible or else MDR (assuming they are present at all) 
[35, 211, 255, 264].  
Importantly, in Salmonella, drug resistance phenotypes and serotypes are much more 
highly associated than is seen across the more prevalent and diverse populations of E. coli 
[255, 265, 266]. These differences in resistance patterns may indicate that Salmonella and E. 
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coli are not regularly sharing their resistance elements in the cattle gut microbiome [264]; 
conversely, they also might not be sharing the same ecological niches in the varying cross-
sections of intestinal regions [81]. One previous experimental study suggested that the use of 
ceftiofur in dairy cattle did not promote the transfer of blaCMY-2 coding plasmids among 
Salmonella and commensal E. coli in calves inoculated with plasmid-bearing bacteria and in 
dairy herds using ceftiofur [30]. However, another study found that the presence of an 
inflammatory condition in the gut could boost horizontal gene transfer between Salmonella 
and E. coli [267], something that is often lacking in studies involving healthy animals. 
Although limited to phenotypic resistance, our study reveals that Salmonella and E. coli 
isolated from the same gut microbiome did not share similar resistance patterns, either at 
baseline or during specified treatment periods and across treatment regimens [35]. 
We detected 6 serotypes in our study population; in decreasing overall prevalence, these were 
Salmonella Mbandaka, Give, Kentucky, Reading, Montevideo, and Anatum. The serotypes 
detected in this study were consistent with those published in previous studies and isolated 
from the lymph nodes, hides, and feces of feedlot and dairy cattle from the same region of 
Texas [150, 151, 159, 160, 167, 255]. Salmonella serotypes often appear to adapt to specific 
animal hosts. Among human clinical isolates reported to the CDC, S. Montevideo was 10th 
among frequently reported serotypes in 2013 [21]. In the current study, S. Mbandaka 
(serogroup C1) was the dominant serotype followed by Give (serogroup E1). The dominance 
of certain serotypes has been observed in other studies in feedlot cattle as well [151, 160]. 
However, it is possible that Salmonella enrichment via RV media may bias the detection 
towards serogroups C1, C2, and E [21]. We detected S. Reading, which belongs to serogroup 
B, but none of these were pan-susceptible. It remains a possibility that pan-susceptible S. 
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Reading isolates were not detected in our study due to enrichment bias or else the resistant S. 
Reading population was stable in the gut microbiota but was not able to outcompete the 
susceptible strains prior to antibiotic pressure. Our study has illustrated that serotype and 
MDR are often strongly associated. Most (96.5%) S. Reading isolates had the ACSSuT 
resistance profile, while the other serotypes did not; this agrees with previous work that 
suggests that S. Reading is more likely to be of the ACSSuT resistance phenotype than other 
serotypes [159, 167]. It remains unclear why certain serotypes are more highly resistant to 
antimicrobials, while others are not. However, all these cited studies suggest that the 
antimicrobial susceptibility of the various Salmonella serotypes might be determined not only 
by their genetic predispositions, but also by coexisting serotypes as well as environmental 
factors, such as antimicrobial selection pressure. 
The first and second replicates of these cattle trials were conducted at the same feedlot 
with a one-month interval between the studies. Cattle were housed in porous-fenced pens 
through which contact could be made with cattle in adjacent pens. Treatments were randomly 
assigned to balance the contact potential across pens; however, sterility could not be 
maintained between pens in such a field setting as is standard in the beef feeding industry. 
The serotype distribution of the first and second replicates was similar throughout the study 
and no S. Reading was found on day 0, even in the second replicate (Figure 13). This latter 
point strongly suggests that MDR Salmonella were transiently detected solely due to the 
antibiotic pressure applied during this trial. All those steers that were detected with S. Reading 
on at least one sampling day also had other serotypes isolated during at least one other 
sampling day (Figure 14, 15). Since these serotypes were not detected at the same time point 
(i.e., since we limited the number of colonies we assayed from each plate), it does not 
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necessarily mean that the steers were infected with 2 or more serotypes at once; however, this 
point does support the idea that S. Reading likely co-resided with other serotypes under 
“normal” non-antibiotic selection pressure conditions, and was more readily detected after the 
antibiotic treatments. 
The steer from which 5 different serotypes were isolated on 5 different days illustrates the 
complexity of Salmonella colonization in cattle; further, this is consistent with another study 
in dairy cattle that showed multiple serotype colonization per animal [255, 268, 269]. In 
agreement with our study, confirmation of Salmonella infection or colonization sometimes 
requires multiple testing methods, enrichment, and sequential sampling time-points. Four 
steers in our study were negative for Salmonella throughout the whole study period (26-days); 
even after this, these could be interpreted as being below the detection limit or else 
intermittent shedding of Salmonella or as being truly negative for Salmonella colonization. 
One limitation of this approach was that we terminated the study on day 26 and thus did 
not track the cattle to the age at which they would be sent to slaughter; that is, when fecal, 
hide, and lymph node Salmonella populations would represent a greater potential threat to 
public health. The feedlot is the final production stage for beef cattle, and thus represents a 
more proximate source of MDR Salmonella contamination at the slaughterhouse than occurs 
earlier in the beef production cycle [165]. In the future, we plan to conduct a similarly 
designed randomized controlled study with follow-up extending to slaughter approximately 
150 days post-treatment. We currently hypothesize that any temporal antibiotic treatment 
effects will wane over such an extended period of time, yielding few, if any, differences 
among the treatment groups by the time animals are ready for slaughter as shown in previous 
studies in E. coli populations [63, 211].  
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In conclusion, we found that CTC and CCFA treatments dramatically decreased overall 
Salmonella prevalence in feedlot cattle; however, multi-drug resistant Salmonella strains 
proliferated after antibiotic susceptible Salmonella population were killed. Even after the 
mandatory slaughter withholding period for ceftiofur crystalline-free acid was complete at 13 
days post treatment, the prevalence of MDR Salmonella remained elevated when compared to 
baseline levels, suggesting it may be important to consider the prevalence of MDR isolates when 
exploring adaptive withholding periods for antibiotics in the future. When new classes of 
antibiotics are introduced to the market, there may be no known resistance elements circulating 
in bacteria. However, after decades of use the situation will change which may warrant 
consideration of a microbial safety endpoint in addition to residue avoidance parameters. 
Salmonella serotypes and antibiotic resistance phenotypes displayed strong associations and 
suggest that specific serotypes may be more likely to carry MDR genes. Although it was 
transient, this study indicates that the use of CCFA and CTC exerts a strong selection pressure 
on the Salmonella populations in the gut of feedlot cattle; therefore, judicious use of 
antimicrobials is necessary for beef cattle feeding operations to aid in preventing increased 
levels of MDR Salmonella being present in cattle destined for slaughter. 
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CHAPTER IV 
QUANTITATIVE DYNAMICS OF SALMONELLA IN FECES OF FEEDLOT 
CATTLE TREATED WITH CEFTIOFUR AND CHLORTETRACYCLINE 
4.1 Introduction 
The objective of this chapter is to explore the quantitative dynamics of Salmonella 
impacted by antibiotic treatments in feedlot cattle. The first part describes a comparison of 
three detection and quantification methods including hydrolysis probe real-time qPCR 
(qPCR), direct spiral plating, and broth enrichment followed by spiral plating. We also 
compared quantitative results arising from qPCR versus direct spiral plating. In the second 
part, utilizing the quantitative data from qPCR and direct culture, we analyzed the temporal 
change of Salmonella and antibiotic resistant Salmonella quantity impacted by antibiotic 
treatments from Day 0 to Day 26. Other variables affecting Salmonella quantitative dynamics, 
in addition to antibiotic treatments, were investigated.  
Salmonellosis is one of the most common foodborne diseases in the United States. 
Detection of Salmonella in retail beef has been low (0.4-2%) in reports from the National 
Antimicrobial Resistance Monitoring System (NARMS) from 2002 to 2015. However, retail 
beef is one of the primary sources of Salmonella infection for humans via food in the United 
States and multiple outbreaks have been reported due to consumption of under-cooked ground 
beef [32, 146]. The finishing period for cattle occurs in the feedlot and this is where 
Salmonella can spread via fecal-oral route or the environment (e.g., feed and flies) between 
infected and uninfected cattle residing in the same pen [270, 271]. Additionally, a few calves 
may be vertically infected from their dams [272]. Most often, cattle are asymptomatic 
carriers, and no clinical signs are shown. Some cattle are super-shedders (i.e., those that shed 
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>104 CFU per gram of feces) and may spread Salmonella to other cattle in the pen and 
beyond. An intermittent shedding pattern makes it more difficult to control the dissemination 
of Salmonella among cattle. Currently, vaccines for Salmonella Newport (S. Newport) and S. 
Dublin are available; however, only 6.5% of feedlots vaccinate for Salmonella because of the 
expense [45]. Additionally, no antibiotics are approved for the treatment and control of 
Salmonella because of the risk that antibiotic use might increase colonization with antibiotic-
resistant Salmonella.  
Salmonella contamination of retail meat mainly occurs at the slaughterhouse through fecal 
contamination of hides and from infected lymph nodes that are incorporated into batches of 
ground beef [159, 180, 181, 273-275]. Several quantitative studies have shown higher 
prevalence of Salmonella on hides than in feces at slaughter; therefore, hides and lymph-
nodes are likely sources of carcass contamination [13, 159, 276]. Since Salmonella is not 
considered an adulterant in raw meat by the USDA, it is crucial to decrease the overall 
Salmonella quantity that enters the slaughterhouse rather than rely on punitive product recalls 
to effect changes at the plant. Additionally, contamination of meat with antibiotic resistant 
Salmonella is a serious public health concern due to there being fewer treatment options for 
infected individuals, especially infants, children, pregnant women, and immunocompromised 
persons.  
In lieu of fluoroquinolones, which may cause musculoskeletal disorders, cephalosporins 
are the choice of treatment for these high-risk populations. Approximately 80% of 
cephalosporins that are sold for food animals are used in cattle production [8]. Since the 
feedlot is the final stage where cattle receive antibiotics for disease treatment, control, and 
prevention, it is crucial to control the antibiotic resistant Salmonella pre-harvest to reduce 
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Salmonella entering slaughter. Proper intervention strategies to reduce antibiotic resistant 
Salmonella are needed. Controlling Salmonella infection and antibiotic use at the feedlot will 
ultimately mitigate hide and carcass contamination of Salmonella and antibiotic resistant 
Salmonella at slaughter; ideally, such reductions will extend to lymph nodes as well.  
The effects of antibiotic use on the quantity of E. coli in cattle has been studied previously 
[30, 210, 211]. However, despite the pathogenicity of Salmonella to humans, the effects of 
antibiotics on the concentration of Salmonella (including susceptible and resistant 
Salmonella) have not been studied extensively in cattle fecal samples but have been studied in 
pigs and mice [222, 277]. Most studies of E. coli have demonstrated that antibiotic treatment 
decreases E. coli concentrations transiently [210]. On the other hand, some studies have 
shown that antibiotic treatments help establish Salmonella populations and induce super 
shedding in mice and pigs [80, 278]. One study that included experimental inoculation of 
Salmonella in pigs showed that pigs that received antibiotic treatment had higher fecal 
shedding. In mice, Salmonella populations were established after antibiotic treatment, 
presumably by the disruption of the healthy microbiota.  
We conducted our study in the Texas Panhandle, where a high prevalence of Salmonella in 
cattle is commonly observed. In this studied population, a third-generation cephalosporin, 
ceftiofur crystalline-free acid (CCFA), and chlortetracycline (CTC) were experimentally 
given to investigate their effects on the quantity of Salmonella present in bovine feces. CCFA 
was given on Day 0 followed by CTC treatment from Day 4 to Day 20 for five consecutive 
days over three time periods with a one-day interval in between. For the CCFA treatment, 8 
pens were mixed with one steer treated with CCFA on Day 0 among 10 steers without CCFA 
to investigate the effect of mixing CCFA treated steer among non-treated cattle. These 
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antibiotics are not approved for the treatment of Salmonella, and their direct impact on 
amount of susceptible and resistant Salmonella populations have not been investigated. Their 
use in feedlot cattle would typically be for the treatment and control of bovine respiratory 
disease.  
Resistance to chlortetracycline is common among E. coli and Salmonella. Tetracycline 
resistant isolates are often co-resistant to cephalosporins and conferred by plasmids carrying 
resistance gene cassettes. In our previous study, we observed that the prevalence of 
Salmonella decreased after antibiotic treatment; however, the proportion of multidrug 
resistant (MDR) Salmonella increased, as determined by broth enrichment methods [88]. 
While it has been shown that the proportion of MDR Salmonella increased with antibiotic 
treatment, it is not clear if the susceptible Salmonella populations were replaced by resistant 
Salmonella within the animals.  
Quantification of Salmonella from cattle, pig, poultry, and horse feces has been reported 
previously using various methods, including most probable number (MPN), spiral plating, 
automated immunomagnetic separation, and quantitative real-time PCR (qPCR) [159, 277, 
279-281]. For accurate and rapid detection and quantification of Salmonella in fecal samples, 
molecular methods like qPCR also can be utilized [282-285]; however, qPCR quantification 
of Salmonella in fecal samples is challenging because of the presence of a complex 
microbiota and PCR inhibitors. A few studies have successfully used hydrolysis probe 
(Taqmanâ) quantitative real-time PCR and TaqManâ quantitative reverse-transcript real-time 
PCR to detect Salmonella in food and environmental samples [285, 286]. The studies that 
have compared culture methods and qPCR for the detection of Salmonella in food, mice, and 
biosolid samples, demonstrated lower detection limits with qPCR [277, 284, 287]. 
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Comparison of culture and qPCR methods have also been studied in Shiga-toxin producing E. 
coli [288-290]. Semi-quantification by enrichment of fecal samples and plating can recover 
weak Salmonella and increase the counts but at the cost of reduced accuracy. Direct plating of 
diluted fecal samples on selective agar is easy and fast, and we used this approach for 
comparison with qPCR.  
In the current study, quantification of Salmonella and antibiotic resistant Salmonella was 
performed by direct spiral plating on plain Brilliant Green Agar (BGA) and BGA containing 
tetracycline (16 mg/L) and ceftriaxone (4 mg/L). Additionally, hydrolysis-probe based real-
time quantitative PCR (qPCR) was conducted targeting the invA gene, which is a specific 
invasion gene necessary for Salmonella to infect epithelial cells [291, 292]. We examined the 
Kappa statistics to compare the results obtained from qPCR, spiral plating, and broth 
enrichment. Additionally, we analyzed the effects of CCFA and CTC treatments by zero-
inflated Poisson models. Lastly, we conducted qPCR performance and analysis following the 
MIQE guidelines for qPCR [293]. 
4.2 Materials and Methods 
4.2.1 Experiment design and sample collection 
The experimental design was the same as described in Chapter III. Briefly, 2 replicates of 
cattle with 4 treatment groups were treated with either CCFA, CTC or both and were sampled 
every other day for 26 days. Glycerol fecal samples from Days 0, 4, 8, 14, 20, and 26 were used 
for the quantification by spiral plating. Fecal samples stored at -80 °C without glycerol from the 
identical sampling days were used for the extraction of total community DNA. At the end of the 
trial, 16 samples were not collected because either cattle required additional antimicrobial 
treatments or else were culled or died. A total of 1,040 samples were included in the study. 
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4.2.2 Broth enrichment method for Salmonella detection 
Salmonella was isolated following a modified enrichment process, as described in the Chapter 
III [88]. Fecal samples were thawed on ice and mixed thoroughly with a transfer pipette. In 
total, 500 mg of feces were pre-enriched in 5 ml of tryptic soy broth (TSB) (Difco, Becton 
Dickinson, Franklin Lakes, NJ) for 2 hours at room temperature and then incubated 6 hours at 
37 °C and then kept at 4 °C for 14 hours. A 1 ml aliquot of the enriched fecal sample in TSB 
was transferred into 9 ml of tetrathionate broth (Difco, Becton Dickinson) and incubated at 
37 °C for 24 hours. After incubation, 100 µl of the tetrathionate broth culture was transferred 
into 10 ml of Rappaport-Vassiliadis R10 (RV) broth (Difco, Becton Dickinson) and incubated 
at 42 °C for 18 hours. The following day, 50 µl of RV broth was spiral-plated onto Brilliant 
Green agar (BGA) (Difco, Becton Dickinson) using an Eddy Jet 2 spiral plater (Neutec Group 
Inc., Farmingdale, NY). A single presumptive Salmonella isolate was plated on tryptic soy 
agar (TSA) with 5% sheep blood agar (RemelTM, Lenexa, KS) for isolation and incubated at 
37°C for 18 hours. 
4.2.3 Quantification of Salmonella by colony counting 
Fecal samples (500 mg) were diluted in 4.5ml of phosphate buffered saline (PBS) in a 1:10 ratio. 
Diluted fecal samples were plated on BGA, BGA with 16 mg/L of tetracycline (BGA-tet), and 
BGA with 4 mg/L of ceftriaxone (BGA-cef) by an Eddy Jet 2 spiral plater with the E-Mode 50 µl 
setting and incubated at 37 °C for 18 hours. The concentrations of antibiotics were determined 
following CLSI breakpoints for tetracycline and ceftriaxone, respectively. Presumptive 
Salmonella colonies were counted by an automated Flash & Go® colony counter the next day 
following the manufacturer’s instructions (Figure 16, 17) (Neutec Group Inc, Farmingdale, NY).  
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Figure 16. Illustration of E-Mode 50 µl spiral plating and methods for colony counting (Adapted from Eddy Jet 2 user’s guide, IUL. 
S.A.) [294]. The area where colonies are growing at the correct density and the dilution factor were incorporated into the final 
calculation of colony forming unit (CFU) per gram of feces. 
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4.2.4 Hydrolysis probe quantitative real-time PCR (qPCR) 
Gene-based quantification of Salmonella in the community DNA was performed using the 
invA gene primers and probes on the AriaMx Real-Time PCR system (Agilent Technologies, 
Santa Clara, California) [281, 285, 286]. Total community DNA extracted from fecal samples 
from days 0, 4, 8, 14, 20, and 26 of replicate 1 and 2 were quantified. The community DNA was 
used directly as a template in the reaction. The reaction plates were set up manually and samples 
were run in duplicate. Quantities were standardized via the 16s rRNA quantity in the community 
DNA as described previously [220].  
 
 
Figure 17. Figure on the left is the presumptive Salmonella colonies grown on Brilliant Green 
Agar (BGA). Figure on the right is the same plate shown on the Flash & Go® colony counter. 
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4.2.4.1 Total community DNA extraction for qPCR 
Total community DNA was extracted from 200mg feces by the QIAamp DNA Stool Mini 
Kit TM (Qiagen, Valencia, CA) in the QIAcube robot TM (Qiagen, Valencia, CA) following the 
manufacturer’s instructions as described previously [220]. The quality and quantity of the 
community DNA was determined via the NanoDrop® ND-1000 UV-Vis Spectrophotometer 
(NanoDrop Technologies, Wilmington, DE) at wavelengths of 260 and 280 nm. DNA samples 
were stored at -20 °C for further genotypic analysis. 
4.2.4.2 Standard curve generation 
The genomic DNA extracted from Salmonella enterica subsp. enterica serovar Typhimurium 
ATCC® 700720™ (ATCC®, Manassas, Virginia) by the QIAcube TM robot (Qiagen, Valencia, 
CA) was used as a template for standard curve generation [286]. The standard curve was serially 
diluted and each standard curve reaction contained 3 µl of diluted genomic DNA, in which the 
final copy numbers were 1x106, 1x105, 1x104, 1x103, 1x102, and 1x101. Gene copy numbers 
were calculated following the Thermo Fisher Scientific web tool 
(https://www.thermofisher.com/us/en/home/brands/thermo-scientific/molecular-
biology/molecular-biology-learning-center/molecular-biology-resource-library/thermo-scientific-
web-tools/dna-copy-number-calculator.html). The total size of the Salmonella Typhimurium 
ATCC 700720 strain is 4,857,450bp (GenBank: AE006468.2). The molar mass per base pair was 
set as 650 (g/mol)/bp. Efficiency was calculated following the equation: efficiency = 10(−1/slope of 
standard curve) − 1 
 4.2.4.3 Primers/probes and reactions setup 
The primers and probes targeting the invA gene and standard curve generation were adapted 
and modified from Gonzalez-Escalona et al. (Table 8) [285]. FAM was used for the 5’-Reporter 
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dye (Table 8). The 16s rRNA data were obtained from a previous study [220, 295]. Primer 
specificity was confirmed by BLAST, which returned only Salmonella enterica subsp. enterica. 
The number of invA gene copies in Salmonella isolates from the study population was confirmed 
by whole genome sequencing data to be 1-gene copy per genome. Each reaction was composed 
of 10 µl of Brilliant III Ultra-Fast QPCR Master Mix with Low ROX (Agilent Technologies, 
Santa Clara, California), 4.6 µl of nuclease-free water, 0.4 µl of probe (0.2 µM), 1 µl each of 
forward and reverse primers (0.5 µM), and 3 µl of total community DNA (Table 9). 
Thermocycler conditions for the reaction were 95°C for 3 min (activation of master mix), and 40 
cycles of 95°C for 5 sec (denaturing), 60°C for 10 sec (annealing/extension) (Table 10). Data 
collection from fluorescence was conducted at the annealing/extension step of each cycle. Each 
sample was run in duplicate. 
 
 
Table 8. Primers and probes used for qPCR 
 
 
 
Gene Primer Sequence Tm 
(°C) 
Product size 
(bp) 
Gene bank 
accession number 
invA invA_176_F 5’-CAACGTTTCCTGCGGTACTGT-
3’ 
60 116 M90846 
invA_291_R 5’-CCCGAACGTGGCGATAATT -3’ 
  
M90846 
invA_FAM_208 
Probe 
FAM-
CTCTTTCGTCTGGCATTATCGATC
AGTACCA-Iowa Black RQ-Sp 
  
M90846 
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Table 9. qPCR reaction protocol 
 
Brilliant III Probe Master Mix Reaction 
Component Volume/Rxn (µl) Primer/Probe Final con. (µM) 
NF water 4.6  
2xBrilliant III qPCR 
MM Low ROX 
10  
invA Probe 0.4 0.2 
invA Primer F 1 0.5 
invA Primer R 1 0.5 
DNA 3  
Total 20  
 
 
 
 
Table 10. qPCR thermocycler protocol 
 
Segment Number of cycles Temp. (°C) Duration Comment 
Activation 1 95 3 min. 
 
Denaturation 
Annealing 
40 
95 5 sec. 
 
60 10 sec. Data collection 
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4.2.5 Statistical Analysis 
After each run, qPCR data were analyzed using the AriaMx ver. 1.0 software (Agilent). 
Gene copy numbers were back-calculated to gene copies per gram of wet feces by taking 
feces loss and dilutions into account at each step of community DNA extraction. Cq derived 
gene copy numbers were multiplied by 583.33 for the complete back calculation. Both non-
standardized invA gene copies per gram wet feces and the quantities obtained by standardizing 
with the 16S rRNA gene were calculated and analyzed. All standardized, non-standardized, 
and colony count derived quantities were logarithmically transformed to log base 10 for use as 
a dependent variable in both multiple imputation and zero-inflated Poisson models using 
Stata/IC 14.2 (StataCorp LLC, College Station, TX). Detection based on qPCR and direct 
spiral plating were used as binary data for detection analyses. Kappa statistics were calculated 
for the agreement among detection methods. Salmonella positive samples by broth 
enrichment, qPCR and direct spiral plating methods were visualized by a Venn-diagram using 
BioVenn [296]. 
4.2.5.1 Analysis of observed qPCR and direct plating data with zero-inflated 
Poisson model and linear regression 
Direct plating and qPCR derived log10 transformed outcomes were rounded and converted 
from continuous numeric to integer data for analysis purposes since many of the qPCR 
reactions and colony counts were below the limit-of-quantification (LOQ) and marked as 
zero. Counts were set as dependent variables, and CCFA (binomial), CTC (binomial), and 
days (ordinal) were included as independent variables specified in a 3-way full factorial 
model. No-CCFA treatment (0), No-CTC treatment (0), and day 0 were set as the baseline. 
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The same variables were used as inflation variables. The log10 transformed counts were used 
for linear regression analyses of qPCR and direct plating.  
4.2.5.2 Imputation of missing values  
When the quantity of the invA gene and colony numbers on BGA were under the LOQ they 
were recorded as missing values. Originally, missing values were given a value of 1 and log10 
transformed to 0 for visualization purposes. The missing values were estimated by imputation 
procedures in Stata/IC 14.2 with linear regression, truncated regression, and interval 
regression to provide a censored continuous variable [297, 298]. Each imputation was 
conducted with the full factorial model including trial replicate as a fixed effect, and a 3-way 
full factorial model using CCFA, CTC, and days as independent variables. The upper limit of 
missing values was set as 3.6 log10 for those with missing observations in truncated regression 
and interval censored regression. The lower limit was set to -¥. The imputed values were 
diagnosed for fit with the observed data [298]. Multiple imputed values from interval 
censored regression estimation were estimated for further analyses utilizing mixed-level linear 
regression with the command “mimrgns” available through “ssc install mimrgns” in Stata 
version 14.2 [299].   
4.3 Results 
4.3.1 Descriptive statistics of broth enrichment, qPCR, and spiral plating 
methods 
4.3.1.1 Description of qPCR runs 
Each community DNA sample was tested in duplicate by qPCR and each run included a 
standard curve. A total of 30 qPCR runs were performed on 96 well plates. The efficiency of 
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qPCR was calculated from the standard curve, in which the mean for 30 runs was 97.8% 
(range: 90.5%-106.9%) (Figure 18). The mean coefficient of correlation (R2) was 98.1% 
(range: 93.8%-99.9%) and the mean slope was -3.38 (ranged -3.57 to -3.17). The Cq value 
ranged from 18.49 to 39.98 with a mean of 29.95. The negative control wells, which 
contained master mix, probe, primer pairs, and water in the reaction, were negative in all of 
the runs.  
 
 
Figure 18. Example of the standard curve regression plot amplified from template genomic DNA 
of Salmonella enterica Typhimurium targeting the invA gene. 
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4.3.1.2 Comparison of detection and quantitation methods 
From 1,040 fecal samples tested, Salmonella was detected in 566 samples (54.4%) 
after the broth enrichment method. Salmonella was detected by qPCR and direct spiral 
plating in 324/1040 (31.2%) and 252/1040 (24.2%) samples, respectively (Table 11). 
Further, 474 (45.6%), 716 (68.8%), and 788 (75.7%) samples were below the LOQ by 
enrichment broth, qPCR, and direct spiral plating, respectively, and therefore were initially 
recorded as zero. The LOQ was log10 2.78 per gram feces for qPCR and log10 2.60 per gram 
feces for direct plating. The 16s rRNA gene was detected in all samples. The mean log10 gene 
copies per gram of feces for qPCR was 4.33 (95% CI: 4.24-4.42) and the log10 CFU per gram 
feces for direct plating was 3.54 (95% CI:3.44-3.63).  
 
Table 11. Number of samples detected with Salmonella in broth enrichment, probe qPCR, and 
direct spiral plating. 
Detection method Detected Below LOQ Total 
Min-Max 
(log10 / g feces) 
Mean 
(log10 / g feces) 
Broth enrichment 566 (54.4%) 474 (45.6%) 1040 - - 
Probe qPCR 324 (31.2%) 716 (68.8%) 1040 2.78-7.99 
4.33  
(95% CI: 4.24-4.42) 
Direct spiral 
plating 
252 (24.2%) 788 (75.7%) 1040 2.60-6.18 
3.54  
(95% CI: 3.44-3.63) 
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4.3.1.3 Comparison of three detection methods 
A total of 623/1040 (59.9%) samples were detected with Salmonella in at least one of 
the detection methods among all of the tested days. A total of 187/1040 (18.0%) samples 
were positive for all 3 methods and 417/1040 (40.1%) samples were negative for all three 
detection methods. Salmonella was detected only by broth enrichment method in 237/1040 
(22.8%) samples, only by qPCR in 48/1040 (4.6%), and only by direct spiral plating in 
6/1040 (0.6%) samples (Figure 19). The sample numbers that were detected by the three 
methods are shown in a Venn diagram (Figure 19). At the individual animal level, the 
Salmonella detection by each method and the detected pattern by day is shown in Figure 
20. Among the 4 animals in which Salmonella was not detected by broth enrichment from 
all 6 tested days (ID 2245, 2344, 2387, and 2356), 3 animals had detection with qPCR on 
day 0 (ID 2245, 2344) or on both day 0 and 4 (ID 2387). Therefore, only 1 animal (ID 
2356) out of 176 did not have Salmonella detected with any of the methods on any of the 
tested days.  
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Figure 19 Number of samples detected by broth enrichment, probe qPCR, and direct spiral 
plating methods shown in a Venn diagram out of 1,040 samples tested in total by each of the 
three methods. Red: Broth enrichment, Yellow: Probe invA qPCR, Green: Direct spiral plating. 
Numbers corresponds to the number of samples detected with Salmonella in each portion of the 
circle.  
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Figure 20 Detection pattern of individual cattle by treatment group and detection methods. Each row represents an individual steer 
with pen and animal identifier. The colors and numbers correspond to the detection methods. Pink: detected with enrichment (all 
containing number 1), containing number 2: detected additionally with direct plating, containing number 3: detected additionally with 
invA qPCR, Yellow: only detected with qPCR (number 300), Green: only detected with direct plating (number 20), Orange: detected 
with direct plating and qPCR, but not with enrichment (number 320), 0: no detection in all methods, Grey: no samples were collected. 
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4.3.1.4 Agreement between direct spiral plating and qPCR 
Measures of association between two tests are shown in 2x2 tables for broth 
enrichment vs. direct spiral plating (Table 12), broth enrichment vs. qPCR (Table 13), and 
direct spiral plating vs. qPCR (Table 14). Kappa (κ) , which measure the agreement of two 
tests beyond chance and prevalence and bias-adjusted kappa (PABAK) statistics, adjusting 
for prevalence and bias, were calculated (Table 15) [300] [301]. Kappa and PABAK 
between broth enrichment vs. direct spiral plating was 0.3894 and 0.3615, respectively, 
and broth enrichment vs. qPCR was 0.3581 and 0.3385, respectively, both of which 
represent fair agreement. Kappa and PABAK between direct spiral plating vs. qPCR was 
0.5292 and 0.6230, respectively, which indicates moderate agreement (Table 15) [302].  
 
 
Table 12. 2x2 table comparing the detection of Salmonella by broth enrichment and direct spiral 
plating methods. 
    
Salmonella detection 
after broth enrichment   
    + - Total 
Direct spiral plating 
+ 243 9 252 
- 323 465 788 
 
Total 566 474 1,040 
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Table 13. 2x2 table comparing the detection of Salmonella by broth enrichment and probe qPCR 
methods. 
    
Salmonella detection  
after broth enrichment   
    + - Total 
qPCR 
+ 273 51 323 
- 293 423 717 
 
Total 566 474 1,040 
 
 
Table 14. 2x2 table comparing the detection of Salmonella by direct spiral plating and probe 
qPCR methods. 
    qPCR   
    + - Total 
Direct plating 
+ 190 62 252 
- 134 654 788 
 
Total 324 716 1040 
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Table 15. Kappa (κ) and PABAK and agreement between direct spiral plating, broth enrichment, 
and probe qPCR. 
 Broth enrichment vs. 
qPCR vs. direct plating 
 Direct plating qPCR 
Agreement 68.08% 66.92% 81.15% 
Expected Agreement 47.72% 48.33% 59.71% 
Kappa (κ)  0.3894 0.3598 0.5322 
PABAK 0.3615 0.3385 0.6230 
Level of agreement Fair Fair Moderate 
Significance P=0.0000 P=0.0000 P=0.0000 
Prevalence (95% CI) 54% (51-57.5) 31% (28-34.1) 
Αgreement: observed agreement between two tests, Expected Agreement: agreement by 
chance, Level of agreement was adapted from Viera et al. [302]. PABAK: prevalence-
adjusted bias-adjusted kappa 
 
4.3.2 Comparison of the quantity by qPCR and direct plating on BGA-plain, 
BGA-tet, and BGA-cef 
4.3.2.1 Quantity difference between qPCR and direct plating on BGA-plain  
The mean quantities determined by qPCR and direct plating are summarized in Table 16. 
The quantity of log10 invA gene copy numbers by qPCR and log10 CFU counts by direct 
plating on plain BGA were significantly correlated by linear regression analysis (p < 0.0000). 
When the samples detected by either qPCR or direct plating on BGA were included (n=386) 
the R2 was 0.3345, the coefficient was 0.86 and the intercept was 2.68 (Figure 21a). When 
only samples that were detected in both methods (n=190) were included, the R2 was 0.4261, 
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the coefficient was 0.54 and the intercept was 0.61 (Figure 21b). The mean quantity 
difference between qPCR and BGA-plain was log10 0.96 and ranged from -1.13 to 3.46 
(Figure 22a). Modelled marginal prediction of log10 invA gene copies were linearly regressed 
by the log10 CFU counts, and were significantly associated (p = 0.000) (Figure 22b). 
 
 
Table 16. Numbers of samples and mean quantities by qPCR and direct plating on BGA by 
tested days.  
 
  invA qPCR BGA 
 
Total # 
of 
Samples 
Number 
positive  (%) 
Mean  
Log10 gene copies (Min-
Max) 
Number  
positive (%) 
Mean  
Log10 CFU (Min-
Max) 
Day 0 176 95 (54.0%) 4.40 (2.81-8.00) 61 (34.6%) 3.6 (2.60-6.19) 
Day 4 176 65 (36.9%) 3.99 (2.78-6.53) 27 (15.3%) 3.13 (2.60-4.60) 
Day 8 175 40 (22.9%) 4.29 (3.21-6.83) 34 (19.4%) 3.62 (2.60-5.08) 
Day 14 173 41 (23.7%) 4.59 (3.26-6.59) 43 (24.9%) 3.60 (2.60-5.9) 
Day 20 171 36 (21.1%) 4.32 (3.09-6.66) 40 (23.4%) 3.57 (2.60-5.33) 
Day 26 169 47 (27.8%) 4.48 (2.85-6.48) 47 (27.8%) 3.55 (2.60-5.83) 
Total 1040 324 (31.2%) 4.33 (2.78-8.00) 252 (24.2%) 3.54 (2.60-6.19) 
BGA: Brilliant Green Agar, log10 gene copies or CFU per gram feces 
.
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Figure 21. Linear prediction line and scatter plot of quantities of log10 invA genes via qPCR and log10 CFU on BGA-plain agar. (a) 
Including samples detected with either method (n=386), (b) Only samples detected with both methods (n=190). 
a. b. 
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Figure 22. Quantity differences of qPCR and BGA-plain agar counts. (a) Quantity differences of qPCR and BGA-plain agar. BGA-
plain agar was subtracted from qPCR. (b) Linear prediction of log10 invA qPCR by rounded log10 CFU of direct plating
a. b. 
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4.3.2.2 Quantity distribution of samples detected with qPCR classified in 4 
groups  
The overall mean log10 invA gene copies distribution of the 324 samples that were 
detected by qPCR is shown in Figure 23a. The distribution was right skewed. The distribution 
was divided into 4 groups based on the overlap between detection methods: 1) samples 
detected only by qPCR (Figure 23b,c: yellow), 2) samples detected with qPCR and broth 
enrichment (Figure 23c: orange), 3) samples detected with all three methods (Figure 23c: dark 
green), and 4) samples detected with qPCR and direct plating (Figure 23c: light green). The 
quantity distribution of samples was different between groups as shown in Figure 23c. Mean 
quantity of Salmonella in the 1st group, from samples that were detected only by qPCR (48 
samples, yellow part in Figure 23b, c), was log10 3.6 gene copies per gram feces ranging from 
a minimum of 1.62 to a maximum of 4.22, which were on the lower end of the quantity 
compared to samples detected by both qPCR and broth enrichment (Figure 23c). This 
compartment may have consisted of animals with very low infection rates or else those that 
had carried viable Salmonella in the past but from which only dead bacteria may be detected 
in the present.  
Among 48 positive samples, 19 samples were from day 0 (40%) and 17 samples from day 
4 (35%). A significant association (P < 0.05) was found by Fisher’s exact test (Table 17). The 
sample numbers in this fraction increased on day 4 in the CCFA treatment group, which may 
include dead cells killed by CCFA treatment on day 0. Samples shown in the orange bar 
(group 2) had a mean and median of 3.8, and ranged from 2.78 to 7.99. Group 2 had 3 
samples that exhibited a very high quantity. Samples in group 3 (pink) had median 4.6 and 
mean 4.7, and ranged from 3.1 to 6.6, which were normally distributed. These samples are 
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certain to be infected with Salmonella. Samples shown in blue (group 4) were 3 samples that 
ranged from 3.9 to 4.7. These samples may be the samples carrying undetected Salmonella 
serotypes by broth enrichment.  
 
 
                      
Figure 23. Distribution of mean quantity of invA gene copies that was detected with qPCR. (a) 
Over all distribution. (a) was further breakdown into those detected only with qPCR (yellow) and 
broth enrichment (gray) in (b). (b) was further broken down in (c). 
 
 
 152 
Table 17. Sample numbers tabulated by day and treatment groups among 48 detected with qPCR 
 
 
4.3.2.3 Quantification of total tetracycline, and ceftriaxone resistant Salmonella 
For the quantification of total Salmonella, tetracycline-resistant Salmonella, and 
ceftriaxone-resistant Salmonella by direct spiral plating, 1,040 fecal samples were plated 
on BGA, BGA-tet (16 mg/L), and BGA-cef (4 mg/L) agar. On BGA, BGA-tet, and BGA-
cef, 252/1040 (24.2%), 32/1040 (3.0%), and 43/1040 (4.1%) samples had colony growth, 
respectively. The sample numbers by day are summarized in Table 18 with mean log10 
CFU and minimum and maximum quantity values. The growth comparison between the 
samples and different agars are shown in a Venn diagram (Figure 24). Although most of 
the samples that had growth on BGA-tet and BGA-cef had growth on BGA, 7 over these 
samples did not grow on BGA. Twelve samples grew on BGA-cef and BGA, but not on 
BGA-tet. Two samples grew on BGA-tet and BGA, but not on BGA-cef.  
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Table 18. Prevalence and mean quantity of Salmonella on BGA, BGA-tet, and BGA-cef. 
  BGA BGA-tet BGA-cef 
Day Total Number (%) Mean Log10 CFU Number (%) Mean Log10 CFU Number (%) Mean Log10 CFU 
Day 0 176 61 (34.6%) 3.6 (2.60-6.19) 2 (1.1%) 3.73 (3.08- 4.38) 3 (1.7%) 4.01 (3.30-4.38) 
Day 4 176 27 (15.3%) 3.13 (2.60-4.60) 1 (0.6%) 2.90 (-) 1 (0.6%) 3.30 (-) 
Day 8 175 34 (19.4%) 3.62 (2.60-5.08) 6 (3.4%) 3.79 (2.90-5.13) 10 (5.7%) 3.78 (2.90-5.06) 
Day 14 173 43 (24.9%) 3.60 (2.60-5.9) 6 (3.5%) 3.66 (2.90-4.13) 8 (4.6%) 3.39 (2.60-3.98) 
Day 20 171 40 (23.4%) 3.57 (2.60-5.33) 7 (4.0%) 3.74 (2.60-4.29) 9 (5.3%) 3.73 (2.90-4.58) 
Day 26 169 47 (27.8%) 3.55 (2.60-5.83) 10 (5.9%) 3.45 (2.6-4.59) 12 (7.1%) 3.69 (2.60-4.74) 
Total 1040 252 (24.2%) 3.54 (2.60-6.19) 32 (3.1%) 3.62 (2.60-5.13) 43 (4.1%) 3.68 (2.60-5.06) 
BGA: Brilliant Green Agar, BGA-tet: supplement with 16 mg/L of tetracycline, BGA-cef: supplement 
with 4 mg/L of ceftriaxone 
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Figure 24. Growth of Salmonella on brilliant green agar (BGA), BGA-tetracycline (BGA-tet), 
and BGA-ceftriaxone (BGA-cef) from PBS diluted fecal samples. 
 
4.3.3 Effects of antibiotic treatments on quantifiable levels of Salmonella 
4.3.3.1 Change on the numbers of animals shedding Salmonella over or below 
LOQ by antibiotic treatments 
In total, 1,040 community DNA (in duplicate for qPCR) and fecal samples were tested 
from 176 steers from days 0, 4, 8, 14, 20, and 26. During the study, 16 fecal samples from 7 
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animals were not collected because either the animal became sick and required retreatment or 
else died during the study. To analyze the change of the proportions of animals shedding more 
than the limit-of-quantification (LOQ), the change of the proportions of animals that started to 
shed more than the LOQ after Day 0 was plotted in Figure 25.  
Overall, the proportion of animals shedding more than the LOQ remained similar 
throughout the study period in the control group (1-CCFA / no CTC; Figure 25). In this group, 
more animals shed ceftriaxone and tetracycline resistant Salmonella on Day 14. With CTC 
treatment alone (1-CCFA & CTC group; Figure 25), most of the animals that were shedding 
quantifiable Salmonella on Day 0 were shedding below the LOQ on Day 8 until 20 and the 
amount of Salmonella was once again quantifiable on Day 26. In this group, more animals 
were shedding ceftriaxone and tetracycline resistant Salmonella on Day 8 and on Day 26 in 
comparison to other days, which implies an expansion of the resistant population from below 
LOQ to enumerable levels after CTC treatment. In the All-CCFA treatment group, animals 
shedding ceftriaxone resistant Salmonella over the LOQ increased and remained shedding 
from Day 8 until Day 26. Lastly, All-CCFA & CTC treatment decreased the animals shedding 
Salmonella until Day 20. After the CTC treatment started on Day 4, animals shedding 
tetracycline and ceftriaxone resistant Salmonella increased on Day 8 and gradually decreased 
to Day 26.  
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Figure 25. Proportion of animals with Salmonella shedding at levels over the limit-of-
quantification (LOQ) by direct plating.  
 
 
4.3.3.2 Observed quantity change of Salmonella by antibiotic treatments 
The observed log10 gene copies or CFU /gram feces per treatments and days are plotted for 
invA qPCR, BGA-plain, BGA-tet, and BGA-cef in Figure 26 The number of animals and 
mean quantity per treatment group and by day are summarized in Tables 19 and 20. The 
significant differences (P < 0.05) in mean log10 invA gene copies were observed in the CCFA 
treatment group (All-CCFA / no CTC) between days 0 & 4 and days 4 & 8, 14, 20, and 26. 
Also, in the All-CCFA & CTC group, following CCFA treatment, the quantity significantly 
decreased from Day 0 to 4 (p < 0.05). The mean log10 CFU counts were significantly different 
between days 0 & 8 and 0 & 14 in the 1-CCFA / no CTC group.  
Considering the animals shedding >104 of Salmonella as super shedders, in the control 
group (1-CCFA / no CTC), super shedders increased from 1/15 (7%) to 6/16 from Day 0 to 
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Day 26, respectively based on BGA growth (Table 21). Additionally, among those shedding 
tetracycline and ceftriaxone resistant Salmonella, 2/2 (100%) of the cattle were shedding more 
than 104 CFU on Day 20 in control group (Figure 26). In the CTC treatment group, the 
number of super shedders increased from 2/16 (12.5%) to 3/8 (37.5%) from Day 0 to Day 26, 
respectively, based on BGA growth. Half of the cattle that were shedding tetracycline and 
ceftriaxone resistant Salmonella were shedding more than 104 CFU on Day 20 and 26. In the 
CCFA treatment group (All-CCFA / no CTC), the number of super shedders dropped to 0% 
on Day 4 from 46% (6/13) on Day 0 and returned to 40% (8/20) on Day 20. In the All-CCFA 
& CTC treatment group, 7/17 (41%) were super shedders on Day 0 and dropped to 0% during 
the study; however, returned to 2/5 (40%) on Day 26. In this group, most of the animals were 
shedding less than 104 CFU. 
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Figure 26. Observed quantity of susceptible, tetracycline, and ceftriaxone resistant Salmonella by antibiotic treatments by day. 
Blue: invA gene copies, Purple: Brilliant green agar (BGA) without antibiotics, Green: BGA with 4 mg/L of ceftriaxone, Orange: 
BGA with 16 mg/L of tetracycline. *indicates significance between days where the line is starting and where the * mark is. Quantity 
above the reference line at log10 4 are supershedders
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Table 19 Prevalance and Salmonella quantity by day and treatment group by qPCR and direct 
plating on BGA 
 
abcdef: specified with different alphabet indicates significant difference between days (p<0.05) 
by regression analysis. In one row, if same alphabet is shared between different days, they are 
not significantly different (P > 0.05). 
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Table 20 Prevalence and Salmonella quantity per treatment group and days by direct plating on 
BGA-tet and BGA-cef  
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Table 21 Counts of super shedder (shedding >104 per gram feces) 
Number super 
shedder/detected (%) 
Detection 
method 
Day 0 Day 4 Day 8 Day 14 Day 20 Day 26 
1-CCFA / no CTC 
BGA-plain 1/15 (7%) 1/12 (8%) 7/19 (37%) 6/19 (32%) 7/16 (44%) 6/42 (38%) 
invA qPCR 11/24 (46%) 11/21 (52%) 13/15 (87%) 15/19 (79%) 9/16 (56%) 14/17 (82%) 
1-CCFA & CTC 
BGA-plain 2/16 (12.5%) 2/11 (18.2%) 1/4 (25%) 0/2 (0%) 1/3 (33.3%) 3/8 (37.5%) 
invA qPCR 11/28 (39.3%) 9/20 (45%) 2/5 (40%) 1/2 (50%) 1/3 (33.3%) 5/8 (62.5%) 
All-CCFA / no CTC 
BGA-plain 6/13 (46%) 0/2 (0%) 1/5 (20%) 3/17 (18%) 8/20 (40%) 6/18 (33.3%) 
invA qPCR 11/17 (65%) 1/14 (7%) 7/17 (41%) 15/18 (83%) 10/15 (67%) 10/16 (63%) 
All-CCFA & CTC 
BGA-plain 7/17 (41%) 0/2 (0%) 0/6 (0%) 0/5 (0%) 0/1 (0%) 2/5 (40%) 
invA qPCR 20/26 (77%) 1/9 (11%) 2/3 (67%) 2/2 (100%) 1/2 (50%) 4/6 (67%) 
 
 
4.3.3.3 Serotype and quantity of Salmonella 
No significant correlation was detected between the numbers of serotypes detected in 
an individual animal and treatment with CCFA (p=0.54), treatment with CTC (p=0.06), pens 
(p=0.26), or replicate (p=0.1), using Poisson regression analysis (Figure 27). No association 
was detected between serotypes and the quantity of Salmonella (Figure 28a). No association 
was detected between the number of serotypes that an animal carried and the quantity of 
Salmonella quantified by qPCR or direct plating (Figure 28b). Most of the animals from 
which S. Reading was isolated by enrichment methods, MDR serotype had growth on BGA-
tet and BGA-cef (odds ratio: 16.1 (CI:3.6-70.9) and 23.0 (CI:5.3-100.2), respectively) by 
direct plating (Figure 28c, d). However, 2 samples (animals 2318 and 2396) from 1-CCFA / 
no CTC group (Figure 29a) and 1 sample (animal 2364) from All-CCFA / no CTC (Figure 
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29c) had growth on BGA-tet and BGA-cef, even though S. Reading was not isolated from all 
6 days. Among them, animal 2318 was only detected with S. Mbandaka throughout the study 
period with high quantity ranged log10 4.36-6.66 gene copies, which can be classified as high-
shedder where the Salmonella population may have been dominated by S. Mbandaka. 
4.3.3.4 Two animals had growth on BGA-cef on Day 0 
On BGA-tet and BGA-cef agar, 2 samples (from animal 2342 and 2343 placed in separate 
pens) had growth on day 0, which was approximately 4.4 log10 CFU/gram feces in the 
samples from animal 2342 and 3.1 log10 CFU/gram feces in sample from animal 2343 on 
BGA-tet and BGA-cef. The colony growth on the plain-BGA of each sample was 6.2 and 3.2 
log10 CFU/gram feces, respectively. The animal 2342 was detected with S. Give on day 0 and 
the animal 2343 was detected with S. Kentucky on day 0.  
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Figure 27 Frequency of animals per number of serotypes detected in one animal by treatment 
groups. 
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Figure 28 (a) Serotype and invA gene quantity, (b) number of serotypes detected per animal and invA gene quantity, (c) and (d) 
Serotypes detected from animals and growth on BGA-tet and BGA-cef. 
b 
d 
a 
c 
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Figure 29. Description of overall population per treatment pens by detected serotypes per sampled days (0, 4, 8, 14, 20, and 26) and quantity of 
Salmonella per gram feces by direct plating and invA qPCR for 176 steers tested in this study. 
Each serotype is color coded; Anatum: dark blue, Give: orange, Kentucky: red, Mbandaka: teal blue, Montevideo: Green, Reading: yellow. 
Serotypes were determined from the isolates derived after broth enrichment. Quantity of direct plating is log10 transformed and each number 
indicates the quantity per gram feces. Zero indicates no detection (LOQ). Gray squares are samples not collected. Number of serotype is the total 
serotypes detected from the animal from 6 sampled days. In each figure, the upper half is replicate 1 and the lower half is replicate 2. Each 
replicate is divided into 2 pens with dotted line. In 1-CCFA group, the one steer that received CCFA is colored in light gray. (a) 1-CCFA / no CTC 
group (b) 1-CCFA & CTC group (c) All-CCFA / no CTC (d) All-CCFA & CTC 
a. 
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Figure 29, Continued. 
 
b. 
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Figure 29, Continued. 
c. 
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Figure 29, Continued.  
d. 
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4.3.4 Modelling the effects of antibiotics on quantity dynamics 
4.3.4.1 Distribution of log10 invA gene copies per gram feces per antibiotic 
treatment before and after imputation 
Among 1,040 samples tested in duplicate (2,080 reactions), 571 reactions (27.5%) were 
detected with the invA gene. The lowest and highest quantified gene copies ranged from log10 
2.78 to 8.00 invA gene copies per gram feces with a median of log10 4.32 and mean of log10 
4.43 (Table 22, Figure 30). To increase the resolution of observed values in Figure 30a, 
missing values (0) were removed in Figure 30b and Figure 30c. From our annotated WGS 
data, only 1 gene copy of invA gene was detected in the representative genomic sequence per 
isolate. The quantities of invA gene copies were standardized with 16s rRNA quantities by 
taking the ratio and these were log10 transformed (Table 22, Figure 31).   
Data for missing 1,509 (72.5%) wells (i.e., those with Cq values > 40) from qPCR runs were 
imputed using interval censored regression on Stata. The assumption was that samples 
containing Salmonella at concentrations less than the LOQ were likely to not harbor exactly zero 
bacteria. Multiple imputation methods impute the missing data as censored data by a parametric 
method given other predictors and assuming a normal distribution from observed data. The upper 
limit value of the left censoring data was set to log10 3.6, which is the mean and median of the 
invA gene copy numbers in the samples with one-missing qPCR value (Table 22). The lower 
limit was set to -¥ on the log10 scale. Predictors were the full factorial model of CCFA and CTC 
treatments by day of sampling. The log10 invA gene copies per gram feces were imputed as 
shown in Figure 32. The average of smallest quantity after 8 imputation runs was as low as 
log10 -2.81 and the largest was log10 3.59 (Figure 32). Figure 33 is the distribution of observed 
(Figure 33a) and imputed (Figure 33b) log10 invA gene copies per gram feces, grouped by 
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missing values per qPCR reaction. Figure 34 is observed (Figure 34a) and imputed (Figure 
34b) log10 invA gene copies per gram feces by CCFA and CTC treatments. Figure 35 is 
observed and imputed by CCFA and CTC treatments by day.  
 
Table 22. Observed and 16s rRNA standardized log10 invA gene copies per gram feces per qPCR 
reaction. 
 
 
 
 171 
 
Figure 30 Distribution of log10 invA gene copies from observed data. (a) Overall distribution of 
log10 invA gene copies per gram feces. 
Missing observations (below LOQ) were given a value 1 and log10 transformed to 0 in (a). (b) 
Distribution of red squared area from (a). (c) Distribution of log10 invA gene copies of samples 
that had no missing values (light blue) and missing 1 (green). 
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Figure 31. Distribution of 16s rRNA standardized log10 invA gene copies from observed data. 
(a). Distribution of log10 invA gene copies per gram feces after 16s rRNA standardization. (b.) 
Distribution of log10 invA gene copies per gram feces after 16s rRNA standardization that had 
no missing values (light blue) and missing 1 (green). 
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Figure 32. Histogram and Kernel density of observed and imputed data. (a) Observed data (red) and imputed data from 8 imputations 
(other lines), X-axis is log10 invA gene copies and Y-axis is density. (b) Distribution of observed (red) and represented imputed data 
(yellow)
 
 174 
 
Figure 33. Distribution of log10 invA gene copies before (a) and after (b) interval censored regression per missing value groups. (a) is 
with missing value 0 and (b) is after imputation.  
The upper limit was set to log10 3.6 for imputation. No missing: all duplicates have values after qPCR; Missing 1: one of the duplicate 
reaction had an observed Cq value; Missing 2: neither of the reaction had observed Cq values. 
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Figure 34. Distribution of log10 invA gene copies per gram feces per treatments before (a) and after imputation (b). 
Missing value was given a value 1, which are shown as 0 after log10 transformation. CCFA: ceftiofur crystalline-free acid, CTC: 
chlortetracycline 
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Figure 35. Distribution of log10 invA gene copies per gram feces by treatments and day from (a) 
observed and (b) imputed data. 
CCFA: ceftiofur crystalline-free acid, CTC: chlortetracycline 
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4.3.4.2 Effects of antibiotic treatments on quantity of invA gene copies by zero-
inflated Poisson regression model with observed data and 16s standardized 
observed data 
 
The effects of antibiotic treatment on the log10 invA gene copies first were modelled by 
a zero-inflated Poisson regression model with the observed data (before imputation). The 
log10 invA values were rounded and converted to numerical values. The distribution of the 
numerical counts are shown in Figure 36a, which are zero-inflated. The median rounded 
log10 was 4. The zero-inflated Poisson Regression model predicted that treatment by CTC 
significantly decreased the rounded log10 count of Salmonella on Day 8, and it remained at 
low levels until the end of the study period (Figure 36b). CCFA treatment on Day 0 
drastically decreased the count on Day 4 in the All-CCFA & CTC group. The zero-inflated 
model predicted that CTC treatment increased the zero inflation significantly (P<0.05); 
interestingly, CCFA treatment was not significant in the same way. Figure 36c and 36d 
illustrates the distribution of 16s standardized log10 invA gene copies, which show a 
similar pattern to that of the non-standardized data.  
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Figure 36. (a) Distribution of rounded log10 invA gene copies per gram feces and (b) modelled margins prediction of invA quantity by 
zero-inflated Poisson regression with 95% CI. (c). Distribution of 16s standardized rounded log10 invA gene copies per gram feces 
and (d) modelled prediction of invA by zero-inflated Poisson regression 95% CI.  
Missing observations were given a value 1 and log10 transformed to 0. CCFA: ceftiofur crystalline-free acid, CTC: chlortetracycline
a. b. 
c. d. 
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4.3.4.3 Multilevel mixed-linear regression model with representative imputed 
values 
A representative imputed value set was chosen for multilevel mixed-linear regression to 
assess the effects of antibiotic treatments by day on the quantity of Salmonella represented by 
invA gene copies per gram of feces. In Stata, estimation following multiple imputation can be 
performed; however, no programmed methods are provided to predict margins from the 
estimation model. As shown in Figure 32, all the imputed values distributed similarly; 
therefore, only one out of the 20 imputed data models was chosen for further estimation and 
margins prediction. Margins of treatment effects on log10 invA gene copies per gram feces 
were predicted by multilevel mixed linear regression (Figure 37a). Random effects were 
replicate, pen, animal, and duplicate repeats of the qPCR reaction. A significant decrease in 
imputed and observed gene copies can be seen with CTC treatment, especially on Day 8, 
where the animals treated with only CTC (red) show a dramatic decrease. With CCFA 
treatment on Day 0, gene copies also significantly decreased (orange). A slight increase in 
gene copies is observed following CTC treatment on Day 8 (orange). In the animals treated 
with CCFA on Day 0 (Green), only a slight decrease of gene copies was observed.  
4.3.4.4 Multilevel mixed-linear regression model with multiple imputed values 
Following the multiple imputations, the multiple imputed values were further used to 
estimate the effects of antibiotics by multilevel mixed-effects linear regression model. Stata 
does not officially provide a method to compute margins following model estimation with 
multiple imputed values; however, a command “mimrgns” provided by UCLA is available for 
installation for margins prediction. To set as panel data, pen was set as the clustering (panel) 
variable and trial replicate was included as a fixed effect. Treatments by CCFA and CTC by 
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day were included for a 3-way full factorial model. Animal ID was included as a random 
effect. Accurate confidence intervals cannot be calculated by this method and therefore are 
not included in Figure 37b. The overall results were very similar to that of Figure 37a. 
Similarly, 16s standardized invA values were imputed and modelled by multilevel mixed-
effects linear regression (Figure 38).   
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Figure 37. Modelled margins prediction with single imputed data (a) and 20 multiple imputed data (b) for log10 invA gene copies per 
gram feces by treatments and days with 95% CI. 95% CI is not shown in multiple imputed data because of the limitation of the 
mimrgns program to predict accurate values. CCFA: ceftiofur crystalline-free acid, CTC: chlortetracycline 
 
a. b. 
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Figure 38. Distribution of 16s standardized invA +10. (b) Mixed linear regression model with observed value. (c) imputed 16s 
standardized invA (+10) log10 gene copies per gram feces. (d) Mixed linear regression model with imputed value 
a. b. 
c. d. 
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4.3.4.5 Distribution of log10 CFU per gram feces per antibiotic treatment before 
and after imputation 
Direct spiral plating was conducted in singlicate. The lowest and highest CFU per gram of 
feces ranged from log10 2.60 to 6.19 in a total of 252 samples (24.2%) for which growth was 
quantifiable on BGA (Figure 39a). Mean count was log10 3.54 and median was log10 3.45 
CFU per gram feces. Missing values were imputed as shown in Figure 39b. Figure 40 and 41 
show per treatment and per treatment and day, respectively. 1-CCFA / no CTC animals had 
the highest detection rate (8.9%, 93/1040) among all treatment groups. In the 1-CCFA / no 
CTC animals, Salmonella were detected constantly throughout the study period (Table 19 
bottom). With All-CCFA / no CTC treatment, less animals were detected with Salmonella on 
Day 4 (Figure 19 bottom). 
Multiple imputation by interval censoring regression was conducted for the missing 
values. After trying a range of different upper limit values (mean 3.6 and higher 4.0), the final 
upper limit of left censored value was set to log10 2.6, which was the lowest observed value. 
Imputed values are visualized for all distributions as per treatments, and per treatments and 
days as green bars in the following figures 40, 41, and 42, respectively. The red bars are the 
observed data. 
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Figure 39. Histogram of log10 CFU per gram feces counted on BGA (a) before and (b) after imputation. 
Red: observed values, Green: imputed values. Numbers are the log10 bacterial counts per sample. 
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Figure 40. Distribution of log10 CFU per gram feces per individual antibiotic treatment from (a) observed and (b) imputed data by 
treatments. Missing value was given a value 1, which are shown as 0 after log10 transformation. CCFA: ceftiofur crystalline-free acid, 
CTC: chlortetracycline 
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Figure 41. Distribution of log10 CFU per gram feces by treatment and day from (a) observed and 
(b) imputed data. CCFA: ceftiofur crystalline-free acid, CTC: chlortetracycline 
 
 
 187 
4.3.4.6 Model prediction with observed and imputed data 
With the observed spiral plating data, much the same as with log10 invA gene copies 
analysis, a zero-inflated Poisson regression was performed because the majority of the values 
were below the LOQ (replaced to 0). The log10 CFU per gram of feces were rounded and 
converted to integer values (Figure 42a). CCFA treatment on Day 0 decreased the log10 CFU 
per gram of feces significantly on Day 4 (p=0.032) (Figure 42b). CTC treatment starting on 
Day 4 decreased Salmonella quantities on Day 8. The animals in pens without any treatment 
showed an increase in Salmonella on Day 8 but remained at a similar quantity until the end of 
the study.  
Following multiple imputation, the imputed values were included in the model prediction 
using multilevel mixed linear regression (Figure 43 a, b). The changes in the quantity of 
Salmonella was similar to that of the zero-inflated model. However, a larger increase on day 8 
in the All-CCFA & CTC treatment group was predicted. Since the growth of Salmonella on 
BGA includes both susceptible and resistant Salmonella, the increase may reflect the resistant 
Salmonella.  
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Figure 42. (a) Distribution of rounded integer log10 CFU per gram of feces and (b) zero-inflated Poisson regression on observed log10 
CFU per gram feces from direct plating on BGA. 
 
a b 
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Figure 43. (a) Multilevel mixed linear regression model with representative imputed log10 CFU per gram of feces from direct plating 
on BGA and (b) multiple imputation multilevel mixed linear regression model with data from all 20 imputations. 
Upper log10 CFU limit for unobserved data was set to 2.6.
a b 
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4.4 Discussion 
4.4.1 Detection methods 
We conducted broth enrichment methods for the accurate prevalence estimation of 
Salmonella from fecal samples, using standard methods [151, 246]. Additionally, we 
conducted qPCR and direct plating of fecal samples for the quantification purposes. Since the 
ultimate purpose was to evaluate the effect of antibiotics on Salmonella quantities so as to aid 
in assessing of risk, we did not conduct any pre-enrichment steps for qPCR or for direct 
plating on BGA. Pre-enrichment will bias the results in that growth rate of Salmonella and 
background bacteria differ, and when the concentration of Salmonella is low, they may be less 
likely to be detected [178]. Here, since qPCR and direct plating were also used for Salmonella 
detection, the three detection methods were compared. Among these, the broth enrichment 
method had the highest detection rate as expected. For accurate detection of Salmonella, broth 
enrichment steps are necessary for diagnostics. However, broth enrichment takes 2-5 days to 
complete, which is time-consuming when the results are required in a short time, such as in 
clinical settings. Also, enrichment steps may bias the serotypes detected. Even without the 
selection pressure of antibiotics in the broth, enrichment broths may provide a fitness 
advantage for particular serotypes.  
In our study, we used two direct Salmonella detection methods, real-time hydrolysis 
probe-based qPCR and direct spiral plating; in addition, we used a broth enrichment method 
as a comparator. For the qPCR, community DNA was extracted directly from fresh fecal 
samples and qPCR was conducted targeting the invA gene. This gene is encoded in the 
Salmonella Pathogenic Island 1, and is a necessary gene for the invasion of epithelial cells 
using the Type III secretion system [303]. The invA gene is present in all known Salmonella 
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genus but not in E. coli [304]. It is specific to Salmonella, and only one gene copy exists per 
Salmonella enterica isolate [292]. Previous studies on the comparison of detection methods 
between real-time PCR and enrichment from feces of cattle, horses, and pigs have shown 
mixed results [277, 283, 305-307]. Target genes in previous publications ranged among invA, 
spaQ, and ttrRSBCA genes. Most of these studies enriched the feces for 20-24 hours before 
DNA extraction for the detection of the genes.  
We did not conduct an enrichment step prior to total community DNA extraction because 
our purpose was to quantify antibiotic resistant genes from metagenomic samples and not for 
clinical diagnosis [220]. For the direct spiral plating method, we diluted the fecal samples with 
PBS and spiral plated on BGA, BGA-tet, and BGA-cef and then incubated overnight. Studies 
by Pusterla et al. [306]and Kurowski et al. [283] had better detection with real-time PCR (RT-
PCR) from enriched samples in horse feces, cattle, and dogs compared with culture, which is 
consistent with our study. In the study of Pusterla et al. Salmonella was not detected by direct 
plating the feces on BGA and XLT-4 agars [306]; however, the detection rate was 100% in 
RT-PCR using the DNA template from an 18-24 hour enrichment of feces in selenite broth. 
Plating on the enriched broth detected Salmonella in only 32% of those samples.  
Overall, the broth enrichment method had the best detection our study. Agreement 
between qPCR and direct plating was moderate. In our assays, all the negative control 
reactions had no detection at all. In a hypothetical situation when broth enrichment is not 
conducted, and only qPCR or direct plating are conducted, vast number of samples will result 
as false-negative. Between qPCR and direct plating, qPCR detected 72 more samples as 
positive than direct plating. Further, only 190 samples were detected by both qPCR and direct 
plating. For the detection/diagnostic purpose and Salmonella prevalence estimation, even 
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though time-consuming, broth enrichment remains the best method for the cattle fecal sample, 
which is in agreement with studies by Eriksson et al. and Jensen et al. [305, 307].  
4.4.2 Quantification by qPCR vs. direct spiral plating 
The LOQ of qPCR and direct plating to BGA was similar, around 2.6 log10 gene copies 
and CFU per gram of feces, respectively (Figure 21). However, among the samples detected 
by both qPCR and direct plating, the quantity of Salmonella was detected at 101 times higher 
in qPCR compared with direct plating. Because qPCR detects both viable and non-viable 
Salmonella, it is possible that the quantity differences between qPCR and direct plating were 
due to the DNA arising from non-viable Salmonella. To detect Salmonella contamination in 
food, RNA has been used for the detection and distinguishing of viable Salmonella by qRT-
PCR (Quantitative Reverse-Transcriptase PCR), which may result in a similar quantity with 
direct plating, although we have not tested this hypothesis in the current study [285]. The 
sensitivity and specificity of the primers and probes used in this study have been tested 
against other common Enterobacteriaceae. Therefore, it is not likely that other bacteria were 
detected [285].  
In qPCR, multiple steps affect the quantity calculation, including efficiency of DNA 
extraction, type of template used for creating the standard curve, original fecal sample 
condition, and back calculation of gene copies to per gram of feces. We generated the 
standard curves from the whole-genome of Salmonella Typhimurium isolates, which can have 
better amplification than actual total community DNA samples mixed with various other 
bacterial and non-bacterial DNA. Although using the community DNA for standard curve 
generation is ideal, reproducibility may be sacrificed; especially when setting a qPCR reaction 
for 30 runs. The total community DNA used in this study was extracted after the fecal 
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samples were collected, having been stored at -80 °C for up to two years, and the extracted 
DNA subsequently stored in the freezer at -20 °C. On the other hand, the fecal samples that 
we used for the direct plating quantification had been stored at -80 °C with 50% glycerol for 
eight years, which could weaken or degrade the bacteria and therefore decrease the counts. 
However, our study showed that even after 8 years of appropriate storage, a quantifiable 
Salmonella can be recovered and quantified. 
We divided the samples that were detected by qPCR into 4 groups as shown in Figure 23c: 
1) detected with qPCR, direct plating, and enrichment (187 samples), 2) detected with qPCR 
and enrichment but not with direct plating (86 samples), 3) detected only with qPCR (48 
samples), and 4) detected with qPCR and direct plating, but not with enrichment (3 samples). 
The first group represent the samples that are highly likely to be Salmonella positive. The 
distribution of the quantity of Salmonella within these samples was normally distributed. 
Samples from the second group were not detected with direct plating but with qPCR and 
enrichment. These samples may have a relatively low quantity of Salmonella, and therefore 
were detected by qPCR and enrichment which have a higher sensitivity. As the histogram 
shows in Figure 23c, the orange bars are on the lower end of the distribution. However, very 
few samples that had the highest quantities were also in this population. The reason why they 
were not detected by spiral plating is unknown; however, the explanation for these could be 
due to a biased localization of Salmonella in the fecal sample, where the portion of sample 
containing Salmonella was not plated.  
The third group that was only detected with qPCR (48 samples) may contain non-viable 
Salmonella or very low quantities of Salmonella that were still below the LOQ by enrichment. 
In fact, 14 out of 48 of these samples were from Day 4 and in animals that were treated with 
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CCFA on Day 0. It is possible that the non-viable Salmonella quantified by qPCR were earlier 
killed by CCFA treatment. Additionally, this idea supports the finding that 3 out of 4 animals 
were not detected with any Salmonella by enrichment on six tested days. Since these three 
animals were detected with the invA gene on day 0 and day 4, but not on the later days, it may 
be due to the non-viable Salmonella shedding at the LOQ or intermittently shedding. CTC is a 
bacteriostatic agent and therefore static bacteria may have been maintained in the gut. The 
quantity differences between direct plating and qPCR may explain this phenomenon. Lastly, 
in the fourth group, 3 samples were detected with direct plating and qPCR but not with 
enrichment. Although we have not confirmed, these samples may have carried Salmonella 
serotypes other than 6 serotypes that were detected in this population since the enrichment 
process can favor certain serotypes [86].  
Again, the portion of samples used for enrichment may not have contained Salmonella. 
Even though broth enrichment was the best method for detection of Salmonella, conducting 
direct detection by qPCR and direct plating in parallel may increase the diversity and numbers 
of samples detected with Salmonella. However, the fact that qPCR detects DNA derived from 
both viable and non-viable Salmonella can bias the quantitative results. Even though qPCR is 
known to have a high sensitivity, applying the technique to community DNA samples with 
substantial background microbiota, such as fecal samples, will require more adjustments. For 
risk assessment purposes, it seems desirable to run qPCR and broth enrichment in parallel if 
resources are available to do so.  
4.4.3 Effects of antibiotics on the quantity of Salmonella 
No antibiotic (MDR) resistant isolates (S. Reading in this population) were detected by 
broth enrichment on day 0 [88]. However, by directly plating the diluted fecal samples on 
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BGA-cef, three samples exhibited growth, of which two were S. Reading. These samples were 
confirmed to be carrying resistant genes by WGS analysis and the ACSSuT-cef phenotype 
was confirmed by microbroth dilution. Therefore, we were able to determine that antibiotic 
resistant Salmonella were present in the population before antibiotic treatment started. We 
were able to determine this by direct plating onto antibiotic selective media rather than by the 
broth enrichment method. We only picked one colony per sample in the broth enrichment 
procedure. Since it is likely that the dominant strains on Day 0 were susceptible serotypes and 
those were equally enriched by broth enrichment procedure, resistant strains were less likely 
to be detected.  
By directly plating the fecal sample onto agar containing antibiotics, it is more likely that 
resistant strains can grow under preferred or favorable conditions. In two animals, an 
additional 2 or 3 serotypes were detected in addition to S. Reading. Therefore, it is highly 
probable that susceptible serotypes were dominant before antibiotic treatment began. In fact, 
in one of the animals that was detected with S. Reading on Day 0 (animal 2342), the quantity 
of Salmonella on BGA on Day 0 was very high (6.2 log10 CFU/gram feces), while colony 
growth on BGA-cef and BGA-tet was around 4.4 log10 CFU/gram feces. These differences are 
likely due to a high number of susceptible Salmonella. After the treatment with CCFA on Day 
0, the quantity on BGA and BGA-cef were similar, which implies that the susceptible 
Salmonella were killed or supressed and only the S. Reading survived the CCFA treatment. 
On the other hand, even though we expected similar growth between BGA-cef and BGA-tet 
because of the ACSSuT-Cef phenotype of S. Reading, no colonies grew on BGA-tet from 
Days 8 to 26.  
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There are two possible explanations for this. The first possibility is the failure of BGA-tet, 
which was initially suspected. Therefore, the initial growth on BGA-cef plates was replica 
plated onto a new batch of BGA, BGA-tet, and BGA-cef agars. Still, no growth was seen on 
new BGA-tet, which suggests that the BGA-tet agar was correctly functioning. Additionally, 
plating of the fecal-sample was conducted per day of the samples and not per animal. Fecal 
samples from same animal (but on different days) were not processed together. Therefore, it is 
not likely that this was a failure of the batch of BGA-tet agar. The second possibility is the 
presence of Salmonella that is explicity resistant to ceftriaxone but behaves differently in the 
presence of tetracycline, which was not detected by our broth enrichment detection method. 
Since fecal samples were directly plated without enrichment on BGA-cef agar, it is possible 
that this population of Salmonella was more dominantly detected than S. Reading.  
We have not confirmed the serotypes nor genotypes of those isolates that grew on BGA-
cef, but not on BGA-tet; therefore, the musings of the previous paragraph are purely 
speculative. Since growth on BGA-tet was seen on days 0 and 4, this Salmonella might have 
been selected for by the CCFA treatment. In other animals, such cases were found but 
sporadically and not consistently within animals. A study by Martin et al. showed that S. 
Heidelberg and S. Kentucky from poultry sources carried the blaCMY-2 gene on an IncI1 
plasmid that only had phenotypic resistance to cephalosporins and not tetracyclines [195]. 
Although not very common in cattle, such Salmonella are commonly detected in food-animal 
derived sources such as poultry. 
The quantity of total quantity of Salmonella significantly decreased on Day 4 in CCFA 
treated animals by approximately 2 to 3 log10 CFUs and also in gene copies. In the animals 
treated only with CCFA, the quantity recovered to that of Day 0 by Day 8, which shows that 
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the decrease was transient. Treatment with CTC also decreased the quantity of Salmonella 
more than the LOQ and the quantity of Salmonella recovered by Day 26. Although previous 
mouse studies have shown that antibiotic treatments cause microbiota disruptions and increase 
Salmonella colonization, the quantity of Salmonella before (Day 0) and after (Day 26) were 
similar in antibiotic treated to untreated cattle. A study from Barman et al. showed that 
Salmonella Typhimurium infection diminished 95% of the indigenous microbiota in mice but 
the microbiota recovered after 30 days [79]. Stetcher et al. studied the relation of Microbiota-
Host-Pathogen response in Salmonella.  
While healthy microbiota protects the host from pathogenic infections, Salmonella can 
overcome the colonization resistance by invading cells and causing inflammation in the host 
[308]. It has been shown that Salmonella can utilize tetrathionate and sialic acids produced as 
a result of inflammation for their growth, hence providing a selective advantage. It is known 
that antibiotic treatment itself can cause disruption of host microbiota. Pathogens like 
Salmonella can take advantage of such conditions to grow to where the host becomes a 
supershedder [278, 309]. A mouse study showed that the presence of one supershedder can 
increase transmission of Salmonella to its cage mates [278]. In our study, around 15 cattle 
increased their Salmonella quantity after the antibiotic treatments. Especially with CCFA 
treatment, around 5 cattle increased by 101 by Day 26 though the sample size remains too 
small to derive conclusions. Additional cattle were detected with Salmonella after CCFA 
treatment. These cattle are not grown in in a controlled laboratory setting like mice but in the 
feedlot, where not only antibiotic treatments but other factors such as feed contamination, 
temperature, the pen environment, and insect bites may affect Salmonella infection and 
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quantities. Even so, cattle treated with antibiotics may be more susceptible to Salmonella 
infection because of a disruption in the gut microbiota.  
Salmonella infection is primarily subclinical in cattle. S. Dublin and S. Newport are 
known to be highly pathogenic to cattle (and humans); however, we did not find these 
serotypes in our study. The serotypes that are not host-adapted and do not cause systematic 
infection may act similar to that of commensal bacteria. Among the Salmonella that were 
detected in our study, resistant Salmonella have an advantage during antibiotic exposure; as 
proof, tetracycline and ceftriaxone resistant Salmonella were detected more frequently from 
those cattle and pens treated with CCFA and CTC. Many mouse Salmonella studies are 
conducted with S. Typhimurium infection following streptomycin treatment to artificially 
induce an enteric colitis model. If our studied cattle had instead been infected with S. Dublin 
and S. Newport, we might have seen a significant increase in their quantities after antibiotic 
treatment, assuming they harbored such resistance. Although we do not know how long our 
studied cattle were infected with Salmonella, they were likely persistently residing in these 
cattle as we have shown the high prevalence of Salmonella on Day 0 and steady prevalence in 
the control group. Additionally, we do not have data on the condition of the host cattle such as 
diarrhea, temperature, and immune response, which may require further investigation. 
It was expected that the antibiotic resistant Salmonella population expands after antibiotic 
treatment. However, no significant increases in quantity were observed after the antibiotic 
treatment at the population level. The quantity of tetracycline and ceftriaxone resistant 
Salmonella were constant around 4 log10 CFU/gram feces. However, as the days increased 
more animals with growth on BGA-tet and BGA-cef were observed, which implies that much 
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of the resistant Salmonella population resided below the LOQ before treatment and increased 
to more than the LOQ, especially following CTC treatment.  
Even though some cattle were detected with 4 to 5 different serotypes, the quantity of 
Salmonella in those cattle was similar to those of cattle detected with only 1 or 2 serotypes. 
However, the detection of serotypes was not conducted at the same time, so cattle were not 
necessarily infected with multiple serotypes at the same time. Even so, there might be a 
biological control such as quorum sensing within Salmonella concerning the maximum cell 
density that can reside in gut microbiota [310]. As expected, the animals detected with S. 
Reading were highly likely to exhibit growth on both BGA-tet and BGA-cef.  
4.4.4 Imputation of missing values 
The qPCR results from our study contained many missing values (72.9% of the total wells 
reacted using qPCR). This is problematic for data analysis due to bias produced because 
incomplete data will not be included in the analysis. To overcome this, we used zero-inflated 
Poisson regression models for the analysis of treatment effects on the count of invA gene 
copies. The log-transformed values were integer-rounded and considered as counts. The zero-
inflated model runs in two separate processes: one part is to analyze the effects on the actual 
counts, and the other is to determine the effects associated with the zero values (binary 
outcome).  
Multiple imputation is a useful estimation procedure to fill in missing values when there is 
evidence that the values are not truly zero. It has been shown that an appropriate imputation 
leads to less bias and better prediction of the model. In our qPCR results, an interval censored 
regression model was chosen between linear regression and truncated regression because we 
expected that most of the values were missing due to being below the LOQ. Other imputation 
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methods impute values within the range of observed values which is clearly inappropriate for 
the situation in this study. Several possibilities for values below the LOQ can be considered; 
1) cattle were not infected with Salmonella (true negative), 2) susceptible Salmonella were 
killed by antibiotic treatments, therefore Ct values are higher than 40 (censored data), 3) 
failure of qPCR runs due to PCR inhibitors, or 4) other reasons. Except for the first reason, 
the negative results can be interpreted as a false negative. It is highly probable that most 
samples belong to 2), because, in the prevalence study, only 4 animals were not detected with 
any Salmonella across the investigated 6 days (24 samples/1040 samples) [88].  
Imputation is useful when the missing values are “missing at random” or “missing not at 
random”. McCall et al. have shown that missing values in qPCR are classified as “missing not 
at random” [311]. In fact, the number of samples with a missing value increased on day 8 
after CTC treatment shown in the second and fourth rows of Figure 26, while it remained 
constant in the animals without antibiotic treatment (first row). Therefore, it is reasonable to 
assume the samples without values in qPCR were below the LOQ in our study. We imputed 
with linear regression and truncated regression models before deciding on the interval 
censored regression model. Both linear regression and truncated regression imputed the values 
only within the observed data, which was not suitable for this study. The missing values in the 
qPCR runs were assumed to be left censored (only upper limit data is known). The upper limit 
value was set for log10 3.6, which was the mean value in the samples that had only one 
observation. While few studies utilizing imputation methods to estimate the missing values in 
qPCR data have been reported, more established methods are clearly needed [220, 311-313].  
To examine the effects of antibiotics from only raw (observed) qPCR data, zero-inflated 
Poisson regression was used. The log-transformed gene copy data were integer-rounded; 
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therefore, gene copy data were transformed to counts. Although the data were over-dispersed 
and the negative binomial is therefore more suitable than Poisson regression, the zero-inflated 
negative binomial model would not converge in Stata for our sudy. In addition, compared 
with the multilevel mixed linear regression model using imputed values, the zero-inflated 
Poisson regression model had a wider standard error suggesting less stable estimates of 
effects.  
4.5 Summary and conclusion of Chapter IV 
 In this chapter, we explored the temporal change in quantity of Salmonella caused 
by antibiotic treatments in a longitudinal study in feedlot cattle. Such explorations have not 
been previously conducted. We also compared the three detection methods: broth enrichment, 
probe-based qPCR, and direct plating, as well as two quantitative methods, probe qPCR and 
direct spiral plating. We modelled the effects of antibiotic treatments by day on the quantity 
of Salmonella using a zero-inflated Poisson regression model with integer-rounded data and a 
mixed-level linear regression model using multiple imputed data.  
Overall, antibiotic treatments decreased the quantity of Salmonella by approximately 2-3 
log10 per gram of feces. More specifically, CCFA treatment decreased the total Salmonella on 
Day 4 and the quantity recovered by Day 8 absent additional antibiotic treatment (specially, 
CTC). Also, the number of cattle shedding over the LOQ was diminished by CCFA treatment 
while additional cattle were shedding Salmonella on Day 26 after the antibiotic effects 
washed out. Similarly, CTC treatment decreased the quantity of Salmonella being shed by 
cattle; however, by Day 26 the quantity was recovering. In CTC treated cattle, cattle shedding 
ceftriaxone and tetracycline resistant Salmonella over the LOQ increased by Day 26 which is 
potentially troubling as it represents a change from the baseline day 0 values.  
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Broth enrichment had the highest detection rate compared with qPCR and direct plating. 
Between qPCR and direct plating, qPCR had higher rate of detection. The qPCR and direct 
plating methods detected samples differently, which may have occurred because qPCR can 
detect both viable and non-viable cells.  
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CHAPTER V 
GENOMIC COMPARISON AND CHARACTERIZATION OF SALMONELLA 
ENTERICA ISOLATED FROM FEEDLOT CATTLE TREATED WITH 
CEFTIOFUR AND CHLORTETRACYCLINE 
5.1 Introduction 
In this chapter, genomic analyses were performed on Salmonella isolates that were 
obtained from the study reported in Chapter III. The isolates were derived from feedlot cattle 
treated with CCFA and/or CTC. In total, 566 isolates derived from cattle naturally infected 
with Salmonella were whole-genome sequenced and the effects of antibiotics on the genomic 
population of Salmonella were explored via phylogenetics and other methods. 
The spread of antibiotic resistant bacteria has been a public health concern for several 
decades. Misuse and overuse of antibiotics in food-animals have been blamed for the 
dissemination of antibiotic resistant bacteria into the human population; typically, via 
contaminated food or the environment [314]. It has been shown that antibiotic use transiently 
increases phenotypically resistant Salmonella in previous work from our group and in other 
studies conducted in feedlot cattle and pigs [88]. In our current study, a third-generation 
cephalosporin, ceftiofur crystalline-free acid (CCFA) and a tetracycline, chlortetracycline 
(CTC) transiently increased phenotypically multidrug resistant (MDR) Salmonella following 
treatment. However, we have not investigated the resistance genes carried by these isolates, 
nor the relatedness of serotypes across animals, pens, and over time. The presence of 
resistance genes was highly correlated with phenotypic resistance in previous studies [136, 
315, 316]. The presence of plasmids was also investigated in our study and associations with 
the resistant genes. All the MDR isolates investigated in this study were of the ACSSuT-Cef 
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phenotype (ampicillin, chloramphenicol, streptomycin, sulfonamide, tetracycline, ceftiofur, 
and ceftriaxone). 
Previously, epidemiologic and genomic comparisons of Salmonella have been explored in 
the isolates derived from different locations and sources (i.e., human vs animal, often in 
different countries across many years), derived from different studies, or outbreaks [317]. 
However, genomic comparisons of Salmonella isolates that were longitudinally collected in a 
single study population that had been treated with antibiotics has not been previously 
reported. The genomic analysis herein was conducted by core-genome single nucleotide 
polymorphism (SNP) analysis, which is a common method applied in outbreak analyses. 
Since our isolates were derived from a single host population over the course of 67 days 
(replicate 1 Day 0 to replicate 2 Day 26), they were treated similarly in an analytical sense to 
an outbreak population. We also phylogenetically explored the similarity between our cattle 
derived isolates with other publicly available Salmonella serotypes. Temporal comparisons of 
genomes and SNP analysis were performed within each serotype to explore the effects of 
antibiotic treatment on the genome evolution of Salmonella. 
5.2 Materials and Methods 
5.2.1 Study design and Salmonella isolation 
Salmonella isolates used in this study were cultured from cattle feces from a 26-day 
longitudinal, experimental study described previously. Briefly, 176 steers were allocated into 
2 replicates, and 4 treatment groups. In each replicate, 88 steers were assigned into 8 pens 
(n = 11 cattle) to distribute the body weights among the pens evenly in a two-by-two factorial 
design with four treatment regimens (Chapter III Fig. 6), as described in previous papers by 
our research group [35, 88]. In 8 pens (4 pens per replicate), all 11 steers received 6.6 mg/kg 
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of CCFA (Excede®, Zoetis Animal Health, Florham Park, NJ) subcutaneously at the base of 
the ear (“All-CCFA & CTC” and “All-CCFA / no CTC” in Figure 6; metaphylaxis treatment 
model), and in the remaining 8 pens (4 pens per replicate), a single steer treated with CCFA 
on day 0 was co-housed (mixed) with 10 non-treated steers. Half of the pens in the CCFA 
treatment group and mixed group were treated with three 5-day pulses of 22 mg/kg CTC 
(Aureomycin®, chlortetracycline complex equivalent to 220.5 g/kg of chlortetracycline, 
Alpharma, Bridgewater, NJ). The CTC was top-dressed in feed with a one-day break between 
each 5-day pulse. The CTC treatment occurred from day 4 until day 20 (“All-CCFA & CTC”, 
“1-CCFA & CTC”). The remaining 8 pens in each replicate did not receive CTC (“All-CCFA 
/ no CTC” and “1-CCFA / no CTC”). Fecal samples were collected every other day per 
rectum as described previously [35]. Fecal samples were mixed with glycerol at a 1:1 ratio 
and preserved at −80 °C. Suspected Salmonella were isolated by standard enrichment broths 
including Tryptic Soy Broth, Tetrathionate Broth, and Rappaport-Vassiliadis broth 
enrichment. One Salmonella isolate was collected from each steer fecal sample that grew on 
brilliant green agar (BGA) as described previously [88]. In total, 566 isolates were isolated. 
 For the isolation of potential cephalosporin resistant Salmonella isolates from Day 0 fecal 
samples, 88 fecal samples were plated onto BGA with 4 µg/ml of ceftriaxone (BGA-cef). 
Only 2 samples grew colonies on BGA-cef. Two isolates from each BGA-cef plate were 
streaked on blood agar and the species were confirmed by MALDI-TOF. All 568 Salmonella 
isolates were preserved in cryobeads at -80 °C for further characterization and analysis.  
5.2.2 Salmonella DNA extraction for whole-genome sequencing  
Salmonella DNA was isolated in a QIAcube HT robot using the QIAamp 96 DNA 
QIAcube HT Kit (Qiagen, Valencia, CA). A single Salmonella colony was suspended into 
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5 ml of TSB and incubated overnight at 37 °C. From the suspension culture, 1 ml was 
transferred into a 1.2 ml micro-collection tube and centrifuged at 4,000 rpm for 15 minutes 
at room temperature. After the supernatant was removed, the pellet was re-suspended in ATL 
buffer (Qiagen) and mixed with reagent DX (Qiagen). One tube of small pathogen lysis beads 
(Qiagen) was mixed with the suspension and mechanically disrupted using the Qiagen 
TissueLyser system (Qiagen) at 25 Hz, for 5 minutes. The tubes were briefly centrifuged and 
40 µl of Proteinase K was added to each tube. The tubes were incubated at 56 °C for 1 hour at 
900 rpm in a ThermoMixer (Eppendorf, Hauppauge, NY) and followed by a heat shock for 
10 minutes at 95 °C. The suspension was cooled to room temperature and 4 µl of RNAse A 
was added. The prepared samples were set in the QIAcube HT for DNA extraction using a 
modified protocol provided by Qiagen. The quality of the DNA was determined by the 
260/280 absorbance ratios on the FLUOstar Omega Microplate Reader (BMG LABTECH, 
Cary, NC). Absorbance ratio between 1.8-2.0 were required. The DNA quantity was measured 
by fluorescence with the Quant-iT™ Pico Green® ds DNA Assay kit (Thermo Fisher 
Scientific). A minimum 10 ng/µl for accurate dilution was set as threshold concentration. The 
DNA was stored at −20 °C until future use. 
5.2.3 Whole-genome sequencing by Illumina MiSeq and de novo assembly 
To determine the serotypes and genotypes of the Salmonella isolates, we performed 
whole-genome sequencing (WGS) using the Illumina MiSeq platform (Illumina, San Diego, 
CA, USA) on the 568 isolates. Libraries for DNA from 32 Salmonella isolates were 
multiplexed and pooled per sequencing run using the Illumina Nextera XT library preparation 
kit and were run with the MiSeq Reagent Kit v3 600 cycle kit with paired-end reads 
(Illumina). Obtained raw reads in fastq format were trimmed with Trimmomatic ver. 0.36 [248]. 
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The quality of the reads was confirmed with FastQC (Babraham Bioinformatics). Reads were de 
novo assembled by Spades ver. 3.10 [249]. The assembly quality was assessed on the QUAST 
web server, which analyzes the number of contigs, total length of genome by bp, GC (%), N50, 
and L50 [250]. Assembled genomes were annotated by Prokka and RAST [318, 319]. The results 
of FastQC and Prokka were aggregated by MultiQC [320]. Minimum requirement for contig 
number was set to 250 base pairs. Contamination was speculated and sequencing repeated if total 
length was more than 5.2Mb. The assembly process was conducted on the Ada cluster provided 
by the High-Performance Research Computing Center at Texas A&M University. 
 
5.2.4 Whole-genome sequencing by Oxford Nanopore MinION 
Two isolate DNA samples, S. Mbandaka (Day 0, no-CCFA/no-CTC treatment group) and S. 
Reading (Day 4, CCFA/no-CTC treatment), extracted as described above and sequenced on the 
Illumina MiSeq, were also sequenced on the Oxford Nanopore MinION R9 flowcell. The library 
preparation and sequence runs were performed following the manufacturer’s protocol at the 
Genomics and Bioinformatics Service of Texas A&M University AgriLife Research. 
 
5.2.5 Serotype, MLST, resistant genes, and plasmids determination 
Raw fastq files obtained from the forward and reverse reads were uploaded to the web-based 
database SeqSero to determine the serotypes from the WGS data 
(http://www.denglab.info/SeqSero) [96]. The multi-locus sequence type (MLST) of each 
Salmonella isolate was determined by the combination of 7 gene alleles (aroC, dnaN, hemD, 
hisD, purE, sucA and thrA) using the PubMLST database in the SRST2 application at the 
Illumina® BaseSpace® Sequence Hub [251, 252]. The PlasmidFinder (20-Feb-2017) and 
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ResFinder (03-July-2017) databases on the Center for Genomic Epidemiology (CGE) web server 
(Danish Technical University) were used to determine plasmid replicons and resistance genes 
[253, 321]. We also de novo assembled the plasmids by the plasmidspades commands available 
on SPAdes ver. 3.10 for those isolates that carried plasmids. The de novo assembled plasmids 
were confirmed with CGE PlasmidFinder. Plasmids were visualized with DNAPlotter and BRIG 
[322, 323]. Genomic islands on the plasmids were analyzed with IslandViewer 4 [324]. 
 
5.2.6 Assembly of MinION data and Illumina short reads 
The reads from the MinION in fastq format were first assembled using Canu assembling 
software [325]. Second, for two isolates, the trimmed paired-end short-reads from the Illumina 
MiSeq and the MinION reads were aligned with Bowtie 2 [326]. After converting the obtained 
Sequence Alignment/Map (SAM) format to Binary Alignment/Map (BAM) format by Samtools 
[327], Pilon software was used to polish the draft assemblies [328]. The assembled reads were 
annotated with RAST, utilizing the PATRIC web resource. Synteny of pairs of plasmids was 
visualized with Gepard [329].  
 
5.2.7 Core-genome alignment, single nucleotide polymorphism (SNP) analysis and 
phylogenetic tree construction 
The de novo assembled genomes were run through Parsnp software (Harvest Suite) to 
analyze the SNP differences in the core genome [330]. For the reference genome, we used the 
isolates within our study from day 0, when present, and if not, from day 4 in addition to the 
complete genome of S. Typhimurium strain LT2 (NCBI accession # PRJNA241). Multiple other 
complete genome sequences and contigs from NCBI were included as well. The tree was 
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visualized with FigTree v1.4.3 and Gingr in the HarvestTools suite [330]. Temporal associations 
between sequences were explored using TemEst software [331]. STRUCTURE software was 
used to analyze the population structure from the SNP data [332]. The SNP output from Gingr 
was exported as a VCF and converted to STRUCTURE format with PGDSpider [333].  
 
5.2.8 Validation of WGS based serotyping with traditional serotyping 
Ten isolates (2 isolates per serotype: S. Give, S. Kentucky, S. Mbandaka, S. Montevideo, S. 
Reading) also were sent to the National Veterinary Services Laboratories (NVSL), United States 
Department of Agriculture (USDA) in Ames, Iowa for traditional serotyping to compare and 
validate the results from the serotyping based on WGS data.   
 
5.2.9 Statistical analysis 
All statistical analyses were conducted in Stata ver. 14 (Stata Corp, College Station, TX). 
Assembly statistics of total length, serotypes, and plasmids were analyzed using a linear 
regression model. Total length was set as a dependent variable (continuous) and serotypes 
(categorical) and plasmids (binary) were independent variables. Figures were created with 
Tableau Desktop 10.3. Agreement between resistance phenotype and the presence of 
corresponding resistance genes were calculated by Kappa agreement for Salmonella isolates. 
Assembly statistics were calculated on QUAST. Depth of coverage was calculated from data 
obtained from FastQC and aggregated with MultiQC. The following calculation was used: 
(average sequence length x total sequence) / assembly size. We performed exact logistic 
regression analysis to analyze the association between independent variables (i.e., treatment, pen, 
replicate, days) and tree clusters for S. Reading isolates. 
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5.3 Results 
5.3.1 Description of studied population from prevalence study 
Salmonella was isolated from all four different treatment groups (i.e., 1-CCFA / no CTC, 
All-CCFA / no CTC, 1-CCFA & CTC, and All-CCFA & CTC) and from all days analyzed in 
this study (i.e., 0, 4, 8, 14, 20, and 26). In total, 566 Salmonella isolates were collected by 
standard enrichment broth method. Two additional isolates were collected from Day 0 by 
direct plating of fecal samples on BGA-cef and BGA-tet. As shown in Chapter III Table 6 and 
Figure 12, 6 serotypes were detected from four treatment groups. In Figure 44, the numbers of 
isolates per serotype and treatment group is illustrated in a circle. Numbers in each circle 
represent the number of the isolates from each serotype/treatment combination. Red colored 
isolates represent MDR isolates and are comprised of 86 S. Reading isolates and one S. 
Kentucky MDR isolate.
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Figure 44. Numbers of Salmonella isolates detected per treatment group, serotype, and day. Teal blue: isolates from 1-
CCFA / noCTC group, grey blue: All-CCFA / no CTC, green: 1-CCFA & CTC, yellow: All-CCFA & CTC, red: MDR 
isolates. Column: treatment and day, Rows: serotype. Size of the circle corresponds to the numbers of isolates cultured per 
day and serotype. 
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5.3.2 Descriptive statistics of WGS assembly results 
We trimmed and de novo assembled the paired-end reads by SPAdes 3.10 for all 566 isolates. 
The assembly quality was assessed by QUAST, which included the following parameters: 
number of contigs, total length of genome, GC (%), and N50. Serotypes included S. Anatum (4 
isolates), Give (108 isolates), Kentucky (77 isolates), Mbandaka (215 isolates), Montevideo (76 
isolates), and Reading (86 isolates). None of the assemblies contained an uncalled bases (N) in 
the sequence. The median number of contigs (³500bp) was 45 (Min. 21-Max. 236) and the 
median N50 was 279,322 bp (Min. 281,811-Max. 435,129). The median GC content was 52.19% 
(Min. 52.12-Max. 52.27). The median total length was 4,798,144 bp (Min. 4,531,234-Max. 
5,148,251) (Table 23). The total length of the assembly was assessed per serotype since the total 
size varied by serotype and the presence of plasmids (Figure 45). The total length of assembly 
was significantly different between serotypes and by the presence of plasmids within serotypes 
(Figure 45). Salmonella Give had smallest total length of 4.5Mb followed by S. Montevideo 
(4.6Mb), S. Anatum (4.7Mb), S. Reading (approximately 4.7Mb: 4.9Mb minus the length of an 
IncA/C plasmid 152,290bp), S. Mbandaka (4.79Mb), and S. Kentucky (4.8Mb) (Figure 45). The 
average sequence coverage depth was 33.8. The number of coding sequences (CDS) per serotype 
correlated to the total length, which was around 4,244 in S. Give and 4,560 in S. Kentucky. 
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Table 23. Descriptive statistics of de novo assemblies by serotype. The numbers in parentheses are the minimum and maximum. CDS: 
coding sequence 
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Figure 45. Descriptive statistics of de novo assemblies by serotype and presence of plasmids. Total length of de novo assembled 
Salmonella genome by serotypes and plasmids. The numbers in parentheses are the number of isolates per serotype with 
corresponding plasmid followed by minimum and maximum total length. When there was only one isolate with a corresponding 
plasmid, no confidence interval is shown. CI: 95% confidence interval of median total length. 
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5.3.3 Oxford Nanopore MinION and Illumina short reads assembly 
The Oxford Nanopore MinION reads and trimmed Illumina short-reads were assembled for a 
single S. Mbandaka and S. Reading isolate each. The final numbers of contigs from this hybrid 
assembly were 9 and 10, respectively. The numbers of contigs were fewer than the contigs 
assembled only with Illumina reads using SPAdes, which were 51 and 47, respectively (Table 
24). 
 
 
Table 24. Comparison of the assembly results between Illumina reads and the hybrid assembly of 
Oxford Nanopore MinION and Illumina reads 
 
 
 
5.3.4 Antimicrobial Resistant genes and plasmids 
Following assembly with SPAdes, antimicrobial resistant genotypes were assessed for all of 
the isolates using the ResFinder database. Resistance phenotype and genotype were completely 
matching (100%) for S. Anatum, Give, Kentucky, and Montevideo isolates. In S. Mbandaka, 1 
isolate carried aadA24, a gene responsible for streptomycin resistance, but the isolate was 
phenotypically pan-susceptible (Table 25). In S. Reading, all 86 isolates displayed a multidrug 
resistance (ACSSuT-Cef) phenotype and carried the resistance genes, aadA7, strA, strB, sul1, 
sul2, floR, blaCMY-2, and tet(A). Three S. Reading isolates were not sulfisoxazole resistant 
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phenotypically; however, sul1 and sul2 genes were detected (Table 25). In one S. Reading 
isolate, aph(3’)-IIa and aph(6)-Ic genes, which correspond to kanamycin and streptomycin 
resistance, respectively, were detected in addition to the resistance genes listed above. Kappa 
agreement was calculated for each resistance phenotype-genotype, and agreement beyond chance 
was found to be between 0.97-1.0 (Table 26).  
Three resistance genes aadA7-truncated, sul1, and tet(A) and an IncI1 plasmid were detected 
from the single S. Kentucky isolate exhibiting antimicrobial resistance. The paired-reads from 
the S. Kentucky isolate were assembled with plasmidSPAdes, which produced 55 contigs and a 
total length of 240,563bp. The annotation by RAST identified all resistance genes from 
plasmidSPAdes derived contigs, which suggests that the genes were located on the IncI1 
plasmid. The results were confirmed with Island Viewer 4, in which the resistance genes were 
shown within the IncI1 plasmid.  
IncI1 plasmids were detected in all the other serotypes, except S. Anatum; however, genes 
encoding for antibiotic resistance were not detected in these isolates. S. Give carried IncI1 and 
IncI2 plasmids. In S. Mbandaka, 21 isolates carried IncI1, IncY, or both plasmids. Interestingly, 
IncY plasmid-replicons were not detected from those fastq files that were assembled with Velvet 
software (instead of SPAdes) and run with PlasmidFinder. Two S. Montevideo carried IncI1 and 
IncY plasmids, respectively and 3 S. Kentucky carried the IncI1 plasmid. All S. Reading were 
detected with the IncA/C2 plasmid and 4 isolates also had an additional IncI1 plasmid (Table 
25).  
 
 217 
Table 25. Antimicrobial resistance phenotype and genotype patterns per serotype and plasmid replicon type 
 
N/D: Not detected 
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Table 26. Kappa agreement between antimicrobial resistance phenotype and detected antimicrobial resistance genes 
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5.3.5 IncA/C2 Plasmids from S. Reading 
5.3.5.1 Description of IncA/C2 plasmid 
All S. Reading isolates carried resistance genes and were determined to harbor IncA/C2 
plasmids. IncA/C2 plasmids are known to be multidrug-resistance plasmids [334]. To localize 
the resistance genes in an S. Reading isolate in silico, the plasmid replicon gene repA for 
IncA/C2 was located on one of the contigs of the S. Reading isolate hybrid-assembled with 
Illumina and Nanopore MinION reads. The repA gene was located on a single contig among 10 
contigs, identified as contig_04 (152,294bp). Resistance genes aadA7, strA, strB, sul1, sul2, floR, 
blaCMY-2, and tet(A) were all also located on contig_04. The plasmid contig_04 carried floR, 
tet(A)-tetR, strB, strA, and sul2 in one region, a blaCMY-2 with insertion sequence ISEc9 in a 
second region, and aadA7, sul1 and a mercury resistance operon on transposon Tn21 in a third 
region (Figure 46). One S. Reading isolate was detected with the additional genes aph(3’)-IIa 
and aph(6)-Ic genes and this isolate was carrying both IncA/C2 and IncI1α plasmids. The 
aph(3’)-IIa and aph(6)-Ic genes were located on a contig (1,714bp) surrounded by repeated 
regions based on PlasmidSpades assembly; however, it could not be determined whether the 
contig was located on the chromosome, the IncA/C2 plasmid, or the IncI1α plasmid. These genes 
are encode aminoglycoside-modifying enzymes commonly found in Tn5 transposons and they 
specify resistance to kanamycin, neomycin, butirosin, paromomycin, and ribostamycin [335].  
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Figure 46. Circular map representation of the IncA/C2 plasmid derived from S. Reading hybrid-
assembled by MinION and Illumina sequencing and visualized with DNA Plotter. 
The dark green region on the outer circle represents genes in the forward CDS region and the 
inner light teal green are genes in the reverse CDS genes. Red genes are antimicrobial resistance 
genes. Bright green genes represent mobile elements including transposons and insertion 
sequences. Purple genes represent a mercury resistance operon. The blue gene is the repliconA 
(repA) gene of the IncA/C2 plasmid.  
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5.3.5.2 Comparison of contig04 plasmid with closed public IncA/C plasmids 
Contig_04 was run through BLASTn at the NCBI website and matched with several 
complete, closed IncA/C plasmid sequences (GenBank: KJ90290.1 (pSN254b, 152,216bp), 
CP012682.1 (p33676, 161,461bp), FJ621587.1 (pAM04528, 158,213bp), CP014658.1 (pSAN1-
1736, 160,227bp), and CP011429.1 (pYU39, 156,323bp)). The closest matching plasmid 
sequence found by a BLASTn search was plasmid pSN254b from Aeromonas salmonicida, a 
bacterium which often causes disease in fish [336]. The query coverage was 100% and the 
identity match was 99%. The pSN254b plasmid has a similar plasmid structure to the pSN254 
plasmid which was derived from S. Newport strain SL254. Plasmid pSN254 has an IncA/C 
plasmid backbone [198]. The differences between pSN254 and pSN254b are that pSN254 carries 
2 copies of the blaCMY-2 gene, while pSN254b has only one copy; additionally, pSN254b has two 
insertion sequences (IS) and genes are absent from the Tn21 transposon [336]. Dot plot analysis 
was conducted between our contig04_IncA/C2 plasmid and pSN254b, pSAN1-1736 (S. Anatum 
derived), and pAM04528 (S. Newport derived) (Figure 47). All sequences shared high similarity. 
Contig04 and pSN254b shared the highest similarity. In both pSAN1-1736 and pAM04528, 
inversion sequences can be seen as a diagonal line. pAM04528 also has frame shifts caused 
either by deletion, insertion, or mutation of nucleotides. 
 
 
 
 222 
 
Figure 47. Dotplot analysis of S. Reading derived IncA/C2 and pSN254b (left), pSAN1-1736 (CP014658.1) (middle), and pAM04258 
(FJ621587.1) (right). 
Vertical sequence is Contig 04 and horizontal sequences are pSN254b, pSAN1-1736, and pAM04258 from left to right, respectively.  
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5.3.5.3 Plasmid assembly with plasmidSPAdes 
The plasmidSPAdes command on SPAdes (ver. 3.10) was used to assemble only the 
plasmid sequences on those isolates that were detected with plasmid replicons from the 
PlasmidFinder results. In total, 85 S. Reading and 30 isolates from among the other five 
serotypes were run on plasmidSPAdes. The fasta files generated from the assembly were run 
on PlasmidFinder to confirm the results of plasmidSPAdes. Of the 85 S. Reading isolates 
originally detected with an IncA/C2 plasmid, 71/85 isolates (83.5%) were detected with 
IncA/C2 plasmid and 4/4 isolates (100%) were detected with additional IncI1_alpha plasmids; 
however, 10 isolates in which plasmids were initially detected (11.8%) were not detected with 
plasmid replicons by PlasmidFinder following assembly with plasmidSPAdes. Among the 30 
isolates from S. Mbandaka, S. Give, and S. Kentucky, 26 matched with the original 
PlasmidFinder results, two isolates were not detected with a plasmid replicon, one isolate was 
detected with an extra IncY plasmid, and one isolate was detected with only one plasmid but 
originally was expected to harbor two plasmids. PlasmidSPAdes is known to work with those 
sequences that have more than 40x depth coverage, which can result in failed assemblies of 
plasmid [337]. Two IncI2_delta plasmids detected in S. Give were assembled into 1 contig 
and BLAST search matched with the complete sequence of E. coli plasmid tig00013784_pilon 
(CP024858.1). The sizes of both contigs were 58,287 bp and GC content (%) were 42.16 and 
42.13, respectively. Assembly of plasmids from WGS sequencing is challenging [337]; 
however, this study illustrated the potential to close the plasmids when the sequence depth 
coverage is high enough.  
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5.3.5.4 Comparison of Velvet and SPAdes assembler on plasmid detection by 
PlasmidFinder 
Initially, all of our raw paired-end reads were uploaded onto the CGE webserver for 
plasmid detection by PlasmidFinder. PlasmidFinder uses Velvet for assembly [100]. Since we 
later assembled with SPAdes, the assembled genomes were reanalyzed with PlasmidFinder. 
Interestingly, IncY plasmids were identified from 8 isolates after SPAdes assembly, which 
were not initially detected when the reads were assembled with Velvet. The same 
PlasmidFinder database from February 2017 was used for both analyses. The detection of the 
IncY plasmids may be explained by differences in the assembly alogrithms between Velvet 
and SPAdes. However, the reason why only IncY plasmids could not be detected by Velvet 
assembled genomes but from SPAdes assembled genomes remains unclear.  
5.3.5.5 Comparison of plasmid assembly results of plasmidSpades and 
IncA/C2_contig04 plasmid 
The plasmid assembled with plasmidSPAdes was compared with the Canu/Pilon 
assembled contig_04 (D4-50 S. Reading isolate) plasmid. plasmidSPAdes assembly resulted 
in 3 contigs with a total length of 142,840bp. Since the total length of the IncA/C2_contig04 
was 152,294bp, around 9,454bp were missing from the plasmidSPAdes assembled plasmid. 
The missing region from the plasmidSPAdes assembled plasmid coded for an insertion 
sequence (IS) (Figure 48). One possibility is that IS are repeated regions, which may not have 
been properly assembled by plasmidSPAdes using only short read sequences. Two other S. 
Reading isolates were successfully assembled into one contig using plasmidSPAdes assembly. 
Similarly, these assembled plasmid genomes were also missing this insertion sequence region. 
However, the true sequences of these two isolates are not known, and therefore it cannot be 
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concluded that this IS area was not assembled properly. It is possible that this region is not 
present in these isolates; however, it is likely that these isolates were carrying similar 
plasmids. In comparison to differences in the detection of plasmids by plasmidSPAdes, all 
resistance genes identified on the Canu/Pilon assembled contig_04 were also detected on the 
plasmidSPAdes assembled plasmid.  
 
Figure 48. Comparison of plasmids assembled from Illumina reads with plasmidSPAdes and 
Illumina&MinION. The inner arrowed circle in brown is the forward and reverse reads of the 
Illumina&MinION assembled contig_04 (reference genome). The outer arrowed circle with red 
(forward) and green (reverse) colors are the plasmid assembled with plasmidSPAdes aligned 
with contig_04. The rectangle area represents the area missing from the plasmidSPAdes 
assembly. 
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5.3.6 Phylogenetic relation of all isolates by core-genome SNPs with publicly obtained 
sequences 
The core genomes of the Salmonella were aligned across and within serotypes using 
Parsnp software. Maximal unique matches (MUMs) are used in Parsnp to recruit similar 
genomes and are used by many researchers for the rapid alignment of multiple genomes [330, 
338, 339]. Because only the core genomes are aligned, any reference genome can be used in 
this process. It is ideal to use a reference genome that is closely related to the analyzed strain 
so that the maximum number of core genomes are selected [330]. Temporal associations 
between isolates and genetic divergence through sampling dates were assessed with the 
TempEst program, using a regression model. 
We aligned the core-genome of 600 Salmonella isolates including 568 isolates from our 
study, 23 other publicly available sequences of the 6 representative serotypes from our study 
(2 of S. Anatum, 4 of S. Kentucky, S. Reading, S. Mbandaka, and S. Give, respectively, and 5 
of S. Montevideo, respectively), 7 other common zoonosis serotypes (S. Enteritidis, S. 
Typhimurium, S. Newport, S. Heidelberg, S. Dublin, S. Typhi), and 2 Salmonella enterica 
subspecies (S. houtenae and S. arizonae). Alignments and phylogenetic analyses were used to 
determine where our feedlot cattle-derived isolates belong within a previously generated 
phylogenetic analysis of Salmonella (Figure 49). One S. Mbandaka that was acquired from the 
public database (ASM183359v1) created an isolated branch; therefore, a BLAST search was 
conducted. The sequence turned out to be from a Salmonella subspecies IIIb (Salmonella 
enterica subsp. diarizonae) and was labeled as such in our analysis. In total of 600 isolates, 
core-genome coverage was 43.7%. All isolates within a serotype belonged to the same cluster 
and had the same ST (Figure 49). Therefore, to increase the resolution of the tree, 2 
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representative isolates were chosen to be aligned with the other publicly available sequences 
named above (Figure 50).  
Previous studies have shown that Salmonella enterica subsp. enterica can be divided into 
at least 2 clades (Clade A and B). From our study, S. Kentucky, S. Anatum, S. Mbandaka, and 
S. Reading belonged to Clade A, while S. Montevideo and S. Give belonged to Clade B. 
Within Clade A, S. Anatum and S. Reading formed a separate sub-cluster (Clade A2) from S. 
Kentucky and S. Mbandaka (Clade A1). Since sequences from these 6 serotypes were also 
included from the NCBI database, we found that, more broadly, S. Montevideo and S. 
Reading had isolates that belonged to both Clade A and B. S. Montevideo from our study was 
strictly of ST138 and belonged to Clade B, while CFSAN004346 belonged to Clade A2. S. 
Reading from our study was ST1628 and belonged to Clade A2, while ST412 isolated from 
turkey in previous work belonged to Clade B, and demonstrates that S. Reading is a 
polyphyletic serotype. S. Mbandaka from our study was ST413 and belonged to Clade A1 
while ATCC51958 (ST3016) belonged to Clade A2. This corresponds with data from previous 
studies. As mentioned above, one S. Mbandaka turned out to be S. diarizonae (IIIb). Only 
ST64 from S. Anatum was included in this tree; however, S. Anatum also has multiple STs. S. 
Give from our study was ST654 and the other 3 different STs included from NCBI belong to a 
different cluster. The same is true for S. Kentucky.  
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Figure 49. Spider tree of 568 isolates (6 serotypes) from this study, and 32 NCBI sequences from the same 6 serotypes, and other 
common serotypes analyzed by core-genome SNP analysis. The S. Typhimurium LT2 complete genome was used as a reference 
genome. The length of S. houtenae, S. arizonae, and S. dizrizonae are modified to fit in the figure.
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Figure 50. Maximum-likelihood tree of Salmonella enterica including two representative isolates 
from each of the 6 serotypes identified in this study, publicly available sequences from the 6 
representative serotypes, and other common serotypes analyzed by core-genome SNP alignment 
with Parsnp. Isolates in the rectangles are isolates from this study. ST: sequence type from 
MLST data. Yellow: S. Montevideo, green: S. Give, blue: S. Anatum, salmon: S. Reading, 
purple: S. Kentucky, red: S. Mbandaka, gray: other common serotypes. An S. Typhimurium LT2 
complete genome was used as the reference genome. The host of each of the isolates from 
publicly acquired databases is shown in parenthesis, when provided. Clades A and B: based on 
den Bakker et al., and Timme et al.[107, 108] 
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5.3.7 Salmonella Reading core-genome analysis 
5.3.7.1 Description of S. Reading isolates 
The temporal association of MDR S. Reading isolates was analyzed by TempEst software. 
S. Reading were isolated from replicate 1 Day 0 until replicate 2 Day 26 (day 67) (Figure 51). 
The numbers of animals that were newly isolated with S. Reading on any given corresponding 
day were plotted in Figure 51. TempEst analyze the correlation between the sample date (day 
0 to day 67) and branch length of the core-genome SNPs phylogenetic tree by regression 
analysis. There were no temporal associations among the isolates (P > 0.05).    
 
 
 
Figure 51. Epidemiologic curve of Salmonella Reading newly detected infections 
 
 
5.3.7.2 Core-genome alignment of S. Reading with isolates from public database 
The core-genomes of the S. Reading isolates were aligned and visualized into 
phylogenetic trees using maximum-likelihood methods. In S. Reading isolates, 97% of the 
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assembled genomic DNA were covered with the core genome. When 17 publicly available S. 
Reading isolates were included in the core-genome alignment, 3 isolates (97-0463 a U.S. 
human isolate from the CDC, CVM N42528 isolated from a pork chop in the U.S., and BCW-
2763 from a human in Taiwan) belonged to the same phylogenetic cluster as our S. Reading 
isolates (Figure 52); however, they remained quite distant in terms of phylogenetic relations 
to our isolates.  
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Figure 52. Maximum likelihood tree of core-genome SNPs of S. Reading with publicly available S. Reading contigs analyzed with 
Parsnp and visualized with FigTree. 
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5.3.7.3 Core-genome alignment of S. Reading isolates from this study 
When only the S. Reading isolates from this study (88 isolates) were aligned, isolates 
grouped into 2 major clusters (Figure 53). The first cluster (Cluster 1) contained 76 isolates 
(86.3%) and the second cluster (Cluster 2) included 12 isolates (13.6%). Cluster 1 was further 
divided into 2 groups, 1a (68 isolates) and 1b (8 isolates). The composition of the clusters was 
evaluated by antibiotic treatment, pen, and day. All isolates that derived from animals that did 
not receive any treatment or else were treated with CCFA were in Cluster 1a. Isolates from 
animals treated with CTC were largely comprised of Cluster 1a (84.8%) Cluster 1b (6%), and 
Cluster 2 (9.1%) (Figure 54). Isolates from animals treated with both CCFA & CTC were in 
Cluster 1a (55.9%), 1b (17.6%), and Cluster 2 (26.5%) (Figure 54). CTC treatment was 
significantly associated with Cluster 2 by exact logistic regression (Odds ratio: 10.2, P=0.02); 
however, Cluster 1b was also composed of isolates from CTC treated animals (Figure 54) so 
the effect was not exclusive. Other variables including CCFA treatment, day, pen and most 
interestingly, replicate, were not significantly associated with phylogenetic clusters by exact 
logistic regression methods. The sample size was too small to allow for multivariable 
analysis. It is also interesting to note that the four isolates that carried both an IncA/C2 
plasmid and IncI1 plasmid (green) were not associated with the cluster formation, since 
accessory genes are not included in core-genome analysis. 
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Figure 53. Maximum likelihood tree of S. Reading by core-genome SNP alignment (left) and corresponding isolate data per animal, 
treatment, replicate, and pen (right). Numbers in the right table corresponds to the clusters. Green isolates carried IncA/C2 and IncI1 
plasmids. All other isolates carried only the IncA/C2 plasmid. 
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Figure 54. Distribution of phylogenetic Clusters 1a, 1b, and 2 by treatment group among the 88 
S. Reading isolates. 
 
5.3.7.4 SNP analysis of S. Reading 
Single nucleotide polymorphisms (SNPs) of S. Reading isolates were visualized with 
Gingr (Figure 55). The SNPs were annotated using the GenBank file acquired by RAST 
annotation of our D0-59 isolate, which was used as a reference for the S. Reading analysis. In 
total, 200 SNPs were located among S. Reading isolates. Using the definition of a SNP as a 
nucleotide difference observed in > 1% of the population, those differences observed in only 
one isolate were not included and therefore only 53 SNPs were included in the analysis. When 
significant clusters of SNPs were observed, annotated genes were confirmed. The major 
difference between Cluster 1 and 2 was a polymorphism in the molybdenum transport ATP 
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binding protein modC gene. The modC gene forms the molybdenum transporter with the 
modABC genes. The adjacent modB and modF genes also had SNPs; however. no SNPS were 
identified in the modA gene. 
The differences between Cluster 1a and 1b were in the phage terminase (ATPase subunit) 
gene. Out of 7 SNPs that were identified in this gene, 4 of them were nonsynonymous. Other 
genes that were detected with major SNPs were within the phosphotransferase system coding 
gene, mannose-specific IIC component coding gene (EC 2.7.1.69), intergenic region of the 
yebE inner membrane protein and FIG01200701 (possible membrane protein), biotin synthase 
gene (EC 2.8.1.6), putative molybdenum transport ATP-binding protein coding gene (modF), 
and galactose-I-phosphate uridylyl transferase coding gene.  
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Figure 55. SNP differences identified in the modC gene between Cluster 1 and Cluster 2.
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5.3.8 Salmonella Mbandaka phylogenetic analysis 
For the isolates derived from this study, the total core-genome coverage was 94.6% among 
all the S. Mbandaka sequences. S. Mbandaka was divided into 4 major clusters among the 
isolates from this study (Figure 56). Overall, 64.8% of Clusters 1, 2 and 3 consisted of isolates 
from CCFA treated animals. Cluster 4 was divided into 4 sub-clusters, which consisted of 
44.4% of isolates from animals without antibiotic treatments and 26.8% of CCFA treated 
animals. Six major SNPs were identified, corresponding with the cluster formations. Due to 
computational limitations, the genes corresponding to the SNPs were not analyzed for S. 
Mbandaka.   
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Figure 56. Maximum likelihood phylogenetic tree of S. Mbandaka isolates. Replicate (Pink: 
Replicate 1, Green: Replicate 2), Day (earlier day - lighter color), Colors of treatment group. 
Green: 1-CCFA / no CTC, yellow: 1-CCFA & CTC, orange: All-CCFA / no CTC, red: All-
CCFA & CTC. 
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5.3.9 Salmonella Kentucky phylogenetic analysis 
The core genome of each S. Kentucky isolate was aligned using Parsnp. S. Kentucky 
isolates shared 96% of the core genome within the sampled population and the phylogenetic 
analysis revealed 3 clusters. The Salmonella Kentucky serotype contains at least 15 different 
sequence types (STs) [109]. The most common ST isolated in the United States is ST152, 
largely from chickens, retail meat, and dairy cattle. All of our S. Kentucky were ST198. 
Occasionally, ST198 has been isolated from dairy calves, ground beef, and human clinical 
isolates. Therefore, in the core-genome alignment, other ST198 sequences available from 
public sources were included. When one isolate of ST152 (CVM 29188) and 10 isolates of 
ST198 were included, 89% of the core genomes were shared and all our isolates were 
clustered with the publicly available ST198 (Figure 57). Isolates from this study were 
classified into two clusters shown in pink and teal (Figure 57). It has been reported that ST198 
has 2 groups: 198.1 and 198.2 [109]. ST198.1 is largely comprised of ground beef and dairy 
calf derived isolates while 198.2 is largely comprised of isolates from human clinical cases 
[109]. When both 198.1 and 198.2 were included in the Parsnp alignment, and one of our S. 
Kentucky isolates was used as a reference genome (D0-3), the sequences shared 75.1% of the 
core genome. All the S. Kentucky isolates from this study formed a clustered in 198.1 together 
with isolates derived from dairy calf feces in Florida (ARS-CC273, ARS-CC274, ARS-
CC938), ground beef from New Mexico (CVM N51290), and ground turkey from California 
(CVM N42453) (Figure 57). One ground beef derived isolate (CVM N41913) clustered in 
198.2 along with ATCC9263 isolates from human clinical cases; however, none of our 
isolates was found in ST198.2.  
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When isolates from only our study were aligned (Figure 58, left side) the total core-
genome coverage among all isolates was 96.7%. Isolates were clustered into three groups. The 
major SNP differences between Clusters 1 and 2 in comparison to Cluster 3 were with the 
Heme exporter protein C. Multiple other SNPs differentiated Clusters 1 and 2, including the 
Thiol:disulfide interchange protein DsbE, 16S ribosomal RNA, a few hypothetical proteins, 
and several intergenic regions. No clear differences in the distribution of the isolates were 
found among the treatment groups (Figure 58, right side). 
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Figure 57. Maximum likelihood phylogenetic tree of S. Kentucky isolates. S. Kentucky core-
genome was aligned using CVM 29188 (ST152) as a reference genome. Tree was rooted at the 
midpoint and branches are proportionally transformed. 
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Figure 58. Phylogenetic analysis of Salmonella Kentucky from this study aligned with Parsnp (left) and corresponding table of isolates 
per replicate, treatment group, day, and animal (right). Grey: cluster 1, green: cluster 2, yellow: cluster 3. Numbers in the cells 
corresponds to the cluster. 
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5.3.10 Salmonella Give phylogenetic analysis 
In total, 108 S. Give were isolated from our study. From NCBI Bioproject PRJNA59703, 
PRJNA186035, and PRJNA224224, 16 publicly available assembled contigs were included in 
the phylogenetic analysis. The additional sequences were included in the analysis to 
determine the relationship between our S. Give isolates to other S. Give isolates since S. Give 
is known to be polyphyletic [108]. One public isolate 
(GCA_000505465.1_CFSAN004343_01.0) was of ST 19, which was from a composite cattle 
fecal sample and belonged to different cluster from the other isolates (Figure 59). In the other 
cluster, one isolate was ST3969 and one ST was unknown (ST allelic gene pattern: 301, 11, 
16, 343, 748, 71, 2), and 4 others were ST516. Within ST654 from the public database, 2 
isolates (ASM48721v1 and ASM187889v1) clustered with our isolates. These isolates were 
derived from a filter on a dairy farm and river water in Mexico, respectively.  
The isolates from our study were aligned using one of the isolates from this population as 
reference genome. Total coverage of the core genome among all our sequences was 95.6%. At 
least 6 well-supported clusters were formed by these isolates (Figure 60). However, the 
cluster formation was not associated with treatment groups. Cluster 4 had multiple SNPs in 
different genes, including inosine-5’-monophosphate dehydrogenase, Ded A family inner 
membrane protein (YqjA), Ferric reductase, and an intergenic region between ATP dependent 
protease HslV and HslU (Figure 61).  
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Figure 59. Salmonella Give core-genome phylogenetic tree including publicly available sequence data. 
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Figure 60. Phylogenetic maximum likelihood tree of S. Give from our study. Colors are coded by 
individual-animal treatments. Black: no treatment, blue: CCFA treatment, green: CTC treatment, 
red: CCFA & CTC treatment.  
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Figure 61. Visualized SNPs of S. Give within the sampled population.
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5.3.11 Salmonella Montevideo 
Among Salmonella Montevideo isolates, the total coverage of the core genome was 96.4% 
among all sequences observed in studied population. Two major clusters were formed for S. 
Montevideo. A few sub-clusters included only isolates from CCFA treated animals (Figure 
62). The major difference identified between Cluster 1 and 2 was in an intergenic region. 
Eight more major SNPs were found within S. Montevideo. In Cluster 1 and 2, one cluster each 
was composed by the isolates treated with CCFA (highlighted in grey and in blue color in 
Figure 62). The SNPs that clustered them were located at an intergenic region. Other cluster 
formation was due to SNPs in DNA gyrase subunit A, diguanylate cyclase/phosphodiesterase 
with PAS/PAC sensor coding gene, clpB, putative inner membrane protein coding gene. 
These SNPs were not associated with antibiotic treatments. 
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Figure 62. S. Montevideo phylogenetic maximum likelihood tree. Color-coded by treatments: 
Black: no treatment, blue: CCFA treatment, green: CTC treatment, red: CCFA & CTC treatment. 
Grey shades are where isolates consisted of mostly CCFA-treated animal-derived isolates. 
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5.4  Discussion 
Whole-genome sequencing of Salmonella is becoming a common practice in bacterial 
molecular epidemiology. We successfully sequenced 568 isolates of Salmonella from a single 
cattle population arising from 2 replicates each studied for 26 days.  
The total sequence length of each serotype differed, in order from S. Give through S. 
Montevideo, S. Anatum, S. Reading, S. Mbandaka, and S. Kentucky as the largest. The length 
also differed by the presence or absence of plasmids. It is known that genome size differs by 
serotype in Salmonella, and also it differs by the number of accessory genes [127, 340]. The 
number of CDS was between 4,200 and 4,560, which agrees with previous studies. A study by 
Laing et al. found that S. Anatum has on average 401.5 Salmonella species-specific genomic 
regions, which was one of the highest numbers followed by S. Kentucky (380.3), S. Mbandaka 
(374.5), S. Reading (370.4), and S. Montevideo (360.1) [127]. S. Give was not included in their 
study.  
An accurate assembly is crucial for downstream analysis, which we achieved by SPAdes 
assembly. SPAdes assembly returned median contig numbers of 45 and a median total length of 
4.7 Mb, both of which were consistent within serotypes. Initially, the assemblies were performed 
in Velvet and the assemblies were searched for the presence of antibiotic resistance genes and 
plasmid replicons. For the most part, we found good agreement among resistance-gene and 
plasmid data when comparing Velvet and SPAdes assemblies. However, IncY plasmid replicons 
were not detected with Velvet assembled genomes but were identified with SPAdes assembled 
genomes. The reason for this may be due to differences in the assembly algorithm between the 
two software packages. Since the same database was used for plasmid replicon searches 
(PlasmidFinder) to compare between the Velvet and SPAdes assembled genome, these 
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differences could not due to database differences. The IncY plasmid may contain repeated 
regions that the Velvet assembler had difficulty assembling, whereas SPAdes could correctly 
assemble the repeats. Either way, the SPAdes assembler had a lower number of contigs and 
optimal total length. Therefore, genomes assembled by SPAdes had high detection of the genes 
and replicons, which is consistent with other reported studies [249, 341].  
Serotyping by SeqSero based on WGS data and traditional serotyping match 100% among a 
small subset of the isolates. Since we did not conduct traditional serotyping on all of the isolates, 
we are unable to assess the accuracy of WGS based serotyping. However, based on the total 
length of the assembled genome, it is highly likely that most of the isolates were serotyped 
accurately. One isolate each from S. Montevideo, S. Mbandaka, S. Mbandaka with IncI plasmid, 
and S. Kentucky had a longer length than the other isolates in these serotypes, respectively, and 
no additional plasmids were detected. Assembly statistics were in an acceptable range, and 
therefore such extended genome isolates may be a variant of the serotype or else may be carrying 
an unknown plasmid that was not included in the PlasmidFinder database. In S. Reading, a few 
genomes were detected with more than 4,700 CDS, while others were below 4,700; despite this, 
only the IncA/C2 plasmid was detected among all of these isolates. These isolates may also carry 
additional plasmids or be a variant of S. Reading. Although we have not used SISTR serotyping 
in this study, the authors of SISTR showed that S. Reading had a relatively low concordance with 
reported serotypes [97]. However, SISTR uses assembled fasta files as an input instead of raw 
fastq reads like SeqSero, so the results are not directly comparable. 
The hybrid assembled genomes using both Oxford Nanopore MinION long sequence reads 
and Illumina MiSeq short sequence reads resulted in a fewer number of contigs. The final 
number of contigs was 9 for S. Mbandaka and 10 for S. Reading isolates. The total length of the 
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genome was similar between the hybrid and Illumina assemblies, but the N50 and largest contig 
size of the hybrid assembly were each significantly larger than that of the assembly derived from 
only Illumina reads.  
The S. Reading IncA/C2 plasmid from the isolate sequenced on the MinION was assembled 
into a single contig via the hybrid assembly with Canu, and was polished with Pilon. Similarly, 
George et al. compared the assembly of plasmids of Klebsiella spp, Citrobacter fruendii, E. coli, 
Serratia marcescens, and Enterobacter cloacae by multiple assembly methods, in which Canu 
alone or Canu and Pilon based assembly approaches showed the best recovery of plasmids when 
compared with plasmidSPAdes, hybridSPAdes, and npScarf [342]. Our study showed that this 
assembly method is feasible for Salmonella and may be a cost-effective method to assemble 
complete plasmid sequences. 
In our studied population, 6 serotypes each were divided into one of two clades: S. 
Mbandaka, S. Kentucky, S. Reading, and S. Anatum were in the first clade, and S. Montevideo 
and S. Give were in the second clade. Previous studies have shown that Salmonella enterica 
generally are divided into 2 major clades, Clade A and B, which was consistent with our study 
[107, 108]. S. Reading and S. Anatum clustered with serotypes highly pathogenic to humans, 
including: S. Typhimurium, S. Dublin, S. Enteritidis, and S. Heidelberg. Several Salmonella 
serotypes are known as polyphyletic, such as S. Newport, S. Kentucky, and S. Give [110]. 
Among the serotypes that were recovered here, S. Give, S. Kentucky, and S. Reading are 
known or suspected to be polyphyletic and have multiple MLST within the serotype [107-
109]. S. Mbandaka has not been reported as polyphyletic previously; however, our S. 
Mbandaka were clustering with a few other NCBI obtained strains and were not clustered 
with the standard S. Mbandaka strain ATCC51958. One S. Mbandaka that formed an isolated 
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branch following core-genome alignment was BLAST searched, and turned out to be 
Salmonella diarizonae. This was unexpected, and the reason for this misclassification is not 
known. This isolate was kept in the phylogenetic tree to be used as an outgroup. S. Give was 
the most divergent serotype and consisted of at least 5 STs when publicly available sequences 
were included into the phylogenetic analysis. The MLST of our S. Give isolates were identical 
to one another.  
The phylogenetic tree of our isolates, when compared with the publicly available 
sequences, showed that all of our isolates were clustering together per serotype in the tree; 
importantly, this shows that they belong to the same lineage. In S. Anatum, S. Montevideo, S. 
Give, and S. Kentucky, our isolates clustered with other bovine-derived isolates. The clusters 
of S. Anatum and S. Kentucky included human-derived isolates, which may suggest a public 
health concern. S. Reading clustered with pork chop and human derived isolates and S. 
Mbandaka clustered with a chicken breast-derived isolate. However, the publicly available 
isolates that were included in this study are limited; therefore, further sequence data are 
needed to investigate comparisons with other isolates. The cattle in our study were all from 
the same source and therefore the same lineage of serotypes may have expanded in these 
cattle. The cattle were comingled prior to the study to normalize the microbiota between 
individuals. Salmonella can easily transmit between cattle within the same pen. In fact, core-
genome coverage was approximately 95% within the same serotype. On the other hand, 
several SNPs were found among the isolates within serotypes and they were further divided 
into several clusters, suggesting at least some within serotype diversity emerged within the 
temporal and geographical limits of this controlled field trial.  
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All Salmonella Reading isolates were phenotypically and genotypically multidrug 
resistant (MDR). The whole-genome sequencing genotypic resistance data of the Salmonella 
isolates showed good agreement with phenotypic data. Complete agreement was observed for 
florfenicol, all tested beta-lactams, and tetracycline. Streptomycin and sulfisoxazole had 
nearly 100% agreement. The disagreements in sulfisoxazole typing were observed among 
susceptible phenotypes harboring sul1 and sul2 resistance genes. The NARMS cutoff value of 
sulfisoxazole resistance is >= 512 mg/L, and susceptible is <= 256 mg/L; meanwhile, the 
three isolates which were classified as susceptible had MIC values = 256, which is on the 
border of resistant and susceptible. Tyson et al. studied the genotypic cutoff values of 
Salmonella, and they too had a single isolate that was detected with sulfisoxazole resistance 
mechanisms, but had a MIC value <= 256 mg/L [132]. The possibility is that these three 
isolates had lower expression of resistance phenotypes. The other possibility is that there was 
an error reading the microbroth dilution plates. Overall, the agreement between resistance 
genotype and phenotype was very high, which supports the previous studies that suggest that 
WGS can be used as a surveillance alternative for phenotypic resistance determination [132, 
136, 315].  
All of the S. Reading isolates were carrying IncA/C2 plasmids and four isolates were 
detected with an additional IncI1 plasmid. The resistant genes detected in S. Reading were 
located on the IncA/C2 plasmid, which is consistent with previous studies suggesting that the 
ACSSuT+cef phenotype encoding genes are commonly carried on IncA/C2 plasmids [200, 
343]. We closed an IncA/C2 plasmid (contig_04) and had a 99% match with plasmid pSN254b 
by BLASTn search, originally isolated with an Aeromonas salmonicida [336]. Our plasmid also 
matched multiple other reported plasmid sequences isolated from E. coli, S. Anatum, and S. 
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Newport, to list a few. The dot plot analysis showed almost complete match of sequences 
between our plasmid and pSN254b, when compared with another two plasmids derived from S. 
Newport and S. Anatum [200]. This result showed that this plasmid has broad bacterial host 
range (A. salmonicida, E. coli and Salmonella enterica) among those Enterobacteriaceae which 
are commonly associated with mammals and fish.  
In a previous study, Cottell et al. reported that the blaCTX-M-32 gene was detected from an 
IncN plasmid in E. coli from the same cattle population [202]. However, in our Salmonella 
population, neither the blaCTX-M-32 gene nor IncN plasmids were detected. Even though IncN is 
an average sized plasmid (30-70kb) and has a broad bacterial host range [344], our results 
suggest that these IncN plasmids were not shared among Salmonella and E. coli among these 
cattle, assuming that the Salmonella we have detected are representative of the Salmonella 
population. Six isolates were carrying an IncY plasmid. It is worth noting that, recently, an IncY 
plasmid was detected with the plasmid-mediated colistin resistant gene (mcr-1) from Salmonella 
in China [345]. When the genome assembly was conducted with the Velvet assembler, the IncY 
plasmid was not detected; however, the plasmid was detected by SPAdes assembly. This can be 
due differences in the assembler algorithms.  
Salmonella Reading is commonly reported in cattle but not in humans; however, 
occasional outbreaks have been reported in North America from alfalfa sprouts and dog food 
[346-348]. Few cases have resulted in hospitalization and septicemia [346, 348]. The most 
common animal reservoirs are turkeys and pigs. Isolates from our study clustered separately 
from S. Reading derived from turkey, but clustered closely to the one isolate from a pork 
chop. Interestingly, the isolates also clustered more closely to a human-derived strain from 
Taiwan. S. Reading is suspected to be polyphyletic as was reported in a previous study [107], 
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which is also supported by our data. Polyphyletic serotypes are those derived from a 
genetically distinct ancestor. In Salmonella, this can occur easily by the recombination 
between different serotypes. As our S. Reading isolates were distinct from those from derived 
from turkey, it is important to investigate the phylogenetic relationship of isolates, especially 
in outbreaks.   
The core-genome coverage of our S. Reading isolates was 97%, which implies clonal 
expansion. We identified two clusters (Cluster 1 and 2) and two sub-clusters (Cluster 1a and 1b) 
within Cluster 1. The major differences between Cluster 1 and Cluster 2 was a polymorphism in 
the modC gene. When isolates were classified by treatment group, Cluster 1a and 2 contained 
only isolates derived from animals treated with CTC or CCFA & CTC. CTC treatment was 
significantly (P < 0.05) associated with cluster. Isolates from Cluster 1b and 2 were detected 
from multiple pens and from both replicates, which implies the Salmonella were not 
proliferating only in one animal or pen, or at a single period of time. Additionally, a few 
animals carried both Cluster 1 and 2 isolates, and therefore it is not likely that mutations 
occurred in situ because of the antibiotic treatment. Therefore, two clusters of S. Reading with 
polymorphisms in modC may have resided in the cattle or the environment initially and were 
selected for by the CTC treatment.  
Further analyses, by including larger datasets of S. Reading sequences, are needed to 
explore whether the isolates with modC polymorphisms were favored by CTC treatment. It is 
also necessary to confirm the mutations by analyzing with different assemblers and variant 
callers to remove the possibility of artifact. Cluster 1b and 2 isolates may have a fitness 
advantage over Cluster 1a in the microbiota affected by the CTC treatment; however, both 
Cluster 1 and 2 were detected without temporal association. The animals carrying S. Reading 
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were not always detected with S. Reading even after antibiotic treatment; in a similar manner, 
after CTC treatment, Cluster 2 isolates were not always detected from animals that carried both 
Cluster 1 and 2 isolates. Mao et al. have shown that when mutant phenotypes were in the 
population at 0.001% rate, after selection by antibiotics, they proliferated to 0.5%; further, with 
two or more successive selection, they were able to proliferate to 100% [349]. The CTC 
treatment may have been confounded by other factors which helped expand both clusters 1b and 
2.  
A detailed investigation of the potential association between modC and antibiotic selection 
was not performed here. However, previous research shows that tetrathionate, which Salmonella 
utilize as respiratory electron acceptor, contains a molybdopterin cofactor. This molybdopterin 
cofactor derives from molybdenum that is metabolized in the bacteria. Since the modC gene is 
part of the modABC, a molybdenum transporter, the intake of isolates in Cluster 2 may provide 
an advantage over other isolates when the microbiota is disrupted by CTC. Although our results 
are limited by isolate numbers, the genomic comparisons suggest that antibiotics may be 
selecting for a subpopulation within those resistant isolates that have survived the antibiotic 
treatments. If the CTC treatment continued, or else the animals were given other antibiotics for 
disease treatment at a later date, this subpopulation may increase.   
Salmonella Kentucky is most common serotype isolated from poultry sources in the 
United States [109]. ST152 and ST198 are the most common sequence types [109, 350, 351]. 
Haley et al. compared 119 isolates of poultry and cattle derived S. Kentucky, which showed 
that the majority of them were ST152 while only 12 were ST198. In the EnteroBase database, 
only around 5% of the S. Kentucky isolates are ST198 and the sources varied from poultry, 
humans, the environment, and livestock. In our study, only ST198 strains were identified, 
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which is interesting considering that most of the S. Kentucky from food animals in the United 
States are ST152. In previous study, within ST198, the authors identified two clusters based 
on the XbaI-PFGE profiles and phylogenetic tree analysis (198.1 and 198.2) [109, 350, 351]. 
The ST198.1 cluster contained isolates derived from dairy cattle feces, a milk filter from 
Florida, and ground turkey from California; meanwhile, ST198.2 contained isolates from 
human clinical cases [109]. All our S. Kentucky derived from cattle clustered with ST198.1, 
which corresponds with the previous result. Recently, there has been concern with an increase 
of S. Kentucky with high-level resistance to ciprofloxacin in Europe, Africa, and the Middle 
East, The source of this increase has been attributed to international travel to Europe from 
Africa and the Middle East, with poultry identified as a potential major vehicle [350, 352]. All 
ciprofloxacin resistant isolates belonged to ST198-X1 in the previously described study, 
which had mutations in the gyrA and parC genes leading to ciprofloxacin resistance [350]. 
Although it is not clear if ST198-X1 belongs to 198.1 or 198.2, it may be a public health 
concern.  
Cattle in our study were derived from a single source and only one S. Kentucky isolate 
was a multidrug resistant phenotype carrying the corresponding resistance genes (aadA7-
truncated, sul1, and tet(A)). The isolate carried an IncI1 plasmid and it is likely that the 
resistance genes were carried on the plasmid based on plasmidSPAdes results and annotation. 
Although this isolate did not have ciprofloxacin resistance, further caution may be needed for 
acquiring other resistant genes including ciprofloxacin resistant genes.   
 Salmonella Give was detected with distinct 6 clusters. S. Give has been isolated 
from dairy farms, water, opossum feces, and soil [353]. It is important to note that these 
antibiotic susceptible serotypes survived treatment by CCFA and CTC, absent the selective 
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advantages provided by antibiotic resistant genes. Salmonella can become persistent and 
survive inside infected host cells by forming Salmonella-containing vacuoles. Even after S. 
Reading dominated the population, we did not observe any other serotypes carrying IncA/C2 
plasmids nor resistant genes that S. Reading were carrying. It may simply because most of 
other susceptible serotypes were killed (or, suppressed) by the antibiotics and S. Reading did not 
have conjugal partners with whom to transfer the plasmids. Even if other serotypes with 
resistance determinants existed post-treatment, they might not have been detected because S. 
Reading was the dominant MDR strain. Antibiotics are known to induce recombination and 
lateral transfer of the genes via SOS response [354]. For example, in E. coli O157:H7, 
fluoroquinolones trigger the expression of prophage genes and promote the transfer of prophages 
[354]. However, it has also been shown that some antibiotics can inhibit conjugation and 
stimulate plasmid curing [354]. Although the mechanisms are not known yet, Salmonella can 
survive inflammatory response caused by antibiotics in the host.  The mechanisms of how these 
susceptible Salmonella survived the antibiotic treatments may be answered by analyzing the 
gene expression data.  
There was no clear temporal relationship among the genomes of the isolates, which implies 
no mutations had occurred as a result of the antibiotic treatments within this studied period. 
Since the mutation rate is estimated as 5.3-3.9x10-7 substitutions per site per year in S. Kentucky 
and S. Agona, this was not surprising [355]. Among wild type E. coli, the mutation rate is 1x10-3 
per genome per generation [356]. It has been shown that exposure of E. coli to long-term sub-
lethal levels of norfloxacin enhances the mutation rates and accelerates adaptation to the 
environment. Further, among E. coli exposure to b-lactams induces the dpiBA operon and the 
dpiA effector binds to the chromosomal replication origin and inhibits replication [354]. This 
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process induces a SOS response which increases genetic variability [354]. Antibiotics can 
increase reactive oxygen species (ROS) in the bacteria, which can damage proteins, lipids, and 
DNA and accumulate mutations in the bacteria. However, Salmonella rapidly change the outer 
membrane permeability by opening or closing the OmpA and OmpC proteins to defend against 
oxidative stress caused by antibiotic treatments [357]. Subinhibitory concentrations of 
tetracycline do not induce an SOS response in E. coli but do induce a response in Vibrio cholerae 
[357].  
These previous studies were conducted in vitro, where direct effects of ROS were measured. 
Our Salmonella resided naturally in the cattle where various and complex host and 
environmental factors, such as the presence of background microbiota, could confound the 
effects of ROS. We also did not follow a single strain of Salmonella as in the inoculation studies, 
and we collected only a single isolate per animal per day, which limits our ability to investigate 
the mutation rate in this study. In order to further investigate the effects of antibiotic exposures 
on the mutation rates of Salmonella in cattle, we would need to collect multiple isolates per 
animal per day and explore the genetic differences between isolates before and after treatment. 
In this chapter, we explored the genomic characteristics of the isolates derived from this 
study population. The resistance genotypes matched with the resistance phenotypes. S. 
Reading was the MDR strain that increased as a result of the antibiotic treatments. Via the 
hybrid Oxford Nanopore MinION and Illumina assembly, we found the resistance genes were 
located on an IncA/C2 plasmid. The IncA/C2 plasmid almost completely matched with an 
Aeoromonas salmonicida derived IncA/C2 plasmid, pSN254b. The genomic comparison 
among the isolates from this study and from publicly available sequences on NCBI showed 
that the S. Reading isolates from this study are clustered differently from those isolated from 
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turkeys and other sources. The S. Reading population was divided into 2 major clusters by 
core-genome-alignment based SNPs, and the cluster membership of isolates was associated 
with CTC treatment. The SNPs responsible for the differences in forming these two clusters 
were located on the modC gene. Most of other serotypes were clustered into 3 to 4 groups. S. 
Give was divided into 6 clusters, which was the most diverse serotype in our study. However, 
in these serotypes the antibiotic treatments were not associated with cluster formation. No 
temporal relationships were observed among all the isolates within the same serotypes in our 
studied period. Mutation induced by antibiotics use was not observed in this study; however, 
antibiotics may be selecting for certain pre-existing populations of resistant Salmonella.  
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CHAPTER VI 
SUMMARY, CONCLUSIONS, AND FUTURE DIRECTION 
In this research, we evaluated the effects of ceftiofur crystalline-free acid (CCFA) and 
chlortetracycline (CTC) treatment on Salmonella populations in feedlot cattle by examining 
the prevalence (both overall and multidrug resistant (MDR)), antimicrobial susceptibility, 
quantification, and genomic comparisons of isolates.  
The prevalence of Salmonella in the studied population was around 70% at the beginning 
of the study. The prevalence was suppressed by both CCFA and CTC treatments. Especially 
evident with the CTC treatment, the prevalence of Salmonella decreased but the proportion of 
MDR Salmonella increased. Among 566 isolates, from 1,040 fecal samples, 87 isolates were 
of MDR Salmonella. Among them, 86 MDR Salmonella isolates were phenotypically resistant 
to aminoglycoside, sulfonamides, chloramphenicol, tetracycline, and b-lactams, which were 
all S. Reading. One S. Kentucky was also an MDR strain. Most of the phenotypically resistant 
isolates were carrying corresponding resistance genes (aadA7, strA, strB, sul1, sul2, floR, 
blaCMY-2, tetA). All of the S. Reading isolates were detected with an IncA/C2 plasmid and a 
few harbored an IncI1 plasmid. The resistant genes detected in S. Reading were located on the 
IncA/C2 plasmid. Five other serotypes S. Anatum, S. Give, S. Kentucky, S. Mbandaka, S. 
Montevideo also were detected, which were determined by WGS. One to five serotypes were 
detected per studied animal. However, serotype distribution was not associated with treatment 
group and day.  
Similar to prevalence, quantity of Salmonella decreased following the antibiotic 
treatments. Phenotypically, ceftriaxone and tetracycline resistant Salmonella were isolated 
from Day 0 fecal samples, which illustrated that resistant isolates were present before the 
 
 263 
antibiotic treatment started. The quantities of phenotypically ceftriaxone- and tetracycline-
resistant isolates were approximately 104 in the animals that were detected on Day 0, and 
remained at the similar level throughout the study period. Together with the prevalence study, 
we have shown here that antibiotic treatments decrease the number of animals detected with 
Salmonella but increase those detected with MDR Salmonella. These results raise a public 
health concern in that resistant Salmonella can possibly enter the slaughterhouse, especially 
considering the withdrawal period of CCFA is 13 days and CTC is 7 days in feedlot cattle. 
However, one of the pens in the All-CCFA & CTC treatment group had more animals 
shedding resistant Salmonella constantly, while in the other pens, no animals were shedding 
over LOQ. This shows that pen level differences in shedding resistant Salmonella could be 
very important. 
The genomic study revealed that the serotypes detected in our study cluster with publicly 
available bovine derived sequences in S. Anatum, S. Montevideo, S. Give, and S. Kentucky. S. 
Reading clustered with pork chop- and human-derived isolates. S. Mbandaka clustered with a 
chicken breast-derived isolate. However, the publicly available isolates were limited. Even 
though 95% of the genomes were shared within the same serotypes, isolates further clustered 
into 2 to 6 clusters within the same serotype. In S. Reading, two major clusters were 
associated with CTC treatment. The SNPs responsible for the cluster formation in S. Reading 
were located on the modC gene, which encodes the molybdenum import ATP-binding protein. 
Although the correlation between this gene and antibiotic use is not known yet, this result 
indicates unknown effects of antibiotics on genes unrelated to antibiotic resistance, which 
may lead to new treatment strategy. Among the other serotypes, no associations between 
antibiotic treatments and cluster formations were observed.  
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